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ABSTRACT 
 
Metal-Catalyzed Carbon-Carbon Bond Forming Reactions for the Synthesis of 
Significant Chiral Building Blocks. 
 (May 2011) 
Alejandro Bugarin Cervantes, B.S., Universidad Autonoma de Zacatecas, Mexico;  
M.S., The University of Texas at El Paso 
Chair of Advisory Committee: Dr. Brian T. Connell 
 
 Morita Baylis-Hillman (MBH) reaction a carbon-carbon bond forming reaction 
between an α,β-unsaturated carbonyl and aldehydes or activated ketones in the presence 
of a nucleophilic catalyst. The MBH reaction is an atom-economical method of rapid 
increase of molecular complexity. The development of this process has received 
considerable attention in recent years. This dissertation presents the development of a 
new catalytic system for the symmetric and asymmetric MBH reaction. The new system 
for the racemic version of this reaction was accomplished employing a 1:1:1 ratio of 
catalytic amounts (10 mol%) of MgI2, TMEDA and DMAP and proved to be highly 
effective. For the asymmetric version was developed a highly enantio-selective system 
based on Fu’s planar chiral DMAP derivative (II) with ee´s up to 98%. Abnormal MBH 
adducts are obtained employing either ethyl 2,3-butadienoate or ethyl propiolate in good 
yields, in the presence if MgI2 and either a tertiary amine or phosphine as the 
nucleophile. The α,β-unsaturated carbonyls where prepared by a modified direct α-
 iv 
methylenation using paraformaldehyde, diisopropylammonium trifluoroacetate, and 
catalytic acid or base with excellent yields for several carbonyls compounds. 
The Negishi cross-coupling reaction is the Pd or Ni-catalyzed stereoselective 
cross-coupling or organozincs and aryl-, alkenyl-, or alkynyl halides. Enantioselective 
Negishi cross-coupling of aryl zincs and α-bromo ketones was accomplished employing 
a NCN Pincer complex as the catalyst with ee´s up 99%. The required pincer complexes 
have been prepared by the oxidative addition of pincer ligands with palladium or nickel.  
Additionally, It has been developed a direct and highly active, (NCN)-Pd 
catalytic system for the α-arylation of ketones with a variety of aryl bromides using the 
air and moisture stable [t-BuPheBox-Me2]PdBr (XVI) as the catalyst. The adducts are 
obtained in excellent yields (92% average for 20 examples) in only 1 hour using 1 mol% 
of catalyst loading. Perhaps more importantly, the work described here shows that XVI 
is highly reactive, highly selective, even on substrates bearing challenging functional 
groups such alkenes.  
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NOMENCLATURE 
 
COD Cyclooctadiene 
EtOAc Ethyl Acetate 
DABCO 1,4-diazabicyclic[2.2.2]octane 
DBU 1,8-diazabicyclic[5.4.0]undec-7-ene  
DMAP 4-N,N-dimethylaminopyridine 
DMF N,N-dimethylformamide 
DMSO Dimethyl sulfoxide 
MBH Morita Baylis Hillman 
Me Methyl 
Ni Nickel 
TBDPS t-butyldiphenylsilyl 
TBS t-butyldimethylsilyl 
TFA Trifluoroacetic acid 
THF Tetrahydrofuran 
TMS Trimethylsilyl 
PheBox Phenyl oxazoline core 
Pd2(dba)3 Tris(dibenzylideacetone)dipalladium 
Pyr Pyridine 
rt Room temperature (18–22 ºC) 
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CHAPTER I 
INTRODUCTION 
 
1.1 MgI2 Catalyzed Symmetric and Asymmetric MBH Reaction  
 
The development of efficient and selective carbon-carbon bond-forming 
reactions, particularly with control of absolute stereochemistry, continues to be an area 
of intense research in organic chemistry. The Morita-Baylis-Hillman (MBH) reaction, 
first reported in 1968,1 is an important carbon-carbon bond-forming reaction between 
electron-deficient alkenes, such as α,β-unsaturated ketones, and carbonyl compounds 
(aldehydes or ketones). This transformation is usually catalyzed by nucleophilic tertiary 
amines or phosphines.2 
In the seminal report,1 Morita and coworkers reported the first nucleophilic 
triggered acrylic α-substitution catalyzed by phosphines. Treatment of acrylonitrile with 
catalytic amounts of tricyclohexylphosphine in the presence of aldehydes produced the 
corresponding adducts (scheme 1.1). However, the chemical yields were only modest 
(<23%) and substrate scope was limited. If one equivalent of Ph3P was used instead, the 
corresponding Wittig products predominated (E-alkenes).  
Scheme 1.1 Phosphine catalyzed MBH reaction. 
 
CN
R
O
H
+
R
OH
CN
Cy3P (cat)
120 ºC, 2h
 
____________ 
This dissertation follows the style of Journal of American Chemistry Society. 
 2 
In 1972, a German patent filled by A. B. Baylis and M. E. D. Hillman from the 
Celanese Corporation described a new method for the synthesis of acrylic compounds, 
which involved the reaction of α,β-unsaturated carboxylic acid derivatives and aldehydes 
catalyzed by tertiary amines (Scheme 1.2).3 The Baylis-Hillman approach featured high 
conversions and yields, broad scope with respect to substrates and catalysts tolerance, as 
well as wide temperature range (0-200 ºC). However, the rate of reactions at room 
temperature or lower was slow (days). 
Scheme 1.2 Amine catalyzed MBH reaction. 
 
R1
O
H
+
R1
OH
3º amine
R2
O O
R2
 
 
Over the last three decades,2,4 the MBH reaction has evolved into one of the most 
useful carbon-carbon bond-forming reactions in organic synthesis and several variations 
of the three essential components have been reported, including several enantioselective 
variants. The three essential components are an activated alkene, an electrophile and a 
nucleophilic catalyst (Scheme 1.3). The most effective catalysts are nucleophilic 
unhindered tertiary amines like DABCO, quinuclidine and pyrocoline.2  
Scheme 1.3 Components of the MBH reaction. 
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N N
DABCO Quinuclidine Pyrocoline  
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The MBH reaction has a broad scope and tolerates several activated alkenes 
including alkyl vinyl ketones,5-7 alkyl and aryl acrylates,8-10 acrolien,11,12 allenic esters,13 
acrylonitriles,6,14 vinyl sulfones and sulfonates,15,16 as well as vinyl phosphonates17 on 
reactions with aldehydes at atmospheric pressure and using tertiary amines like DABCO 
as catalyst (Scheme 1.4). As can be expected, β-substituted alkenes with bulky groups 
require higher pressures and extended reaction times. On the electrophilic component, 
aldehydes, α-keto-esters and fluorinated ketones are known to react at atmospheric 
pressure; however, ketones are inert at this pressure and often require high pressures. 
 
Scheme 1.4. Scope of the MBH reaction with several activated alkenes. 
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Some of the advantages of the MBH reaction include formation of carbon-carbon 
bond under mild conditions, broad scope of substrates (both alkenes and electrophiles). 
It is atom economical and the products of MBH reactions are usually highly 
functionalized and hence can be used as components of further transformations such as 
aldol, Michael, and Diels-Alder reactions, or 1,2- additions, among others. This in turn 
can lead to the synthesis of complex molecules including natural products and other 
biologically important materials. The mechanism of the MBH reaction is believed to 
proceed through a conjugate addition followed by an aldol addition, and then β-
elimination (Scheme 1.5).18  
Scheme 1.5. Mechanism of the MBH reaction. 
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The first step in the catalytic cycle is a Michael-type addition of the tertiary 
amine or phosphine to the activated alkene that produces a zwitterionic enolate, which 
then adds to the aldehyde. After a proton transfer, the product and catalyst are released 
by a β-elimination (Scheme 1.5). 
 Since the MBH reaction forms a new stereogenic center, any of three essential 
components; the activated alkene, the electrophile or the nucleophilic catalyst, can be 
used to control the absolute stereochemistry. Chiral auxiliaries have been combined with 
activated alkenes and successfully applied in asymmetric MBH reactions. One of the 
most impressive examples is that of Leahy,19 in which the use of camphor derived 
sultam and two equivalents of aldehyde formed the corresponding dioxanone. In this 
transformation the chiral auxiliary was cleaved in situ. The dioxanone was then 
converted into the MBH adduct by treatment with mild acids in methanol (Scheme 1.6). 
Scheme 1.6 Substrate control in the MBH reaction. 
N
S
O
O
O
O
O
O
RR
R
O
H+
DABCO
CH2Cl2
MeO
O OH
R
CSA
MeOH
33-98% yield
>99% ee  
 Chiral non-racemic electrophiles have been used as well in the asymmetric MBH. 
A chiral glycoxylate derived from 8-phenylmenthol was shown to induce good 
diasteroselectivities and also provided high yields in diastereoselective MBH reactions 
under Kataoka modified reaction conditions (Scheme 1.7).20 
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Scheme 1.7 Chiral auxiliaries in the MBH reaction. 
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Me
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O Me
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Me
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78% yield, >95:5 dr  
Various attempts to accelerate this reaction through the use of chiral catalysts, 
cocatalysts, and a chiral medium have been studied.4 Hatakeyama reported a chiral 
quinidine-derived catalyst for the reaction of a highly activated acrylate with aldehydes, 
providing the corresponding adducts with ee values up to 99%.21 Connon was the first to 
use thioureas to accelerate the DABCO-promoted MBH reaction.22 Recently, several 
other thiourea-derived23-27 and BINOL-derived28-30 systems have been reported. Each of 
these methods has been limited in substrate scope to varying extents. 
 By far, the most appealing approach to the asymmetric MBH reaction is the use of 
chiral catalysts. However, most of the catalytic systems reported so far are not general 
and suffer from low yields and enantioselectivities as well as the need for high pressures 
and long reaction times. Among the best catalyst reported to date are Cinchona alkaloid 
derivatives,21 C-2 symmetric DABCO derivatives31 and some chiral Lewis acids32,33 
(Scheme 1.8). 
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Scheme 1.8. Catalytic asymmetric MBH reactions. 
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 In general, all of these approaches faces certain limitations, and although there 
have been significant improvements in this area. A general enantioselective version of 
the MBH reaction has yet to be developed.  
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1.2 Results and Discussion 
 
1.2.1 Acceleration of the MBH Reaction  
 
The possibility of improvements in the chemistry of the MBH reaction prompted 
us to develop a catalytic system for the MBH reaction, which would be amenable to 
asymmetric catalysis in a straightforward manner (i.e., by using a chiral catalyst). In our 
initial studies, we identified several Lewis acidic metal salts, which were capable of 
catalyzing the reaction of benzaldehyde (1) with cyclopentenone (2) in the presence of 
TMEDA and a catalytic Lewis base (DMAP). Several metal salts NiCl2, PdCl2, SnCl4, 
LiCl, LiClO4, Cu(OTf)2, and SmI2 were found to catalyze MBH reaction under these 
conditions; however, the yields were generally low and/or required extended reaction 
times. No reactions were observed when Zn(II) halides were employed. When the more 
reactive Zn(OTf)2 was used, quantitative dimethylacetalization of 1 was observed 
(Scheme 1.9).  
To our delight, we found Mg(II) salts to be quite reactive, with MgI2 being  more 
reactive than its congeners MgBr2 and MgCl2. 
 
Scheme 1.9 Dimethylacetalization of benzaldehyde. 
Ph
O
rt, 15 h
1 equiv 1.1 equiv
DMAP, MeOH Ph
O
OMe
OMe
Zn(OTf)2, TMEDA
H
1 2 3, 100%
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We then focused our attention to find potential nucleophilic catalysts that were 
compatible with the combination of Lewis acidic MgI2 and TMEDA. Our initial 
screening included DABCO, DBU, triethylamine, Hünig's base, and pyridine. We 
observed that the strong base DBU deactivated the catalyst, whereas weak nucleophiles 
like triethylamine and pyridine showed very low reaction rates and Hünig's base did not 
promoted the reaction at all. We were pleased to find that the use of MgI2 and DMAP as 
catalytic partners dramatically accelerated the MBH reaction. 
Table 1.1. MBH reaction between cyclopenten-2-one and benzaldehyde in the presence 
of MgI2, TMEDA, and DMAP.a 
Ph
O
1 equiv 1.1 equiv
O
H
1 2 rt, 15 h
DMAP, MeOH
Ph
OH O
MgI2, TMEDA
Entry
1
2
3
4
5
6
MgI2 (%)
10
10
20
–
DMAP (%)
10
–
NR
91
36
54
TMEDA (%)
NR
Yieldb (%)
–
10
10
10
–
–
10
10
–
20
–
10
NR
4
 
a The reactions were performed with 0.5 mmol of 1, 1.1 equiv of 2, in 
1.5 mL of MeOH at rt for 15 h. b Isolated yield after purification by 
silica gel chromatography. 
 
No reaction was observed between 1 and 2 in the absence of MgI2 (10 mol% 
DMAP or 10 mol% TMEDA) in MeOH (Table 1.1). However, the addition of 10 mol% 
MgI2 to the reaction mixture afforded the adduct (4) in low yield when combined with 
either 10 mol% DMAP (36% yield) or 10 mol% TMEDA (54% yield). Increasing the 
amount of DMAP present provided no improvement in reaction yields. On the other 
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hand, the use of equimolar amounts of Lewis acid, ligand, and Lewis base in the system 
afforded the adduct in 91% yield (Table 1.1, entry 4).  
After we identified the optimal Lewis acid and nucleophile catalysts for the 
MBH reaction between 1 and 2, the effect various solvent systems was investigated. We 
observed that the reaction was faster in protic solvents like MeOH than in THF, EtOAc, 
CH2Cl2 or dioxane. Although beneficial in other systems,34 a mixed solvent system of 
MeOH–H2O also afforded lower yields in this system (Table 1.2). 
Table 1.2. Solvent optimization.a 
Ph
O
1 equiv 1.1 equiv
O
H
1 2
MgI2, 10 mol%
Solvent, rt, 15 h
TMEDA, 10 mol%
DMAP, 10 mol%
OH
Ph
O
4
Entry Yieldb (%)Yielda (%)
1
2
9
12
Toluene
Benzene
3 28THF
4 39CH2Cl2
5 46MeCN
6 54Pyr
MeOH/H2O
Solvent Solvent
69
72
NR
76
63
91
Et2O
EtOAc
H2O
MeOH
EtOH
Entry
7
8
9
10
12
13  
a The reactions were performed with 0.5 mmol of 1, 1.1 equiv of 2, 0.1 
equiv of each catalyst, in 1.5 mL of solvent at rt for 15 h. b Isolated 
yield after purification by silica gel chromatography. 
 
Having optimized the reaction conditions for the MBH reaction between 1 and 2, 
we then investigated the scope of the MgI2/TMEDA/DMAP-catalyzed MBH reaction by 
exploring a variety of electrophiles (Table 1.3).  For electron-deficient aldehydes, the 
system was very efficient; the MBH adduct of p-nitrobenzaldehyde and cyclopentenone 
(5) was obtained after only 5 hours in 94% yield. Additionally, this system afforded 
reasonable yields for electron-rich aldehydes. The MBH adduct for the aromatic 
aldehyde p-methoxybenzaldehyde (6) was obtained in 67% yield, and the MBH adducts 
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for the aliphatic aldehydes cyclohexane carboxaldehyde (8) and isobutyraldehyde (9) 
were obtained in 66% and 62% yield, respectively (Table 1.3). The system was also 
efficient for α,β-unsaturated aldehydes; the MBH adduct for trans-cinammaldehyde (10) 
was obtained in 93 % yield. It is worth to mention that the lower yields obtained for 
several of the MBH adducts was the result of incomplete reaction. The presence of 
starting materials was observed after 15 hours for all entries with yields lower that 90%. 
This reaction time of 15 hour was used as benzaldehyde, a moderately reactive aldehyde 
with neither electron-rich nor electron-poor characteristics, was completely consumed 
after this time period. By performing all reactions in this 15 hours time window, we 
could compare the effects of electron-donating or electron-withdrawing functionalities 
on the rate of reaction. 
Table 1.3. Scope of the MBH reaction of cyclopenten-2-one.a,b 
R
O
1 equiv
1.1 equiv
R
O OH O
H
MgI2, 10 mol%
MeOH, rt, 15 h
TMEDA, 10 mol%
DMAP, 10 mol%
OH O
Me
Me
OH O
62%66%, 91% 48 h
OH O
94% 5 h
OH O
67%, 83% 48 h
O2N MeO
OH O
Ph
OH O
Ph
93%89%
1
5 6
987
10
OH O
91%
4
2
4-10
 
a The reactions were performed with 0.5 mmol of aldehyde, 1.1 equiv of 2, 0.1 equiv of 
each catalyst, in 1.5 mL of MeOH at rt for 15 h. b Isolated yield after purification by silica 
gel chromatography. 
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Table 1.4. MBH reaction of benzaldehyde.a 
Entry Yieldb (%)Enone/Enoate Product (#)
O
Me
Me
Ph
OH O
Me Me
Ph
OH O
Me Me
75
91
O
Me Me
86
84
89
O
1
2
3
4
5
Ph
OH O
S
O
S
6c
O
O
53
Ph
OH O
47
78
O
O
7c,d
Ph
OH O
O
92
Ph
OH O
O
O
Ph
OH O
56
Time (h)
15
15
48
15
48
15
15
48
2
1
MgI2, 10 mol%
Ph
O
MeOH, rt1 equiv 1.1 equiv
O
R1
R2
R1
O
TMEDA, 10 mol%
DMAP, 10 mol%
11–17
H
OH
Ph
R2
time
11
12
13
14
15
16
17
1
 
a The reactions were performed with 0.5 mmol of benzaldehyde, 1.1 
equiv of enone/enoate, 0.1 equiv of each catalyst, in 1.5 mL of 
MeOH at rt for 15 h. b Isolated yield after purification by silica gel 
chromatography.c EtOH solvent; d Reaction performed at –15 °C. 
 
To further examine the scope and utility of these catalytic reaction conditions, a 
variety of α,β-unsaturated ketones, esters and thioesters were treated with 1 under our 
optimized reaction system conditions (Table 1.4). Again, most reactions were quenched 
after 15 hours for comparison purposes, although starting material was still remaining. In 
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all cases, the reaction proceeded smoothly in the presence of catalytic amounts of 
equimolar Lewis acid, ligand, and the nucleophile and afforded the corresponding 
adducts in good to high yields at room temperature.  
Notable examples from Table 1.4 included reactions with γ-disubstituted enones 
such as 4,4-dimethylcyclopenten-2-one and 4,4-dimethylcyclohexen-2-one (Table 1.4, 
entries 1 and 3), which gave 86% and 75% yield respectively, after 15 hours. 
The reactivity of the MBH reaction was also demonstrated for cyclic enones, which 
contain five, six and seven member rings (Table 1.4) in moderate to high yields of 91%, 
84%, and 56%, respectively. 
Scheme 1.10 Reaction of cyclohexen-2-one and salicylaldehyde. 
O
sonification
DABCO, 50 mol%
Water, rt, 48 h
OH
O
OH
O
83%
H
MgI2, 10 mol%O
MeOH, rt, 15 h
1 equiv 1.1 equiv
TMEDA, 10 mol%
DMAP, 10 mol%
OH
O
O
O
77%
H
O
O
–H2O
OH
18 19
20
21
18 19
21
 
Bräse and coworkers have previously reported the synthesis of xanthenes starting 
from 2-hydroxybenzaldehydes and 2-cyclohexenone using DABCO as catalyst.35 He 
employed DABCO (50 mol%) as a catalyst in water under sonification conditions to 
obtain 2,3,4,4a-tetrahydro-1H-xanthen-1-one (21) in 83% yield after 48 h by a presumed 
sequence of MBH, conjugate addition, and elimination reactions. When we investigated 
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this sequence under our reaction conditions, we obtained the product 21 in 77% yield in 
significantly less time (15 hours) and under milder reaction conditions (Scheme 1.10).  
Scheidt and coworkers had published several articles regarding the addition of 
silyloxyallenes to aldehydes trying to solve the poor reactivity of enones, specially β–
substituted.36-38 We envisioned that our catalytic partner could also help to solve this 
limitation. Unfortunately the dual catalytic system was not capable of accelerating the 
Morita-Baylis-Hillman reaction of acylic enones or acrylates with aldehydes. 
 
1.2.2 Enantioselective MBH Reaction 
 
The development of an asymmetric version of the MBH reaction has attracted 
considerable interest in recent years,4 driven by the easy accessibility of starting 
materials and the potential of the poly-functionalized adducts, that can be used as 
components of further transformations in the synthesis of complex molecules. 
The mechanism of the MBH reaction allows the use of a Lewis acid cocatalyst to 
increase reaction rates.18,39-41 For example, In 2009 we reported a mild reaction system 
employing a 1:1:1 ratio of catalytic amounts (10 mol%) of MgI2, TMEDA and DMAP to 
accelerate the rates of the MBH reaction between cyclic enones and enoates with 
aldehydes in methanol.42 Based on this protocol, we studied an enantioselective process 
utilizing cyclopentenone as a substrate. MBH adducts of cyclopentenone have potential 
utility towards the total synthesis of natural products containing cyclopentenone or 
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cyclopent(en)yl moieties, including Lathyranoic acid A and Euphorbia factor L11,43 as 
well as Acutaxyline A and B (Figure 1.1).44 
Me Me
Me
CO2HOBzOAc
Me
O
Lathyranoic acid A Euphorbia factor L
Me
Me
Me
OBz
AcO
Me
HO
O
BzO
H
H
H
O
Me
Me
O
Me
H
H
Me
HO MeMe
OAc
H
CO2Me
O
Me
Me
O
Me
H
H
Me
HO MeMe
OH
H
CO2Me
Acutaxylines A Acutaxylines B
HO
 
Figure 1.1 Natural Products containing cyclopentenone or cyclopent(en)yl moieties. 
 
Our initial studies identified chiral nucleophiles (Figure 1.2), which were capable 
of catalyzing the reaction of trans-cinnamaldehyde with cyclopentenone in the presence 
of catalytic MgI2 (Table 1.5). TMEDA and several chiral TMEDA-equivalent ligands45 
were also screened, but they resulted in low enantioselectivity due to a reasonably high 
background reaction rate. Lewis acids other than MgI2, including NiCl2, SnCl4, LiCl, 
LiClO4, Cu(OTf)2, and Zn(OTf)2, showed poor or no reactivity under these conditions. 
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N
NMe2
FePh Ph
PhPh
Ph
N
N
FeMe Me
MeMe
Me
Fu (+)-PPY, I Fu (+)-DMAP, II
N
S
N
Ph N
N
S
Ph
(–)-Tetramisole, VI(–)-HBTM, V
N
OH
NH
(–)-Cinchonine, IV
FePh2P
Ph2P
NMe2
Taniaphos, III
 
Figure 1.2. Chiral amine catalysts examined as nucleophiles. 
 
Table 1.5 shows the catalytic activity of several chiral nucleophiles (I-VI)46-50 
towards the asymmetric MBH coupling of trans-cinnamaldehyde with cyclopentenone in 
the presence of 50 mol% MgI2. The reaction mediated by the most nucleophilic catalyst 
(Fu’s chiral PPY I) occurred with the highest yield (98%) but lower ee (81%) (Table 1.5, 
entry 1) than Fu’s less nucleophilic II, which delivered the product in a 96% yield and 
94% ee (Table 1.5, entry 2) Other catalytic nucleophiles showed lower enantioselectivity 
and reactivity (Table 1.5, entries 3-6). The chiral thiourea derived [(–)-HBTM V and (–)-
tetramisole VI] were also notably less reactive (Table 1.5, entries 5-6) than the DMAP 
derivatives I and II. 
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Table 1.5. Enantioselective MBH reaction between cyclopenten-2-one and trans-
cinnamaldehyde.a 
1
2
98
96
I
II
3 45III
4 89IV
5 5V
6 19VI
Entry Yieldb (%)Catalyst ee
c (%)
1 equiv 1.5 equiv
O
i-PrOH, –20 ºC
         24 h
10 mol% Catalyst
 50 mol% MgI2
O OOH
Ph Ph
81
94
54
45
63
48
H
22 2 (–)-10
 
a The reactions were performed with 0.075 mmol of 22, 1.5 
equiv of 2, 0.1 equiv of catalyst, 0.5 equiv of MgI2, in 1.5 mL of 
i-PrOH at –20 ºC for 24 h. b Isolated yield after purification by 
silica gel chromatography.c Enantiomeric excess determined by 
chiral HPLC. 
 
 With these results in hand, optimization of the reaction conditions utilizing 
catalyst II was carried out (Table 1.6). At –20 °C, no reaction was observed between 
trans-cinnamaldehyde and cyclopentenone in the absence of MgI2 (Table 1.6, entry 1). 
However, increasing the amount of MgI2 from 10 mol% to 50 mol% increased the yield 
of the reaction from 45% to 96% yield without having a dramatic effect on the ee (92% 
vs 94%) (entries 2 and 5). Intermediate quantities of MgI2 provided intermediate yields 
(entries 3 and 4). i-PrOH proved to be the best solvent, delivering the product in 
excellent yield while maintaining a high level of enantioselectivity as compared to 
MeOH and EtOH (entries 6 and 7). The use of less catalyst II (5 mol%) afforded a 
slower reaction but no loss of ee (entry 8), while 20 mol% of catalyst II was no better 
than 10 mol% (entry 5 vs 9). Higher reaction concentration had a negligible effect on the 
reaction (entry 10) while higher temperatures eroded the observed ee (entries 11 and 12). 
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Lower temperature slowed the reaction with no marked increase in enantioselectivity 
(entry 13).  
Table 1.6 Optimization of the enantioselective MBH reaction.a 
Solvent, –20 ºC
        24 h
Catalyst II, MgI2
O
Ph
OH
1
2
3 10 i-PrOH 45 92
4
5
20
50
i-PrOH
i-PrOH
57
96
93
94
6
7
8
9 50
50
i-PrOH
MeOH
50
93
89
98
94
77
53
10d 50 92 94
11e
Entry Yieldb (%)MgI2 (mol %) ee
c (%)SolventII (mol %)
12f
13g
50
50
i-PrOH
i-PrOH
97
94
70
91
50 39 95
10
10
10
5
10
10
20
10
10
10
i-PrOH
EtOH
i-PrOH
5
0
i-PrOH
i-PrOH
21
NR
80
NA
10
10
50 60 9410 i-PrOH
1 equiv 1.5 equiv
O
O
Ph H
22 2
(–)-10
 
a The reactions were performed with 0.075 mmol of 22, 1.5 equiv of 2, 0.1 
equiv of catalyst II, 0.5 equiv of MgI2, in 1.5 mL of i-PrOH at –20 ºC for 24 
h. b Isolated yield after purification by silica gel chromatography. c 
Enantiomeric excess determined by chiral HPLC d [c] = 0.1 M instead of 
0.05 M. e Reaction performed at 20 °C. f Reaction performed at 0 °C. g 
Reaction performed at –50 °C. 
 
We then investigated the scope of this enantioselective MBH reaction by 
examining a variety of electrophiles (Table 1.7). For aromatic aldehydes, the system was 
very efficient. The MBH reaction of 1-naphthaldehyde and cyclopentenone delivered the 
product in 94% yield and 98% ee (Table 1.7, entry 1). The adduct of electron-rich p-
methoxybenzaldehyde was obtained in 73% yield and 95% ee (Table 1.7, entry 2). The 
electron-poor p-nitrobenzaldehyde afforded a lower yield (75%), likely due to solubility 
of the aldehyde in i-PrOH (Table 1.7, entry 8). Additionally, this chiral DMAP/MgI2 
mixture afforded reasonable yields (54–68%) and moderate ee’s (53–63% for the 
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aliphatic aldehydes (Table 1.8). The lower yields obtained in these cases were the result 
of incomplete reaction, and extended reaction times will likely provide increased yields.  
 
Table 1.7. Enantioselective MBH reaction with various aromatic aldehydes.a,b,c 
OOH
(S)Ph
OOH
O2N
OOH
OOH
MeO
R
O
1 equiv 1.5 equiv
OO OH
RH
OH O
F3C
OH O
Me
94% yield
98% ee
i-PrOH, –20 º C, 24 h
10 mol% II, 50 mol% MgI2
OH O
75% yield
89% ee
96% yield
94% ee
73% yield
95% ee
93% yield
94% ee
87% yield
94% ee
81% yield
92% ee
92% yield
89% ee
OOH
(R)Ph
(+)-23 (+)-6 (–)-10 (+)-10d
(+)-5(+)-25(+)-24(+)-4
2
 
a The reactions were performed with 0.075 mmol of aldehyde, 1.5 equiv of 2, 0.1 equiv of catalyst 
II, 0.5 equiv of MgI2, in 1.5 mL of i-PrOH at –20 ºC for 24 h. b Isolated yield after purification by 
silica gel chromatography c Enantiomeric excess determined by chiral HPLC d The  (–)-enantiomer 
of catalyst II was used. 
 
To further extent the scope and utility of these reaction conditions, a variety of 
cyclic and acyclic α,β-unsaturated ketones and esters were treated with benzaldehyde, 
but no significant reaction occurred. Similar to other reported MBH catalytic systems 
(vide supra), the present system demonstrates a limited scope with respect to the 
nucleophilic component, so a careful analysis of substrates is necessary when evaluating 
various MBH reaction catalysts. 
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Table 1.8 Enantioselective MBH reaction with aliphatic aldehydes.a,b,c 
 
R
O
1 equiv 1.5 equiv
OO OH
RH
i-PrOH, –20 º C, 48 h
10 mol% II, 50 mol% MgI2
2
OOH
Ph
OOH
59% yield
63% ee
OH O
68% yield
53% ee
54% yield
58% ee
Me
Me
(–)-9(–)-8(–)-7
 
a The reactions were performed with 0.075 mmol of aldehyde, 1.5 equiv of 2, 0.1 
equiv of catalyst II, 0.5 equiv of MgI2, in 1.5 mL of i-PrOH at –20 ºC for 24 h. b 
Isolated yield after purification by silica gel chromatography c Enantiomeric excess 
determined by chiral HPLC. 
 
1.2.3 1,3-Allylic Transpositions of β-Iodo BH Adducts 
 
Morita-Baylis-Hillman type (MBH-type) couplings have emerged as important 
carbon-carbon bond forming processes in organic synthesis in recent years. Highly 
functionalized BH adducts can be subjected to a large number of further transformations 
for the synthesis of natural products and synthetic derivatives. In 2002, Paré and 
coworkers developed new approaches for the synthesis of substituted α-
(hydroxymethyl)-β-iodoacrylates and ketones as shown in scheme 1.11.51,52 The main 
advantage that these approaches offered was the fact that β-substituted acrylate olefins 
could be used as substrates in these BH-type reactions, which had been proven poor 
substrates in the original MBH reaction. However, Et2AlI is a moisture-sensitive reagent, 
which is difficult to handle, and the alternative route via the intermediary iodo-allene 
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suffered from long reaction times, in contrast to the synthesis of ketones,53 which 
proceeded both rapidly and efficiently.  
 
Scheme 1.11 Paré’s approach to the synthesis of β-iodo Baylis Hillman adducts. 
R H
O
R
OH
OMe
O
Et2AlI (1 equiv)
CH2Cl2, 0 °C
90 %
OMeO
H I
R
OH
OMe
O
 rt, 3 h
OMeO
H I
TMSI, CH2Cl2
R H
O
OMeTMSO
IH
MgI2 (0.1 equiv)
rt, 10 h
85%
RCHO
rt, 20 min
MgI2, CH2Cl2
R H
O
MgI
I
 0 °C, 1 h
86%
COMe
R
OH
Me
O
H I
 
 
We were interested in extending our reaction conditions developed for the 
symmetric and asymmetric Morita-Baylis-Hillman reaction54,55 to the synthesis of β-iodo 
Baylis-Hillman adducts. Our study started utilizing the same protocol reported by Paré 
and co-workers.53 We synthesized several β-iodo Baylis Hillman adducts (Table 1.9). 
All adducts were obtained as the Z isomers. We found that the aldehyde and MgI2 had to 
be mixed in CH2Cl2 at room temperature for 20 min before addition of the propargylic 
ester. Under these conditions, the reaction between 1 and methyl prop-2-ynoate (42) was 
complete within 1 h, and the desired product (26) was obtained in 92% yield with a Z/E 
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ratio of >95:5 (Table 1.9). The high yields obtained under these conditions were 
attributed to the lower Lewis acidity of MgI2 compared to Et2AlI, which minimizes the 
production of side products. 
 
Table 1.9 Synthesis of β-iodo Baylis Hillman adducts.a,b 
R1
O
1 equiv
H
92% yield
85% yield
89% yield94% yield 95% yield
65% yield 71% yield 88% yield
26 27 28 29
33323130
R1
OH
I
O
R3
R2
CH2Cl2, 0 ºC-rt, 2 h
1.3 equiv
MgI2 (1.2 equiv)
R2
O R3
OH
I
OEt
O OH
I
OEt
O
O2N
OH
I
OEt
O
MeO
OH
I
Me
O
OH OH
II
OEt
O
OEt
O
Me Ph
OH
I
Me
O
Ph
OH
I
OEt
O
Ph
91% yield
90% yield
85% yield86% yield 89% yield
96% yield 93% yield 92% yield
34 35 36 37
41403938
OH
I
OEt
O
Ph
OH
I
OEt
O
Me
OH
I
OEt
O
Ph
OH
I
OEt
O
TBSO
OH
I
Ph
O
Ph
OH
I
Ph
O
Me
OH
I
Me
O
Me
OH
I
Me
O
Ph
 
a The reactions were performed with 0.367 mmol of aldehyde, 1.3 equiv of ynone/ynoate, 1.2 equiv of 
MgI2, in 4 mL of CH2Cl2 at rt for 2 h. b Isolated yield after purification by silica gel chromatography. 
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The high Z-selectivity was rationalized to arise from the close transition state on 
the reaction mechanism, in which, the iodide substituent is away from the phenyl group 
on the aldehyde (Scheme 1.12). 
 
Scheme 1.12 Mechanism and selectivity of the β-iodo Baylis Hillman adducts. 
CH2Cl2, rt, 2 h
42, 1.3 equiv
O
H
OH
I
O
OEt
MgI2 (1.2 equiv)
CO2Et
H
H
O
MgI
O
EtO
Ph
H
IH
26
O
MgI
O
EtO
Ph
H
HI
1
 
We were able to assign the Z geometry of the tetrasubstituted olefin 
unambiguously by single crystal X-Ray analysis of the β-iodo Baylis Hillman Adduct 31 
(Figure 1.3). 
 
OH
I
OEt
O
Ph
31
 
Figure 1.3 X-Ray structure of the β-iodo Baylis Hillman adduct 31. 
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We then applied our reaction conditions developed for the asymmetric Morita-
Baylis-Hillman reaction.55 When CH2Cl2 was used as the solvent the expected β-iodo 
BH adducts were obtained (Table 1.10, entry 1). Adding to this mixture a catalytic 
amount of Fu’s chiral DMAP II, the product was obtained in only 2% ee. The low 
enantioselectivity was due to the fact that the background reaction was faster than the 
catalyzed by the chiral DMAP II Catalyst. Other solvents and reaction conditions were 
screened as well, however no increase on the enantioselectivity was observed.  
Table 1.10 Attempted asymmetric synthesis of β-iodo Baylis Hillman adducts. 
Entry
1
Yieldb (%) ee (%)Solvent
80CH2Cl2 NA
2 75CH2Cl2 2%
3 NRCH2Cl2 NA
4 Ai-PrOH NA
 0 ºC, 1 h
!
OH
5 Ai-PrOH NA
6 NRi-PrOH NA
I
O
OEt
MgI2, II, CH2Cl2
II (%)MgI2 (mol %)
120
120
–
120
120
–
–
5
5
–
5
5
7 NRi-PrOH NA
8 A+Bi-PrOH NA
9 Bi-PrOH NA
0
5
120
100c
100c
100c
I
O
OEt
OH
43 4442, 1.3 equiv
O
H
CO2Et
H
1 26
N
NMe2
FePh Ph
PhPh
Ph
Fu (+)-DMAP, II
 
a The reactions were performed with 0.367 mmol of 1, 1.3 equiv of 42, 1.2 equiv of MgI2, in 4 mL 
of CH2Cl2 at 0 ºC for 1 h. b Isolated yield after purification by silica gel chromatography c Racemic 
DMAP was used. 
 
While screening different solvents it was found that using isopropanol, the sole 
product observed was (E)-ethyl 3-iodoacrylate (43), which was the product of the 
addition of iodide to ethyl propiolate. Also, it was found that in the presence of 
stoichiometric DMAP and MgI2 the major product was benzyl alcohol (44). This alcohol 
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was the product of and Meerwein-Ponndorf-Verley (MPV) redox reaction between 
benzaldehyde and isopropanol with the aid of MgI2.56 To validate this observation, we 
subjected of p-nitrobenzaldehyde to the same reaction conditions excluding the enoate, 
and the MVP redox reaction was again observed in quantitative yield (Scheme 1.13). 
Scheme 1.13 Meerwein-Ponndorf-Verley redox of p-nitrobenzaldehyde and isopropanol. 
O
H
O2N
MgI2 ( 0.1 equiv)
i-PrOH, DMAP
OH
O2N
H O
H
Mg
O
H
Me
Me
I
I
Ar
Me Me
O
46, 100%45 47MPV  
While this Oppenauer redox reaction was certainly unwanted, we were 
encouraged by the possibility of using this side reaction as an entry to access 
cyclopentenones of the type of 49 through a tandem Oppenauer-Nazarov sequence of 
reactions. In the event, however, no cyclopentenone was observed, instead; a 1:1 mixture 
of aldehydes 50 were observed, along with recovered starting material (Scheme 1.14). 
The formation of the aldehyde product is the result of a Lewis acid mediated 1,3-allylic 
transposition of the hydroxyl group, followed by the elimination of the elements of HI. 
Scheme 1.14 Attempted tandem Oppenauer-Nazarov reaction. 
CH2Cl2, DMAP
45, MgI2 (1 equiv) MgI2
Nazarov34
48 49
OH
I
O
OEt
Ph
O
I
O
OEt
Ph I
O
OEt
O
Ph
O
OEt
Ph H O
50, ~5%
CH2Cl2, DMAP
45, MgI2 (1 equiv)
Oppenauer
1,3-Allylic Transposition
HI
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Intrigued by these observations, we then subjected the β-iodo Baylis-Hillman 
adduct 34 to several reaction conditions to optimize the formation of aldehyde 50. We 
found that treatment of 34 with one equivalent of MgI2 in refluxing CH2Cl2 provided a 
clean and quantitative conversion to the corresponding aldehyde 50 as 1:1 mixture of 
E/Z isomers (Scheme 1.15). Others β-iodo Baylis-Hillman adducts were also subjected 
to these conditions. Compound 38 afforded the corresponding aldehyde 51 in 98% yield 
as a 1:1 mixture of E/Z isomers. Interestingly, when the phenyl group was replaced by a 
methyl group (35), the regiochemistry of the 1,3-allylic transposition changed, and 
afforded the allylic diene 52 in 60% yield (Scheme 1.15). 
Scheme 1.15 1,3-Allylic transpositions of β-iodo Baylis-Hillman adducts. 
OH
I
O
OEt
CH2Cl2, reflux
MgI2 (1 equiv)
Ph
O
OEt
Ph H O
O
Ph
Ph H O
E/Z 1:1, 98% yield
50
51
OH
I
O
OEt
CH2Cl2, reflux
MgI2 (1 equiv)
Me I
O
OEtMe
OH
5235
34
99% yield, E/Z 1:1
OH
I
O
Ph
CH2Cl2, reflux
MgI2 (1 equiv)
Ph
38
60%  
Our proposed reaction mechanism for the 1,3-allylic transposition is shown on 
scheme 1.16. Initial activation of the hydroxyl group by MgI2 leads to the formation of a 
stabilized carbocation, the hydroxy then add regioselective to either C1 or C5 depending 
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on the substituent at C5. If a phenyl group is attached to C5 then the 1,3-allylic 
transposition occurs at C1 possible due to stabilization of the carbocation by resonance 
of the phenyl. Also this addition leads to a higher level of conjugation (Scheme 1.16, 
right). On the other hand, when a methyl group is present at C5, the 1,3-allylic 
transposition occurs at C5. This could be likely to less hindrance in the molecule 
(Scheme 1.16, left). This information shows that the rate-determining step should be the 
hydroxy addition since the 1,3-allylic transposition depends on the nature of the system. 
 
Scheme 1.16 Proposed reaction mechanism for the 1,3-allylic transpositions of β-iodo 
Baylis-Hillman adducts. 
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We hope to further explore the scope of this 1,3 allylic transpositions of β-iodo 
Baylis-Hillman adducts in the near future, since the products of these reactions are quite 
functionalized and are amenable for subsequent transformations such as aldol, Michael, 
and Diels-Alder reactions, or 1,2- additions, cross-couplings, among others. Also this 
approach offers a unique entry to differentiated 1,3 carbonyls (50, 51) as well as β-iodo-
dienoates (52). 
 
1.2.4 Abnormal MBH Reactions of Allenic Esters 
 
The synthesis of highly functionalized α-hydroxyalkyl allenic esters continues to 
attract the interest of synthetic chemists due to the fact that this structural motif is often 
encounter in many natural products and also are useful building blocks in synthetic 
chemistry. Several catalytic methods employing amines as nucleophilic triggers have 
emerged recently for the synthesis of these type molecules (Scheme 1.17).13 
Another approach to the synthesis of α-hydroxyalkyl allenic esters is the indium 
mediated coupling of aldehydes with 3-(ethoxycarbonyl)propargyl bromide (Scheme 
1.17),57 however, these reactions needed 1 equivalent of In, 3 equivalents of LiI and a 
long reaction times (up to 20 h).  
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Scheme 1.17 Approaches to the synthesis of α-hydroxyalkyl allenic esters. 
R H
O
R
OH
OEt
ODABCO (0.15 equiv) 
or  n-BuLi (1 equiv)
THF, rt or –92 °C, 5-34 h
54-60 %
OEt
O
Br
O
OEt
R H
O
R
OH
OEt
O
In ( 1 equiv), LiI
DMF, rt, 2-20 h
69-93 %  
Despite the abundance of coupling reactions between allenes and various 
electrophiles under nucleophilic catalysis, there is only one report on phosphine-
catalyzed reactions between allenes and aldehydes reported by Kwon and coworkers in 
2005,58 in which they reported the reaction of allenoates with aldehydes to produce 2,6- 
disubstituted-1,3-dioxan-4-ylidene-acetates in excellent to moderate yields with 
complete diasteroselectivity (exclusively cis) and high E/Z-selectivities. This phosphine-
mediated annulation reactions to form heterocycles offers a powerful reaction to 
construct masked δ-hydroxy-β-ketoester, which can be released by hydrolysis under 
acidic conditions in excellent yields (Scheme 1.18). 
 
Scheme 1.18 Phosphine catalyzed reaction of allenoates with aldehydes. 
Ar H
O PMe3 (0.20 equiv)
CHCl3, rt
47-99 % yield
excusively cis
E/Z = > 20:1~4:1
Oi-Pr
O
Ar
O O
Ar
i-PrO O
HCl (1.0 equiv)
CHCl3, rt
96 % yield
Ar = 3-chlorophenyl
Ar Oi-Pr
OH O O
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 We were encouraged to investigate preparative methods of functionalized α-
hydroxyalkyl allenic esters. Our method employing ethyl 2,3-butadienoate, showed a 
remarkable regiochemistry when a specific combination of nucleophile and solvent is 
used, switching between α or γ additions (Table 1.11).  
Table 1.11 Synthesis of abnormal Baylis Hillman adducts.a,b 
Ar
O
CO2Et
Nu 5 mol%
Ar
CO2Et
Solvent, 
rt, 2 h
OH
Entry Conversionb 100%Nucleophile Solvent
1 CH2Cl2 54
2 CH2Cl2 55
3 EtOH 54
4 EtOH 54
DMAP
DMAP
PPh3
PPh3
Ar
OO
Ar
54
OEtO
55
H
45, Ar=p-NO2C6H4–
53
 
a The reactions were performed with 0.367 mmol of 45, 1.3 equiv of 
53, 0.5 equiv of nucleophile, in 4 mL of CH2Cl2 at rt for 2 h. b 
calculated by 1H NMR. 
 
When p-nitrobenzaldehyde (45) was reacted with ethyl 2,3-butadienoate (53) in 
CH2Cl2 in the presence of catalytic DMAP (5 mol %), the normal BH adduct was 
obtained in only 2 h at room temperature. On the other hand, when PPh3 was employed a 
complete different reactivity was observed giving the 2,6-disubstituted-1,3-dioxan-4-
ylidene-acetate as the sole product. If EtOH is used as solvent, the outcome for the two 
nucleophiles is similar with the normal BH adduct as the only product. A plausible 
mechanism is proposed on scheme 1.19 for the 1,4-addition. 
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Scheme 1.19 Proposed mechanism for the formation of 1,3-dioxan-4-ylidene. 
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1.2.5 Direct α-Methylenation of Carbonyl Compounds 
 
Molecules containing the α,β−unsaturated carbonyl functionality are commonly 
utilized as substrates for a range of chemical transformations including nucleophilic 
addition,59-61 Michael addition,62,63 the Morita-Baylis-Hillman,2,64-67 Diels-Alder,68,69 and 
several organocatalytic reactions.70-73 The importance of the α-methylene is amplified by 
its presence in numerous biologically active natural products. α-Methylenation has 
attracted attention because it is generally an atom economical method for conversion of 
simple carbonyls compounds to their α,β-unsaturated derivatives.  
Several methods have been developed for the α−methylenation of carbonyls 
(Scheme 1.20), but a practical approach has yet to be generalized and optimized.74-82 
Pihko recently reported an α-methylenation of aldehydes in aqueous media employing 
catalytic pyrrolidine and propionic acid,83,84 but for the synthesis of complex, 
functionalized α,β−unsaturated carbonyls, the three step Mannich 
reaction/alkylation/elimination procedure with dimethylmethylideneammonium iodide 
(Eschenmoser’s salt) has been the most popular choice,85 where the mild reaction 
conditions are more important than the shortest possible sequence.86-90 Gras had earlier 
reported a direct one step α-methylenation of ketonic compounds using N-
methylanilinium trifluoroacetate as a catalyst with 1,3,5-trioxane in a refluxing aprotic 
solvent (THF or 1,4-dioxane).91,92 This reaction affords α,β-unsaturated carbonyls by 
way of a Mannich-type reaction on a transiently formed methyleneammonium salt. 
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Scheme 1.20 Approaches for the α−methylenation of carbonyls. 
TBDPSO
Me
CO2Me NaH, THF, rt;
Horner–Wadsworth–Emmons
TBDPSO
Me P(OMe)2
CO2Me
O
16 h,   89%
(HCHO)n (2 equiv)
O
Me
77%
CH2Cl2, 40 ºC, 8 d
O
MeEt2NH (4 equiv)
Dibromomethane Based Reaction
15 equiv
CH2Br2
 THF or 1,4-Dioxane
Direct Synthesis of !-Methylene Ketones
73% to 96%
reflux, min to daysR1 Me
O
H2N
Me
CF3CO2
4 equivR1 = aliphatic
R1
O
O O
O
1.1 to 2.5 equiv
O
Me
Me
Me
Me
58%
ii. MeI, K2CO3
N
Me
Me
Cl
O
Me
Me
Me
Mei. CH3CN, 82 ºC, 1 h
Mannich Reaction
2 equiv
 
We were attracted to this simple method but needed a more robust system with 
greater substrate scope and better reproducibility to reliably deliver a wide range of 
unsaturated substrates that would be used on our Morita-Baylis-Hillman ongoing 
projects. In our initial study, we screened a variety of ammonium salts for the α-
methylenation of acetophenone (Figure 1.4).  
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MeNH•TFA MeNH•AcOH MeNH•HCl
NH•TFA
VII VIII IX X
XI XII XIII XIV
NH•TFA NH•TFAO NH•TFA
Me
NH•TFA
Me
Me
Me
 
Figure 1.4 Aminomium salts screened as catalysts. 
Diisopropylammonium trifluoroacetate (XIV) was found to be the optimal amine 
component in a reaction between acetophenone and paraformaldehyde in refluxing THF 
affording a 92% yield (Table 1.12).  
Table 1.12 Screening of ammonium salts as catalyst.a,b 
1
2
82
5
VII
VIII
3 50IX
4 34X
5 45XI
6 89XII
Entry Yieldb (%)Catalyst
Catalyst 1 equivMe
O O
THF, reflux, 8 h4 equiv
(HCHO)n
56 57
7 78XIII
8 92XIV  
a The reactions were performed with 1 mmol of 56, 4 equiv of 
paraformaldehyde, 1 equiv of catalyst, in 1.0 mL of THF at 67 °C 
for 8 h. b Determined by GC.  
 
We then optimized the reaction conditions using diisopropylamine as the catalyst 
(Table 1.13). Addition of 10 mol% of diisopropylamine in the catalytic system increased 
the yield from 92% to 95%. On the other hand, addition of 10 mol% of trifluroacetic 
acid (TFA) raised the yield to >99%. 
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Table 1.13 Optimization of the reaction conditions.a,b,c 
 
CatalystMe
O O
THF, reflux, 8 h4 equiv
(HCHO)n
92%
Me
NH•TFA
Me
Me
Me
95%
Me
NH•TFA
Me
Me
Me
>99%
Me
NH•TFA
Me
Me
Me
1:1 equiv 1:1.1 equiv1.1:1 equiv
 
a The reactions were performed with 1 mmol of acetophenone, 4 equiv of 
paraformaldehyde, 1 equiv of catalyst, in 1.0 mL of THF at 67 °C for 8 h. b 
Determined by GC. c 4 equiv of paraformaldehyde added at once gave 83% yield. 
 
We were pleased to find that with ammonium salt XIV complete conversion of 
the starting material to the α,β−unsaturated carbonyl could be obtained in 8 h. The scope 
of this reaction was then assessed with a representative selection of aldehydes, ketones 
and esters (Table 1.14). 
Table 1.14 Synthesis of α,β-unsaturated carbonyls from cyclic and acyclic ketones.a,b 
R1
O
R2
R1
O
R2
i-Pr2NH:TFA, 1:1.1 equiv
THF, reflux, 8 h4 equiv
(HCHO)n
59, 93%57, 99% 58, 91%
62, 97%61, 84%60, 92%
Ph
O
t-Bu
O
Cy
O
O O O
Me
Me Me
Me
64, 83%
63, 98%
66, 91%
65, 88%
O
O
Cl
O
Me
O
CO2Et
 
a The reactions were performed with 1 mmol of ketone, 4 equiv of paraformaldehyde, 1 
equiv of catalyst, in 1.0 mL of THF at 67 °C for 8 h. b Isolated yield after purification by 
silica gel chromatography. 
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As shown in Table 1.14, a wide variety of aliphatic and aromatic ketones can be 
reliably converted to the corresponding α,β−unsaturated ketones in good to excellent 
yields with catalyst XIV. Also cyclic symmetrical ketones were good substrates for this 
transformation, affording exclusively the mono-methylenated product in good yields. 
Sterically demanding ketones are also tolerated as evidenced by 2,2,5,5-
tetramethylcyclohexanone affording an 84% yield of the desired product 61. 
Furthermore, no isomerization of the double bond could be detected in any of these 
adducts by 1H NMR spectroscopy. 
Aldehydes are easy converted to acroleins using this catalytic system. 3-
Phenylpropional afforded a 95% yield (Table 1.15). The TBDPS protecting group is 
stable to these reaction conditions. Several reactions produced similar or higher yields of 
products when the reaction conditions were buffered with additional i-Pr2NH instead of 
additional TFA. For example, when the TES protected methyl acetylene ketone (4-
(triethylsilyl)but-3-yn-2-one) was treated under our standard reaction conditions, no 
desired product was observed. But, by adding 1 equiv i-Pr2NH, the desired adduct 71 
was obtained in 2 h in 62% yield. 
These reaction conditions are mild as evidenced by the variety of functional 
groups which compatible with this system. For example, β-ketoesters reacted cleanly 
affording a 98% yield of the desired product. Hydroxy groups are also tolerated by these 
conditions. Interestingly, 2-hydroxyacetophenone underwent intramolecular conjugate 
addition after initial α-methylenation to form 4-chromanone which then underwent a 
second α-methylenation to afford adduct 74 in 85%. For phenoxyacetone, almost 
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exclusively the adduct 2-phenoxybut-1-en-3-one was obtained in 85% yield. Inseparable 
traces of 1-phenoxybut-3-en-2-one were observed as well. Such regioselectivity can be 
explained by the selective reaction of the thermodynamic enol (Table 1.16, entry 4).  
 
Table 1.15 Synthesis of α,β-unsaturated carbonyls from aldehydes, alkynylketones and 
diesters.a 
R1
O
R2
R1
O
R2
i-Pr2NH:TFA, 1:1.1 equiv
THF, reflux, 8 h4 equiv
(HCHO)n
95
92
99
H
O
Ph H
O
Ph
O
81
Ot-Bu
t-BuO O
O
H
Substrate Yield
b (%)Product (#)
TBDPSO
O
H
TBDPSO
Ot-But-BuO
OO
Entry
1
2
3
4
67
68
69
70
Me H
Me Me O
Ph
O
62
62
96
TESTES
5
6c
7
O O
Me
71
72
73
(S)-citronellal
CO2H
Ph
O
Me
Ph
O
CO2H
Ph
O
  
a The reactions were performed with 1 mmol of carbonyl compound, 4 equiv of 
paraformaldehyde, 1 equiv of catalyst, in 1.0 mL of THF at 67 °C for 8 h. b Isolated 
yield after purification by silica gel chromatography.c  (HCHO)n 2 equiv, 2 h, catalyst 
ratio i-Pr2NH:TFA (2:1). 
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As a final note, several reactions that we tried were significantly slower when a 
catalytic amount (10-50 mol%) of i-Pr2NH•TFA was utilized. Given the modest cost and 
convenience of this reagent, we have not further explored the application of catalytic 
reaction conditions. 
 
Table 1.16 Synthesis of α,β-unsaturated carbonyls from functionalized ketones.a 
R1
O
R2
R1
O
R2
i-Pr2NH:TFA, 1:1.1 equiv
THF, reflux, 8 h4 equiv
(HCHO)n
94
84
85
85
Substrate Yield
b (%)Product (#)Entry
1
2
3c
4
O
O
Me
O
O
O
O
O
O
O
Me
OH
O
OH
Me
O
O
Ph Me
O
O
Ph
O
OH
(3:1)
74
75
74
76
 
a The reactions were performed with 1 mmol of carbonyl compound, 4 equiv of 
paraformaldehyde, 1 equiv of catalyst, in 1.0 mL of THF at 67 °C for 8 h. b Isolated 
yield after purification by silica gel chromatography. c A 3:1 ratio of enol:methyl 
ketone is observed. 
 
The proposed mechanism for the formation of α,β-unsaturated carbonyls is 
shown on scheme 1.21 and proceeds through the expected iminium intermediate, 
followed by Mannich reaction. After a tautomerization and β-elimination, the desired α−
β-unsaturated carbonyl compound is obtained. 
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We anticipate that this method will be of wide use in organic synthesis due to the 
mildness of the reaction conditions as well as the inexpensive cost of the reagents and 
most important, to the tolerance of several functional groups in the substrates. 
 
Scheme 1.21 Proposed mechanism for the formation of α,β-unsaturated carbonyls. 
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1.3 Experimental Section 
 
1.3.1 General Information 
 
All reactions were carried out under an argon atmosphere in oven-dried 
glassware with magnetic stirring. All commercially obtained reagents were used as 
received. All aldehydes were distilled before use. Any impure starting material from 
stock was purified by distillation, column chromatography, or recrystallization. Solvents 
were distilled under its specific drying agent or obtained from a purification system. 
Water was distilled and deoxygenated under nitrogen flush. 
Cooling was accomplished using an ice bath or an isopropanol bath. Heating was 
accomplished by either a heating mantle or silicone oil bath. Purification of reaction 
products was carried out by flash column chromatography using silica gel, distillation or 
by recrystallization. Visualization was accompanied with UV light and/or ceric 
ammonium molybdate or potassium permanganate staining. 
1H NMR spectra were recorded on a 300 MHz instrument and recorded relative 
to the deuterated solvent used, in ppm units. 1H NMR coupling constants (J) are reported 
in Hertz (Hz) and multiplicities are indicated as follows: s (singlet), d (doublet), t 
(triplet), m (multiplet). Proton-decoupled 13C NMR spectra were recorded at 75 MHz. 
High-resolution mass spectra (HRMS) were obtained at Texas A&M. Infrared spectra 
were recorded on a spectrometer using a thin film on NaCl plates.  
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1.3.2 Acceleration of the MBH Reaction 
 
General procedure for the synthesis of Baylis-Hillman adducts 4-17: To a stirred 
mixture of aldehyde (0.5 mmol) and activated alkene (0.55 mmol) in MeOH (1.2 mL) at 
room temperature under argon atmosphere was added a solution of MgI2 (13.9 mg, 0.05 
mmol) and TMEDA (8.3 mg, 0.05 mmol) in MeOH (0.2 mL), followed by dropwise 
addition of a solution of DMAP (6.1 mg, 0.05 mmol) in MeOH (0.1 mL). After, the 
mixture was stirred for 15 h at rt under argon atmosphere. The reaction was quenched by 
addition of saturated aqueous NH4Cl solution (1.0 mL). The solution mixture  was 
extracted twice with dichloromethane (5.0 mL) and dried over anhydrous Na2SO4. The 
solvent was removed under reduced pressure, and the residue was purified by flash silica 
gel column chromatography (20% EtOH/Hexanes or CH2Cl2) (Table 1.17). 
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Table 1.17 References to known compounds (MBH adducts).93-99 
Adduct (#) ReferenceProduct
Ph
OH O
Me Me
Ph
OH O
Me Me
93
95
93
9
7
10
5
4
6 99
Ph
OH O
98
8
Ph
OH O
O
Ph
OH O
93
OOH
Me
Me
OOH
Ph
OOH
Ph
OOH
O2N OOH
OOH
MeO
OOH
ReferenceProduct
97
96
93
94
93
94
96
Adduct (#)
11
12
13
14
15
21
O
O
 
 
 
Details for the Unknown Adducts 16 and 17. 
OH O
O
 
3-(hydroxy(phenyl)methyl)furan-2(5H)-one (16): To a stirred mixture of 
benzaldehyde (53 mg, 0.5 mmol) and furan-2(5H)-one (46.2 mg, 0.55 mmol) in EtOH 
(1.2 mL) at room temperature under argon was added a solution of magnesium iodide 
(13.9 mg, 0.05 mmol) and TMEDA (8.3 mg, 0.05 mmol) in EtOH (0.2 mL) was added 
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followed by dropwise addition of a solution of dimethylaminepyridine (6.1 mg, 0.05 
mmol) in EtOH (0.1 mL). After, the mixture was stirred for 2 h at rt under argon. The 
reaction was quenched by addition of saturated aqueous NH4Cl solution (1.0 mL). The 
solution mixture  was extracted twice with dichloromethane (5.0 mL) and dried over 
anhydrous Na2SO4. The solvent was removed under reduced pressure, and the residue 
was purified by flash silica gel column chromatography (dichloromethane) to give 
compound 16 (50.4 mg, 53%) as a colorless oil; IR (thin film) ν 3424, 2869, 1745, 1201 
cm-1; 1H NMR (CDCl3, 300 MHz) δ 7.43–7.31 (m, 5 H), 7.19 (q, J = 1.55 Hz, 1 H), 5.56 
(s, 1 H), 4.78 (t, J = 2.0 Hz, 2 H), 3.45 (d, J = 4.0 Hz, 1 OH). 13C NMR (75 MHz, 
CDCl3) δ 172.9, 146.0, 140.0, 136.3, 128.5, 128.2, 126.3, 70.5, 69.0. MS (ESI) calcd for 
C11H10O3 + Li requires m/z 197.0790, found 197.0795. 
OH O
S
 
3-(hydroxy(phenyl)methyl)thiophen-2(5H)-one (17): To a stirred mixture of 
benzaldehyde (53 mg, 0.5 mmol) and thiophen-2(5H)-one (55 mg, 0.55 mmol) in EtOH 
(1.2 mL) at –15 ºC under argon was added a solution of magnesium iodide (13.9 mg, 
0.05 mmol) and TMEDA (8.3 mg, 0.05 mmol) in EtOH (0.2 mL) was added followed by 
dropwise addition of a solution of dimethylamine-pyridine (6.1 mg, 0.05 mmol) in EtOH 
(0.1 mL). After, the mixture was stirred for 1 h at –15 ºC under argon. The reaction was 
quenched by addition of saturated aqueous NH4Cl solution (1.0 mL). The solution 
mixture  was extracted twice with dichloromethane (5.0 mL) and dried over anhydrous 
Na2SO4. The solvent was removed under reduced pressure, and the residue was purified 
 44 
by flash silica gel column chromatography (dichloromethane) to give compound 17 
(94.8 mg, 92%) as a pale yellow oil; IR (thin film) ν 3419, 2918, 1659, 1170 cm-1; 1H 
NMR (CDCl3, 300 MHz) δ 7.42-7.32 (m, 5 H), 7.16 (m, 1 H), 5.63 (s, 1 H), 3.98 (t, J = 
1.08 Hz, 2 H), 3.20 (d, J = 3.63 Hz, 1 OH). 13C NMR (75 MHz, CDCl3) δ 199.9, 148.9, 
147.7, 140.6, 128.6, 128.1, 126.4, 70.1, 35.5. MS (ESI) calcd for C11H10O2S + Li 
requires m/z 213.0562, found 213.0573. 
 
1.3.3 NMR Studies of Complex TMEDA–MgI2 
 
N N
Me
Me Me
Me
N N
Me
Me Me
Me
Mg
I I
MgI2
E-1 E-2  
NMR Studies of TMEDA (E-1): 
A solution of TMEDA (20 mg, 0.172 mmol) (E-1) in 1 mL of CDCl3 or CD3OD 
was analyzed by 1H NMR and 13C NMR.  
 
TMEDA. 1H NMR (CDCl3, 300 MHz) δ 2.388 (s, 4H), 2.245 (s, 12H) 
TMEDA. 13C NMR (CDCl3, 75 MHz) δ 57.604, 45.806. 
 
TMEDA. 1H NMR (CD3OD, 300 MHz) δ 2.469 (s, 4H), 2.261 (s, 12H) 
TMEDA. 13C NMR (CD3OD, 75 MHz) δ 58.017, 45.938. 
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NMR Studies of TMEDA/MgI2 (E-2): 
To a stirred mixture of MgI2 (47.9 mg, 0.172 mmol) in 1 mL of CDCl3 or 
CD3OD at room temperature under argon atmosphere was added TMEDA (20 mg, 0.172 
mmol), the mixture was stirred for 5 min at rt under argon atmosphere. Then, analyzed 
by 1H NMR and 13C NMR. 
 
TMEDA + MgI2. 1H NMR (CDCl3, 300 MHz) δ 2.596 (s, 4H), 2.364 (s, 12H) 
TMEDA + MgI2. 13C NMR (CDCl3, 75 MHz) δ 56.422, 45.359. 
 
TMEDA + MgI2. 1H NMR (CD3OD, 300 MHz) δ 2.541 (s, 4H), 2.311 (s, 12H) 
TMEDA + MgI2. 13C NMR (CD3OD, 75 MHz) δ 57.529, 45.752. 
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1.3.4 Enantioselective MBH Reaction 
 
General procedure for the synthesis of enantiomeric enriched BH adducts: To a 
stirred mixture of (R)-(+)-4-dimethylaminopyrindinyl(pentaphenylcyclopentadienyl) 
iron (II) (5 mg, 0.0075 mmol, 10 mol%), MgI2 (10 mg, 0.038 mmol, 50 mol%) in i-
PrOH (1.5 mL) was added the aldehyde (0.075 mmol) at room temperature under argon. 
Then, the reaction mixture was cooled down to –20 ºC followed by the addition of 
cyclopent-2-enone (2) (9 mg, 0.11 mmol, 1.5 equiv). After, the mixture was stirred for 
24 h at –20 ºC under argon atmosphere. The reaction was quenched by addition of 
saturated aqueous NH4Cl solution (1.0 mL). The solution mixture was extracted twice 
with CH2Cl2 (5 mL) and dried over anhydrous Na2SO4. The solvent was removed under 
reduced pressure, and the residue was purified by flash silica gel column 
chromatography using 20% EtOH/hexanes or CH2Cl2 as the eluents to afford the 
respective adducts (Table 1.18). HPLC was used to verify the enantiomeric excess for 
each adduct (Table 1.19). 
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Table 1.18 References to known compounds (enantioenriched adducts).33,42,93-97,100,101 
Compound 
No.
Product
OH O
95
94
(+)-23
(+)-6
(–)-10
(+)-4
(+)-24
–
OOH
Me
Me
OOH
Ph
OOH
Ph
OOH
O2N
OOH
OOH
MeO
OOH
Reference
(racemic)
Product
97
96
95
94
93
94
96
Compound
No.
(+)-25
(+)-5
(–)-9
(–)-8
(–)-7
F3C
OH O
Me
OH O
–
33
33
101
33
–
–
100
33
–
Reference
(nonracemic)
Reference
(racemic)
Reference
(nonracemic)
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Table 1.19 HPLC data (enantioenriched MBH adducts). 
Adduct (#) HPLC RTProduct
OH O
(+)-23a
(+)-6b
(–)-10a
(+)-4b
(+)-24c
OOH
Me
Me
OOH
Ph
OOH
Ph
OOH
O2N
OOH
OOH
MeO
OOH
HPLC RTProduct
tmajor = 23.67 min
tminor = 26.64 min
Adduct (#)
(+)-25c
(+)-5b
(–)-9c
(–)-8c
(–)-7b
F3C
OH O
Me
ee (%)ee (%)
92
98
94
94
95
89
63
53
89
58
tmajor = 22.23 min
tminor = 24.29 min
tmajor = 12.39 min
tminor = 13.49 min
tmajor = 24.68 min
tminor = 25.94 min
tmajor = 30.60 min
tminor = 27.25 min
tmajor = 8.79 min
tminor = 9.19 min
tmajor = 21.45 min
tminor = 24.70 min
tmajor = 7.94 min
tminor = 8.51 min
tmajor = 10.47 min
tminor = 10.83 min
tmajor = 17.61 min
tminor = 20.33 min
OH O
+17.3
–25.4
–18.9
+38.5
–21.7
+15.8
+66.1
–22.7
+18.2
+26.7
22 d
D[!]
22 d
D[!]
 
a Enantiomeric excess was determined by HPLC with a Chiralcel OJ-H column (hexane/iPrOH = 
90/10), 1.0 mL/min, 254 nm. b Enantiomeric excess was determined by HPLC with a Chiralcel 
OJ-H column (hexane/iPrOH = 85/15), 1.0 mL/min, 254 nm. c Enantiomeric excess was 
determined by HPLC with a Chiralcel OJ-H column (hexane/iPrOH = 95/5), 1.0 mL/min, 254 
nm.d Optical rotation at (c 1.00, CHCl3). 
 
The absolute (S) configuration of products (–)-4, (–)-5, (–)-7, (–)-8, (–)-9 and (–)-
10 was determined by comparison of the sign of optical rotation with the known 
compounds (see previous page). Other absolute configurations are assigned by analogy. 
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Procedures and characterization data for the asymmetric BH adducts: 
Compounds (+)-5, (+)-6, (–)-7, (–)-8, (–)-9, (–)-10, (+)-24 and, (+)-25 are known 
compounds (Table 1.18). Compound (+)-23 is a new compound. Full tabulated data is 
available below for the new compound (+)-23 and the adduct of the optimization 
reaction (–)-10. 
OH O
 
(S)-2-(hydroxy(naphthalen-1-yl)methyl)cyclopent-2-enone ((+)-23): To a stirred 
mixture of (R)-(+)-4-dimethylaminopyrindinyl-(pentaphenylcyclopentadienyl) iron (II) 
(5 mg, 0.008 mmol), MgI2 (10.4 mg, 0.038 mmol) in i-PrOH (1.5 mL) was added 1-
naphthaldehyde (12 mg, 0.075 mmol) at room temperature under an argon atmosphere. 
Then the reaction mixture was cooled down to –20 ºC followed by the addition of 
cyclopent-2-enone (9 mg, 0.11 mmol, 1.5 equiv). After, the mixture was stirred for 24 h 
at –20 ºC under argon atmosphere. The reaction was quenched by addition of saturated 
aqueous NH4Cl (1 mL). The mixture was extracted twice with CH2Cl2 (5 mL) and dried 
over anhydrous Na2SO4. The solvent was removed under reduced pressure, and the 
residue was purified by flash silica gel column chromatography to give compound (+)-
23 (14 mg, 94%) as a colorless oil (CH2Cl2); IR (thin film) ν 3403, 3028, 2920, 1695, 
1611, 960 cm-1; 1H NMR (CDCl3, 300 MHz) δ 7.93-7.88 (m, 2H), 7.82 (d, J = 8.7 Hz, 
1H), 7.76 (d, J = 7.2 Hz, 1H), 7.70-7.46 (m, 3H), 7.02 (m, 1H), 6.30 (s, 1H), 3.79 (s, 
1OH), 2.50 (m, 4H). 13C NMR (CDCl3, 75 MHz) δ 210.1, 161.1, 147.2, 136.6, 133.8, 
130.4, 128.8, 128.4, 126.1, 125.6, 125.5, 124.4, 123.7, 66.5, 35.2, 26.6. HRMS (ESI) 
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calcd for C16H14O2 + Li requires m/z 245.0409, found 245.0411. [α]22D = +66.09 (c 1.0, 
CHCl3). Enantiomeric excess was determined by HPLC with a Chiralcel OJ-H column 
(hexane/iPrOH = 90/10), 1.0 mL/min, 254 nm, tmajor= 30.60 min, tminor= 27.25 min; 98% 
ee. 
OH O
 
(S,E)-2-(1-hydroxy-3-phenylallyl)cyclopent-2-enone ((–)-10): To a stirred mixture of 
(R)-(+)-4-dimethylaminopyrindinyl-(pentaphenylcyclopentadienyl) iron (II) (5 mg, 
0.0075 mmol, 10 mol%), MgI2 (10 mg, 0.038 mmol, 50 mol%) in i-PrOH (1.5 mL) was 
added trans-cinnamaldehyde (10 mg, 0.075 mmol) at room temperature under an argon 
atmosphere. Then the reaction mixture was cooled down to –20 ºC followed by the 
addition of cyclopent-2-enone (9 mg, 0.11 mmol, 1.5 equiv). After, the mixture was 
stirred for 24 h at –20 ºC under an argon atmosphere. The reaction was quenched by 
addition of saturated aqueous NH4Cl (1 mL). The solution mixture was extracted twice 
with CH2Cl2 (5 mL) and dried over anhydrous Na2SO4. The solvent was removed under 
reduced pressure, and the residue was purified by flash silica gel column 
chromatography to give compound (–)-10 (16 mg, 96%) as a colorless oil (CH2Cl2); IR 
(thin film) ν 3400, 3026, 2921, 1691, 1605, 970 cm-1; 1H NMR (CDCl3, 300 MHz) δ 
7.55 (td, J = 1.1 Hz, 1.4 Hz, 3.1 Hz, 1H), 7.41 (m, 2H), 7.27-7.17 (m, 3H), 6.70 (dd, J = 
1.1 Hz, 14.8 Hz, 1H), 6.35 (dd, J = 6.5Hz, 9.8 Hz, 1H), 5.17 (d, J = 6.7 Hz, 1H), 3.31 (d, 
J = 4.1 Hz, 1OH), 2.65 (m, 2H), 2.49 (m, 2H). 13C NMR (CDCl3, 75 MHz) δ 209.6, 
158.8, 146.3, 136.3, 131.1, 128.6, 128.5, 127.8, 126.5, 68.4, 35.1, 26.7. HRMS (ESI) 
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calcd for C14H14O2 + Li requires m/z 221.115, found 221.114. [α]22D = -22.66 (c 1.0, 
CHCl3). Enantiomeric excess was determined by HPLC with a Chiralcel OJ-H column 
(hexane/i-PrOH = 90/10), 1.0 mL/min, 254 nm, tmajor= 23.67 min, tminor= 26.64 min; 94% 
ee. 
OH O
 
When (S)-(+)-4-dimethylaminopyrindinyl-(pentaphenylcyclo-pentadienyl) iron (II) was 
used the values obtained for (+)-10 are: (15 mg, 93%) as a colorless oil (CH2Cl2); IR 
(thin film) ν 3400, 3026, 2921, 1691, 1605, 970 cm-1; 1H NMR (CDCl3, 300 MHz) δ 
7.55 (td, J = 1.1 Hz, 1.4 Hz, 3.1 Hz, 1H), 7.41 (m, 2H), 7.27-7.17 (m, 3H), 6.70 (dd, J = 
1.1 Hz, 14.8 Hz, 1H), 6.35 (dd, J = 6.5Hz, 9.8 Hz, 1H), 5.17 (d, J = 6.7 Hz, 1H), 3.31 (d, 
J = 4.1 Hz, 1OH), 2.65 (m, 2H), 2.49 (m, 2H). 13C NMR (CDCl3, 75 MHz) δ 209.6, 
158.8, 146.3, 136.3, 131.1, 128.6, 128.5, 127.8, 126.5, 68.4, 35.1, 26.7. HRMS (ESI) 
calcd for C14H14O2 + Li requires m/z 221.115, found 221.114. [α]22D = +22.66 (c 1.0, 
CHCl3). Enantiomeric excess was determined by HPLC with a Chiralcel OJ-H column 
(hexane/i-PrOH = 90/10), 1.0 mL/min, 254 nm, tminor= 23.67 min, tmajor= 26.64 min; 94% 
ee. 
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1.3.5 Synthesis of β-Iodo BH Adducts  
 
R1
O
H
R1
OH
I
O
R3
CH2Cl2, rt, 2-16 h
MgI2 (1.2 equiv)
R1= Alkenyl, Aryl, Alkyl, Akynyl
R2= H, Me, Ph
R3= OEt, Me, PH
O R3
R2
R2
26-41
 
To an 8 mL glass vial containing a stir bar was added MgI2 (0.441 mmol, 122.6 
mg, 1.2 equiv) and capped with a phenolic cap equipped with a teflon/silicone septa. The 
vial was filled and purged with argon. A solution of aldehyde (0.367 mmol, 1.0 equiv) in 
dry dichloromethane (4 mL) was added via syringe under argon. The mixture was stirred 
for 20 min at room temperature. Then, ynone/ynoate (0.478 mmol, 1.3 equiv) was added 
via syringe and stirred for 2 h at rt under argon. The reaction mixture was concentrated 
under reduce pressure. Finally, the residue was loaded to a flash silica gel column 
chromatography and purified using (0-10% EtOAc-Hexanes) as the eluents to afford the 
pure adducts 26–41 (Table 1.20). 
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Table 1.20 References to known compounds (β-Iodo BH adducts).102-105 
Compound No. Product
104
–
26
27
28
29
30
102
ReferenceProduct
–
–
103
104
105
102
–
Compound No.
34
35
36
37
38
Reference
OH
OH
OH
OH
–39
I
I
I
I
OEt
O
OEt
O
OEt
O
Me
O
O2N
MeO
–
31
32
–
OH
OH
I
I
OEt
O
OEt
O
Me
Ph
OH
OH
OH
OH
OH
I
I
I
I
I
OEt
O
OEt
O
OEt
O
OEt
O
Ph
O
OH
OH
I
I
Ph
O
Me
O
40
Ph
Me
Ph
TBSO
Ph
Me
Me
105
–33
OH
I
Me
O
OH
I
Me
O
41
Ph
105
Ph
OH
I
OEt
O
Ph
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1.3.6 Synthesis of Carbonyl Starting Materials 
E-3 E-4
Ph
O
Ph
OH
MnO2, CH2Cl2
rt, 6 h, 78%
 
1-phenylprop-2-yn-1-one (E-4):106 In a 25 mL round bottom flask equipped with a stir 
bar was added MnO2 (3 equiv) then a solution of 1-phenylprop-2-yn-1-ol (7.5 mmol, 1 
g) in dichloromethane (10 mL) was added. After stirring at room temperature for 6 h, the 
reaction was filtered through a pad of celite to remove the solids. The filtrate was 
washed sequentially with water and brine and dried over MgSO4. The solvent was 
removed under reduced pressure to afford a yellow residue that was purified by flash 
silica gel column chromatography using (0-10% EtOAc-Hexanes) as the eluents to 
afford pure E-4 in 78% yield as a white solid. 1H NMR (300 MHz, CDCl3): δ 8.17 (d, J 
= 7.2 Hz, 2H), 7.64 (t, J = 7.8 Hz, 1H), 7.51 (t, J = 7.2 Hz, 2H), 3.46 (s, 1H). 13C NMR 
(75 MHz, CDCl3): δ 177.3, 136.0, 134.5, 129.6, 128.6, 80.8, 80.2. 
E-5 E-6
H
O1. n-BuLi, THF, 
    –78°C to rt
Ph
Ph
H
2. DMF, –78°C to rt
3. Hydrolysis
93%  
3-phenylprop-2-ynal (E-6):107,108 To a solution of phenyl acetylene (48.9 mmol, 5 g) in 
20 mL of THF that had been cooled to –78 °C under argon was added 19 mL of n-BuLi 
(2.57 M in THF, 49 mmol) while stirring. To this solution was added N,N-
dimethylformamide (20 mL, excess) dropwise over 10 min. The cooling bath was 
removed and the solution allowed to warm up to rt. After 1 h of further stirring, the 
solution was quenched with saturated NH4Cl and extracted with Et2O. The organic layer 
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was washed sequentially with water and brine. Dried over Na2SO4. The solvents were 
removed under reduced pressure to afford a light yellow residue that was purified by 
flash silica gel chromatography using (0-5% EtOAc-Hexanes) as the eluents to afford 
pure E-6 in 93% yield as colorless oil. 1H NMR (300 MHz, CDCl3): δ 9.43 (s, 1H), 7.61 
(d, J = 6.9 Hz, 2H), 7.53 (t, J = 7.2 Hz, 1H), 7.43 (t, J = 7.5 Hz, 1H). 13C NMR (75 
MHz, CDCl3) δ 176.8, 133.2, 131.3, 128.7, 119.3, 95.1, 88.4. 
E-7 E-8
LiAlH4, THF
reflux, 18 h
91%
OH
HO
OH
HO
 
(E)-but-2-ene-1,4-diol (E-8):109 In a 250 mL round bottom flask equipped with stir bar 
and a condenser was added LiAlH4 (140 mmol, 5.3 g, 1.2 equiv) and dissolved in THF 
(150 mL) under argon. Then, cooled down to –78 °C. A solution of but-2-yne-1,4-diol 
(110 mmol, 10 g) in THF (50 mL) was added while stirred vigorously at –78 °C. After 
the addition the mixture was warmed up slowly to reflux. The reflux was continued for 
18 h. The mixture was then cooled down to rt and quenched carefully with saturated 
NH4Cl solution. Filtered using a paper filter and the white cake was washed with Et2O. 
The solvents were removed under reduced pressure to afford a light yellow residue that 
was purified by flash silica gel chromatography using (80% EtOAc-Hexanes) as the 
eluents to afford 9.3 g of pure E-8 in 91% yield as colorless oil. 1H NMR (300 MHz, 
CDCl3): δ 5.88 (m, 2H), 4.16 (m, 4H), 2.15 (bs, 2H). 13C NMR (75 MHz, CDCl3): δ 
130.3, 62.8. 
 
 56 
E-9
TBSCl, 6 h
72%
OH
TBSO
OH
HO
E-8
n-BuLi, THF, 
–78°C to rt;
 
(E)-4-(tert-butyldimethylsilyloxy)but-2-en-1-ol (E-9):109 In a 250 mL round bottom 
flask equipped with a stir bar and a septa was added a solution of (E)-but-2-ene-1,4-diol 
(E-8) (45 mmol, 4 g) in 100 mL of THF under argon. Cooled down to –78 °C. Then, was 
added 25 mL of n-BuLi (1.8 M in THF, 45 mmol) while stirring. Once the addition was 
completed, the mixture was allowed to warm up to rt and stirred for 30 min. To this 
mixture was added a solution of TBSCl (49 mmol, 7.35 g, 1.1 equiv) in 20 mL of THF at 
rt under argon. After 6 h of further stirring, the solution was quenched with saturated 
NH4Cl and extracted with EtOAc. The organic layer was washed sequentially with water 
and brine. Dried over Na2SO4. The solvents were removed under reduced pressure to 
afford a yellow residue that was purified by flash silica gel chromatography using (20-
50% EtOAc-Hexanes) as the eluents to afford 6.6 g of pure E-9 in 72% yield as light 
yellow oil. 1H NMR (300 MHz, CDCl3): δ 5.82 (m, 2H), 4.18 (m, 2H), 4.15 (m, 2H), 
1.68 (bs, 1OH), 0.91 (s, 9H), 0.07 (s, 6H). 13C NMR (75 MHz, CDCl3) δ 130.7, 128.9, 
63.1, 63.0, 25.9, 18.5, -5.3. 
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E-10
–78°C to rt
72%
O
TBSO
OH
TBSO
E-9
(COCl)2, CH2Cl2, 
DMSO; Et3N
H
 
(E)-4-(tert-butyldimethylsilyloxy)but-2-enal (E-10):109 In a 250 mL round bottom 
flask equipped with a stir bar and a septa was added oxalyl chloride (27.2 mmol, 2.36 
mL, 1.1 equiv) in 100 mL of DCM at – 78 °C under argon. To this mixture, DMSO 
(24.7 mmol, 1.75 mL, 1 equiv) was added dropwise and stirred for 30 min. Then, a 
solution of (E)-4-(tert-butyldimethylsilyloxy)but-2-en-1-ol (E-9) (24.7 mmol, 5 g, 1 
equiv) in 20 mL of DCM was added dropwise via syringe and stirred for 10 more min. 
Finally, a solution of Et3N (54.3 mmol, 7.52 mL, 2.2 equiv) in 20 mL of DCM was 
added dropwise via syringe. The mixture was allowed to warm up to rt and stirred for 2 
h. Quenched with saturated NH4Cl and extracted with DCM. The organic layer was 
washed sequentially with water and brine. Dried over Na2SO4. The volatiles were 
removed under reduced pressure to afford a light brown residue that was purified by 
flash silica gel chromatography using (20% EtOAc-Hexanes) as the eluents to afford 
4.35 g of pure E-10 in 88% yield as light yellow oil. 1H NMR (300 MHz, CDCl3): δ 9.61 
(d, J = 8.1 Hz, 1H), 6.89 (dt, J = 3.0, 15.3 Hz, 1H), 6.40 (qt, J = 2.4, 8.1 Hz, 1H), 4.45 
(m, 2H), 0.91 (s, 9H), 0.08 (s, 6H). 13C NMR (75 MHz, CDCl3) δ 193.4, 153.5, 130.5, 
62.2, 25.7, 18.2, -5.5. 
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Procedures and characterization data of adducts: Compounds 26–29, 40 and 41 
are known compounds (Table 1.20). Compounds 30–33 and 36–39 are new compounds. 
Full-tabulated data is available below for all compounds.  
OH
I
OEt
O
 
 (Z)-ethyl 2-[Hydroxy(phenyl)methyl]-3-iodoprop-2-enoate (26): From benzaldehyde 
and ethyl propiolate as described in the general method (see above). Light yellow oil 
(92%). IR (thin film) ν 3443, 3070, 2934, 1719 cm-1. 1H NMR (300 MHz, CDCl3): δ 
7.33 (m, 5 H), 7.27 (d, J = 1.5 Hz, 1 H), 5.55 (s, 1 H), 4.20 (q, J = 7.2 Hz, 2 H), 2.92 (bs, 
1 OH), 1.22 (t, 12.3 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 165.8, 145.0, 140.1, 128.6, 
128.2, 126.5, 86.8, 76.2, 61.4, 13.9. HRMS (CI, CH4) calcd for C12H13IO3+ requires m/z 
331.9909, found 331.9906. HPLC values, with a Chiralcel OJ-H column (hexane/i-PrOH 
= 85/15), 1.0 mL/min, 254 nm, t1= 16.60 min, t2= 21.50 min. 
OH
I
OEt
O
O2N  
(Z)-ethyl 2-[Hydroxy(4-nitrophenyl)methyl]-3-iodoprop-2-enoate (27): From p-
nitrobenzaldehyde and ethyl propiolate as described in the general method (see above). 
Light yellow oil (94%). IR (thin film) ν 3448, 3070, 2950, 2835, 1718 cm-1. 1H NMR 
(300 MHz, CDCl3): δ 8.20 (d, J = 8.4 Hz, 2H), 7.53 (d, J = 8.8 Hz, 2H), 7.42 (s, 1H), 
5.62 (s, 1 H), 4.20 (q, J = 7.2 Hz, 2 H), 3.35 (bs, 1 OH), 1.24 (t, 7.2 Hz, 3H). 13C NMR 
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(75 MHz, CDCl3): δ 166.1, 148.1, 147.7, 144.4, 127.9, 124.4, 89.7, 76.3, 62.5, 14.6. 
HRMS (CI, CH4) calcd for C12H12INO5+ requires m/z 376.9760, found 376.9759. 
OH
I
OEt
O
MeO  
(Z)-ethyl 2-[Hydroxy(4-methoxyphenyl)methyl]-3-iodo-prop-2-enoate (28): From p-
methoxybenzaldehyde and ethyl propiolate as described in the general method (see 
above). Colorless oil (89%). IR (thin film) ν 3451, 3070, 2934, 2836, 1719 cm-1. 1H 
NMR (300 MHz, CDCl3): δ 7.26 (d, J = 10.2 Hz, 2H), 7.25 (s, 1H), 6.89 (d, J = 4.5 Hz, 
2H), 5.52 (s, 1 H), 4.21 (q, J = 7.2 Hz, 2 H), 3.82 (s, 3H), 2.73 (bs, 1 OH), 1.25 (t, 7.2 
Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 165.9, 159.5, 145.3, 132.2, 127.9, 113.9, 86.1, 
75.7, 61.4, 55.3, 13.9. HRMS (CI, CH4) calcd for C13H15IO4+ requires m/z 362.0015, 
found 362.0013. 
OH
I
Me
O
 
(Z)-3-(hydroxy(phenyl)methyl)-4-iodobut-3-en-2-one (29): From benzaldehyde and 
but-3-yn-2-one as described in the general method (see above). Colorless oil (95%). IR 
(thin film) ν 3428, 3061, 2938, 2854, 1701 cm-1. 1H NMR (300 MHz, CDCl3): δ 7.35 
(m, 5H), 6.72 (d, J = 1.2 Hz, 1H), 5.58 (s, 1 H), 2.71 (bs, 1 OH), 2.94 (s, 3H). 13C NMR 
(75 MHz, CDCl3): δ 204.3, 154.2, 139.3, 128.1, 126.2, 124.8, 78.7, 76.2, 30.2. HRMS 
(CI, CH4) calcd for C11H11IO2+ requires m/z 301.9804, found 301.9809. 
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OH
I
OEt
O
Me  
(Z)-ethyl 2-(hydroxy(phenyl)methyl)-3-iodobut-2-enoate (30): From benzaldehyde 
and ethyl but-2-ynoate as described in the general method (see above), except this 
reaction was reacted overnight at reflux dichloromethane. Colorless oil (65%). IR (thin 
film) ν 3445, 3039, 1715 cm-1. 1H NMR (300 MHz, CDCl3): δ 7.41 (m, 5 H), 5.78 (d, J 
= 4.6, 1 H) 4.20 (q, J = 7.2 Hz, 2 H), 3.21 (d, J = 5.4, 1 OH), 2.75(s, 3H), 1.16 (t, 12.3 
Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 167.5, 141.1, 139.8, 128.5, 128.1, 127.5, 124.5, 
70.1, 61.2, 30.5, 13.6. HRMS (CI, CH4) calcd for C13H15IO3+ requires m/z 346.0066, 
found 346.0059. 
OH
I
OEt
O
Ph  
(Z)-ethyl 2-(hydroxy(phenyl)methyl)-3-iodo-3-phenylacrylate (31): From 
benzaldehyde and ethyl 3-phenylpropiolate as described in the general method (see 
above) except this reaction was reacted overnight at reflux dichloromethane. Colorless 
oil (71%). A sample suitable for X-Ray was obtained from a slow evaporation of a 
biphasic mixture of dichloromethane / hexanes. IR (thin film) ν 3439, 3042, 1721 cm-1. 
1H NMR (300 MHz, CDCl3): δ 7.35 (m, 4 H), 7.28 (m, 6 H), 5.28 (d, J = 4.6, 1 H) 4.07 
(q, J = 7.2 Hz, 2 H), 3.41 (d, J = 5.4, 1 OH), 1.02 (t, 12.3 Hz, 3H). 13C NMR (75 MHz, 
CDCl3): δ 168.1, 143.2, 142.5, 141.14, 128.4, 128.1, 125.8, 125.5, 104.1, 81.7, 72.1, 
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61.5, 31.2, 13.8.  HRMS (CI, CH4) calcd for C18H17IO3+ requires m/z 408.0222, found 
408.0225. 
 
OH
I
OEt
O
Ph
 
 
X-Ray Crystal Structure Data for (Z)-ethyl 2-(hydroxy(phenyl)methyl)-3-iodo-3-
phenylacrylate (31): C18H17IO3, M = 408.22, colorless plate, 0.30 x 0.20 x 0.20 mm3, 
monoclinic, space group C2/c, a = 20.654(10), b = 7.358(4), c = 22.576(6) Å, b = 
98.350(6)°, V = 3395(3) Å3, Z = 8, Dc = 1.598 g/cm3, F000 = 1616, MWPC area detector, 
CuKa radiation, l = 0.71069 Å, T = 110(2)K, 2qmax = 120.0º, 14935 reflections collected, 
2902 unique (Rint
 
= 0.0278).  Final GooF = 1.002, R1 = 0.0405, wR2 = 0.0797, R indices 
based on 1451 reflections with I >2sigma(I) (refinement on F2), 200 parameters, 1 
restraint. Lp and absorption corrections applied, m = 1.896 mm-1. Absolute structure 
parameter = -0.6(7) (Flack, H. D. Acta Cryst. 1983, A39, 876-881). Displacement 
ellipsoid plot (50% probability) of 31 is shown above with all atoms numbered. 
Hydrogen atoms have been omitted for clarity. Selected bond distances (Å) and angles 
(deg): I(1)-C(1) 2.131(5), C(1)-C(2) 1.481(6), C(1)-C(8) 1.324(6), C(8)-C(9) 1.531(6), 
C(8)-C(16) 1.496(6), C(8)-C(1)-C(2) 126.8(4), C(8)-C(1)-I(1) 120.3(3), C(2)-C(1)-I(1) 
112.9(3), C(9)-C(8)-C(1) 123.4(4), C(16)-C(8)-C(1) 121.5(4), C(9)-C(8)-C(16) 115.1(4). 
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OH
I
Me
O
Ph
 
(Z)-4-hydroxy-3-(iodomethylene)-6-phenylhex-5-yn-2-one (32): From 3-phenylprop-
2-ynal (E-6) and but-3-yn-2-one as described in the general method (see above). 
Colorless oil (88%). IR (thin film) ν 3433, 3061, 2938, 1705 cm-1. 1H NMR (300 MHz, 
CDCl3): δ 7.45 (d, J = 8.1 Hz, 2H), 7.35 (m, 3H), 7.30 (d, J = 1.2 Hz, 1H), 5.40 (s, 1 H), 
2.82 (bs, 1 OH), 2.62 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 202.8, 150.4, 131.9, 129.2, 
128.5, 121.7, 88.5, 85.4, 82.9, 65.8, 30.4. HRMS (CI, CH4) calcd for C13H11IO2+ 
requires m/z 325.9804, found 325.9809. 
OH
I
OEt
O
Ph
 
(Z)-ethyl 3-hydroxy-2-(iodomethylene)-5-phenylpent-4-ynoate (33): From 3-
phenylprop-2-ynal (E-6) and ethyl propiolate as described in the general method (see 
above). Colorless oil (85%). IR (thin film) ν 3444, 3037, 1719 cm-1. 1HNMR (300 MHz, 
CDCl3): δ 7.72 (d, J = 1.2 Hz, 1H), 7.45 (m, 2H), 7.34 (m, 3H), 5.44 (d, J = 1.2 Hz, 1H), 
4.36 (q, J = 7.2 Hz, 2 H), 3.12 (d, J = 6.6 Hz, 1 OH), 1.40 (t, 7.2 Hz, 3H). 13C NMR (75 
MHz, CDCl3): δ 165.3, 141.7, 131.7, 128.5, 128.3, 121.7, 89.6, 87.8, 85.5, 65.2, 61.8, 
14.1. HRMS (CI, CH4) calcd for C14H13IO3+ requires m/z 355.9909, found 355.9905. 
 
 
 63 
OH
I
OEt
O
Ph  
(2Z,4E)-ethyl 3-hydroxy-2-(iodomethylene)-5-phenylpent-4-enoate (34): From trans-
cinnamaldehyde and ethyl propiolate as described in the general method (see above). 
Light yellow oil (91%). IR (thin film) ν 3443, 3070, 2934, 1719 cm-1. 1H NMR (300 
MHz, CDCl3): δ 7.34 (m, 6 H), 6.66 (dd, J = 1.2, 14.7 Hz, 1 H), 6.21 (dd, J = 6.6, 9.3 
Hz, 1 H), 5.13 (d, J = 5.4 Hz, 1 H), 4.32 (q, J = 7.2 Hz, 2 H), 2.95 (bs, 1 OH), 1.35 (t, 
7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 165.9, 144.6, 135.9, 132.3, 128.6, 128.1, 
127.7, 126.6, 86.5, 74.9, 61.6, 14.1. HRMS (ESI) calcd for C14H15IO3 - H requires m/z 
356.9982, found 356.9981. 
OH
I
OEt
O
Me  
(2Z,4E)-ethyl 3-hydroxy-2-(iodomethylene)hex-4-enoate (35): From trans-
crotonaldehyde and ethyl propiolate as described in the general method (see above). 
Colorless oil (86%). IR (thin film) ν 3434, 3094, 2924, 2850, 1718 cm-1. 1H NMR (300 
MHz, CDCl3): δ 7.18 (d, J = 3.3 Hz, 1 H), 5.76 (m, 1 H), 5.48 (m, 1 H), 4.86 (d, J = 5.1 
Hz, 1 H), 4.32 (q, J = 7.2 Hz, 2 H), 2.62 (bs, 1 OH), 1.70 (d, J = 6.6 Hz, 3 H), 1.35 (t, 
7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 166.1, 145.3, 129.8, 129.5, 85.3, 74.9, 61.4, 
17.7, 14.1. HRMS (ESI) calcd for C9H13IO3 - H requires m/z 294.9826, found 294.9822. 
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OH
I
OEt
O
Ph  
(Z)-ethyl 3-hydroxy-2-(iodomethylene)-5-phenylpentanoate (36): From 3-
phenylpropanal and ethyl propiolate as described in the general method (see above). 
Light yellow oil (85%). IR (thin film) ν 3441, 3059, 2934, 1719 cm-1. 1H NMR (300 
MHz, CDCl3): δ 7.25 (m, 2 H), 7.18 (m, 3 H), 7.09 (s, 1 H), 4.39 (t, J = 5.4 Hz, 1 H), 
4.30 (q, J = 7.2 Hz, 2 H), 2.73, (m, 2 H), 2.65 (bs, 1 OH), 1.94 (q, J = 7.3 Hz, 2 H), 1.34 
(t, 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 166.4, 146.6, 141.3, 128.6, 128.5, 126.1, 
84.8, 74.3, 61.6, 37.6, 31.8, 14.2. HRMS (ESI) calcd for C14H17IO3 - H requires m/z 
359.0139, found 359.0138. 
OH
I
OEt
O
TBSO
 
(2Z,4E)-ethyl 3-hydroxy-2-(iodomethylene)hex-4-enoate (37): From (E)-4-(tert-butyl-
dimethylsilyloxy)but-2-enal (E-10) and ethyl propiolate as described in the general 
method (see above). Light yellow oil (89%). IR (thin film) ν 3443, 3094, 2925, 2848, 
1719 cm-1. 1H NMR (300 MHz, CDCl3): δ 7.21 (d, J = 1.2 Hz, 1 H), 5.81 (m, 2 H), 4.97 
(s, 1 H), 4.28 (q, J = 7.6 Hz, 2 H), 4.16 (m, 2 H), 2.71 (bs, 1 OH), 1.34 (t, 7.2 Hz, 3H), 
0.89 (s, 9 H), 0.05 (s, 6 H), 13C NMR (75 MHz, CDCl3): δ 166.1, 144.9, 132.7, 128.3, 
86.2, 74.5, 62.8, 61.6, 26.0, 18.5, 14.3, -5.2. HRMS (ESI) calcd for C15H27IO4Si - H 
requires m/z 425.0640, found 425.0638. 
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OH
I
Ph
O
Ph  
(2Z,4E)-3-hydroxy-2-(iodomethylene)-1,5-diphenylpent-4-en-1-one (38): From trans-
cinnamaldehyde and 1-phenylprop-2-yn-1-one (E-4) as described in the general method 
(see above). Light yellow solid (96%). IR (thin film) ν 3433, 3060, 2938, 1703 cm-1. 1H 
NMR (300 MHz, CDCl3): δ 8.00 (d, J = 7.2 Hz, 2 H), 7.59 (m, 1 H), 7.48 (m, 3 H), 7.29 
(m, 4 H), 6.92 (d, J = 0.9 Hz, 1 H), 6.66 (d, J = 15.9 Hz, 1 H), 6.24 (dd, J = 7.2, 8.7 Hz, 
1 H), 5.18 (s, 1 H), 2.77 (bs, 1 OH). 13C NMR (75 MHz, CDCl3): δ 197.8, 152.5, 135.8, 
134.5, 133.9, 132.8, 129.9, 129.0, 128.5, 128.1, 127.2, 126.6, 79.8, 76.0. HRMS (ESI) 
calcd for C18H15IO2 - H requires m/z 389.0033, found 389.0037. 
OH
I
Ph
O
Me  
(2Z,4E)-3-hydroxy-2-(iodomethylene)-1-phenylhex-4-en-1-one (39): From trans-
crotonaldehyde and 1-phenylprop-2-yn-1-one (E-4) as described in the general method 
(see above). Light yellow solid (93%). IR (thin film) ν 3425, 3065, 2932, 1702 cm-1. 1H 
NMR (300 MHz, CDCl3): δ 7.98 (d, J = 5.7 Hz, 2 H), 7.63 (t, J = 4.9 Hz, 1 H), 7.48 (t, J 
= 7.2 Hz, 2 H), 6.83 (d, J = 1.5 Hz, 1 H), 5.76 (m, 1 H), 5.55 (dd, J = 8.7, 6.3 Hz, 1 H), 
4.93 (d, J = 6.9 Hz, 1 H), 2.27 (bs, 1 OH), 1.66 (d, J = 6.3 Hz, 3 H). 13C NMR (75 MHz, 
CDCl3): δ 198.2, 152.8, 133.9, 130.3, 129.9, 129.5, 128.8, 83.5, 79.0, 76.1, 17.6. HRMS 
(ESI) calcd for C13H13IO2 - H requires m/z 326.9876, found 326.9873. 
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I
Me
O
Me  
(3Z,5E)-4-hydroxy-3-(iodomethylene)hept-5-en-2-one (40): From trans-
crotonaldehyde and but-3-yn-2-one as described in the general method (see above). 
Light yellow solid (92%). IR (thin film) ν 3423, 3060, 2938, 1700 cm-1. 1H NMR (300 
MHz, CDCl3): δ 6.71 (d, J = 1.2 Hz, 1 H), 5.78 (m, 1 H), 5.50 (m, 1 H), 4.78 (d, J = 6.8 
Hz, 1 H), 2.46 (s, 3 H), 2.35 (d, J = 6.3 Hz, 1 OH), 1.73 (d, J = 4.4 Hz, 3 H). 13C NMR 
(75 MHz, CDCl3): δ 204.3, 154.4, 130.3, 129.7, 78.5, 75.7, 30.4, 17.8. HRMS (ESI) 
calcd for C8H11IO2 - H requires m/z 264.9720, found 264.9719. 
OH
I
Me
O
Ph  
(3Z,5E)-4-hydroxy-3-(iodomethylene)-6-phenylhex-5-en-2-one (41): From trans-
cinnamaldehyde and but-3-yn-2-one as described in the general method (see above). 
Light yellow solid (90%). IR (thin film) ν 3421, 3064, 2936, 1701 cm-1. 1H NMR (300 
MHz, CDCl3): δ 7.36 (m, 5 H), 6.87 (d, J = 1.2 Hz, 1 H), 6.68 (d, J = 15.9 Hz, 1 H), 6.21 
(dd, J = 7.1, 8.9 Hz, 1 H), 5.13 (t, J = 7.2 Hz, 1 H), 2.54 (s, 3 H), 1.62 (s, 1 OH). 13C 
NMR (75 MHz, CDCl3): δ 204.1, 153.8, 135.9, 132.9, 128.8, 128.4, 127.5, 126.8, 79.9, 
75.8, 30.5. HRMS (ESI) calcd for C13H13IO2 - H requires m/z 326.9876, found 326.9879. 
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1.3.7 1,3-Allylic Transposition of β-Iodo BH Adducts 
 
A β-iodo Baylis-Hillman adduct 34, 35 or 38 (0.1 mmol; 1.0 equiv) was added to 
a solution of MgI2 (28 mg, 0.1 mmol; 1.0 equiv) in dichloromethane (5 mL) at room 
temperature under argon. The mixture was then stirred for 6 h at reflux dichloromethane. 
Then, the reaction was quenched with saturated ammonium chloride (5 mL). The 
reaction mixture was diluted with Et2O (20 mL), washed with distilled water (10 mL) 
and brine (10 mL), dried over sodium sulfate, and concentrated under reduce pressure. 
The crude products were purified by flash silica gel column chromatography using (0-
10% EtOAc-Hexanes) as the eluents to afford the pure adducts 50-52. 
 
Scheme 1.22 1,3-Allylic transposition adducts and yields. 
OH
I
O
OEt
CH2Cl2, reflux
MgI2 (1 equiv)
Ph
O
OEt
Ph H O
O
Ph
Ph H O
E/Z 1:1, 98% yield
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OH
I
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OEt
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MgI2 (1 equiv)
Me I
O
OEtMe
OH
5235
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99% yield, E/Z 1:1
OH
I
O
Ph
CH2Cl2, reflux
MgI2 (1 equiv)
Ph
38
60%  
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Procedures and characterization data of 1,3 allylic transposition adducts: 
Compounds 50–52 are new compounds. Full-tabulated data is available below for all 
compounds. 
O
OEt
O
Ph H  
(4E)-ethyl 2-formyl-5-phenylpenta-2,4-dienoate (50): From adduct 34 as described in 
the general procedure (see above). Light yellow oil (99%). 1:1 mixture of isomers: IR 
(thin film) ν 3076, 3026, 2871, 2789, 1692 cm-1. 1H NMR (300 MHz, CDCl3): δ 10.21 
(d, J = 3.0 Hz, (Z) isomer, 1 CHO), 9.95 (s, (E) isomer, 1 CHO), 8.30 (dd, J = 9.0, 3.3 
Hz, 1 H ), 7.95 (dd, J = 12.0, 3.6 Hz, 1 H ), 7.64 (dd, J = 1.8, 10.9 Hz, 1 H ), 7.56 (m, 5 
H), 7.37 (m, 6 H), 7.27 (s, 1 H), 7.21 (s, 1 H), 4.36 (m, 4 H), 1.38 (m, 6H). 13C NMR (75 
MHz, CDCl3): δ 191.4, 189.7, 166.1, 164.9, 151.1, 150.8, 149.9, 135.3, 135.2, 130.7, 
130.6, 129.1, 128.9, 128.8, 128.5, 128.3, 126.3, 124.4, 124.0, 123.6, 61.0, 60.9, 14.2. 
HRMS (ESI) calcd for C14H14O3 + Li requires m/z 237.1103, found 237.1104. 
O
Ph
O
Ph H  
(2E,4E)-5-phenyl-2-(phenylcarbonyl)penta-2,4-dienal (51): From adduct 38 as 
described in the general procedure (see above). Light yellow oil (98%). 5:1 mixture of 
isomers: IR (thin film) ν 3066, 3018, 2875, 2783, 1731, 1692 cm-1. (E) isomer: 1H NMR 
(300 MHz, CDCl3): δ 9.73 (s, (E) isomer, 1 CHO), 7.90 (m, 2 H), 7.61 (tt, J = 1.2, 7.5 
Hz, 1 H), 7.50 (m, 3H), 7.42 (m, 2H), 7.33 (m, 3H), 7.19 (d, J = 15.3 Hz, 1 H), 6.99 (dd, 
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J = 11.4, 3.9 Hz, 1 H) . 13C NMR (75 MHz, CDCl3): δ 194.5, 190.4, 150.8, 146.4, 139.4, 
136.7, 135.1, 134.0, 130.4, 129.5, 128.9, 128.8, 128.0, 123.1. HRMS (ESI) calcd for 
C18H14O2 + Li requires m/z 269.1154, found 269.1149. 
I
OEt
O
Me
OH
 
(2Z,3E)-ethyl 5-hydroxy-2-(iodomethylene)hex-3-enoate (52): From adduct 35 as 
described in the general procedure (see above). Light yellow oil (60%). IR (thin film) ν 
3434, 3094, 2924, 2850, 1719 cm-1. 1H NMR (300 MHz, CDCl3): δ 7.69 (s, 1 H), 6.60 
(dd, J = 5.7, 10.2 Hz, 1 H), 6.40 (d, J = 16.0 Hz, 1 H), 4.45 (quintet, J = 5.3 Hz, 1 H), 
4.26 (q, J = 7.2 Hz, 2 H), 1.56 (bs, 1 OH), 1.33 (t, 7.2 Hz, 3H), 0.85 (d, J = 6.6 Hz, 3 H), 
13C NMR (75 MHz, CDCl3): δ 163.1, 142.3, 138.7, 125.2, 97.7, 68.7, 61.4, 23.1, 14.1. 
HRMS (ESI) calcd for C9H13IO3 - H requires m/z 294.9826, found 294.9821 and for 
C9H13IO3 + H requires m/z 296.9988, found 296.9987. 
 
1.3.8 Synthesis of Abnormal BH Adducts 
 
 
Ar
O
CO2Et
Ar
CO2Et
OH
Ar
OO
Ar
54
CO2Et55
H
Ar=p-NO2C6H4–
CH2Cl2, rt, 2 h
DMAP or PPh3
5345  
To an 8 mL glass vial containing a stir bar was added the nucleophile (0.018 
mmol, 0.05 equiv) and p-nitrobenzaldehyde (45) (0.367 mmol, 1.0 equiv), then the vial 
was capped with a phenolic cap equipped with a teflon/silicone septa. The vial was filled 
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and purged with argon. A solution of ethyl buta-2,3-dienoate (53) (0.477 mmol, 1.3 
equiv,) in dry dichloromethane (4 mL) was added via syringe under argon. The mixture 
was stirred for 2 h at room temperature. The reaction mixture was concentrated under 
reduce pressure. Finally, the residue was loaded to a flash silica gel column 
chromatography and purified using (0-10% EtOAc-Hexanes) as the eluents to afford the 
pure adducts 54-55. 
 
Procedures and characterization data of adducts: Full-tabulated data is available 
below for compounds 54 and 55.  
OH O
OEt
O2N  
Ethyl 2-(hydroxy(4-nitrophenyl)methyl)buta-2,3-dienoate (54): From p-nitro-
benzaldehyde, ethyl buta-2,3-dienoate and DMAP as described in the general method 
(see above). Light yellow oil (99%). IR (thin film) ν 3465, 2917, 1704 cm-1. 1H NMR 
(300 MHz, CDCl3): δ 8.12 (dd, J = 1.8, 7.5 Hz, 2 H), 7.50 (dd, J = 1.5, 9.0 Hz, 2 H), 
5.60 (d, J = 6.0 Hz, 1 H), 5.12 (d, J = 2.7 Hz, 2 H), 4.15 (q, J = 7.2 Hz, 2 H), 3.66 (d, J 
= 2.7 Hz, 1 OH), 1.21 (t, 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 212.9, 166.6, 
148.4, 127.2, 127.1, 123.4, 102.1, 81.6, 71.3, 61.8, 14.1. HRMS (EI) calcd for C13H13IO5 
requires m/z 263.0794, found 263.0796. HPLC values, with a Chiralcel OJ-H column 
(hexane/i-PrOH = 85/15), 1.0 mL/min, 254 nm, t1= 14.60 min, t2= 16.13 min. 
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O2N
O
EtO O
NO2
 
(E)-ethyl 2-(2,6-bis(4-nitrophenyl)-1,3-dioxan-4-ylidene) ethanoate (55): From p-
nitrobenzaldehyde, ethyl buta-2,3-dienoate and PPh3 as described in the general method 
(see above). Light yellow solid (99%). IR (thin film) ν 3070, 2917, 1709 cm-1. 1H NMR 
(300 MHz, CDCl3): δ 8.31 (m, 4H), 7.85 (d, J = 7.5 Hz, 2 H), 7.61 (d, J = 7.2 Hz, 2 H), 
6.18 (s, 1H), 5.22 (m, 2 H), 4.22 (q, J = 7.2 Hz, 2 H), 2.65 (m, 2 H), 1.21 (t, 7.2 Hz, 3H). 
13C NMR (75 MHz, CDCl3): δ 177.9, 164.1, 160.5, 148.1, 146.5, 141.8, 128.1, 127.7, 
123.8, 123.1, 104.1, 101.6, 98.1, 59.8, 36.5, 14.1. HRMS (EI) calcd for C13H13IO5 
requires m/z 263.0794, found 263.0796. 
 
1.3.9 Synthesis of Ammonium Salts (VII-XIV) 
 
To a stirred mixture of secondary amine (100 mmol) in Et2O (100 mL) at 0 °C is 
added dropwise the acidic counter-anion (100 mmol). The reaction mixture is stirred at 0 
°C for 5 min. The new-formed crystals are filtered and washed with Et2O (20 mL), dried 
under vacuum to afford the pure white crystalline salt. 
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1.3.10 General Procedure for the α-Methylenation 
 
To a mixture of a carbonyl compound (1.0 mmol) and paraformaldehyde (2.0 
mmol, 200 mol %) in dry THF (1.0 mL) is added the catalyst (1.0 mmol, 100 mol %) 
and trifluoroacetic acid (0.1 mmol, 10 mol %). The reaction mixture is stirred at reflux 
for 2 h, the mixture will become clear, then the reaction mixture is cooled down to room 
temperature and a second addition of paraformaldehyde (2.0 mmol, 200 mol %) is 
performed. Next, the reaction mixture is stirred at reflux for an additional 6 h open to the 
atmosphere. The reaction mixture is cooled down and the solvent is removed under 
reduce pressure, dissolved with Et2O and washed with 1N HCl, 1N NaOH, and brine. 
The solution mixture is dried (Na2SO4) and concentrated under vacuum. The crude 
product is purified by silica gel column chromatography using 5% (Et2O–Hexanes or 
EtOAc–Hexanes) as the eluents (Table 1.21).  
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Table 1.21 References to known compounds (α-methylenation).83,91,110-123 
O
Cl
Adduct (#) ReferenceProduct
57
58
59
60
61
62
63
ReferenceProduct Adduct (#)
Ph
O
t-Bu
O
Cy
O
O
O
O
Me
Me Me
Me
64
65
O
Me
O
CO2Et
74
67
75
76
70
68
O
O
H
O
Ph
O
OH
O
Ot-But-BuO
OO
Me
O
O
Ph
83
91
110
111
112
91
113
114
115
119
117
116
115
123
114
120NH2Me
CF3CO2
H
TBDPSO
VII
Me H
Me Me O
CO2H
Ph
O
Ph
O
69 115
66
O
122
72 118
73 121
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1.3.11 Characterization of Ammonium Salts VII-XIV 
 
NH2Me
CF3CO2  
N-methylbenzenaminium 2,2,2-trifluoroacetate (VII): To a stirred mixture of N-
methyl aniline (100 mmol, 10.7 g) in Et2O (100 mL) at 0 °C was added trifluoroacetic 
acid dropwise (100 mmol, 11.2 g). The reaction mixture was stirred at 0 °C for an 
additional 5 min. The new-formed crystals were filtered and washed with Et2O (20 mL), 
dried under vacuum to afford pure compound VII (21.04 g, 96%) as white solid; IR (thin 
film) ν 3418, 3002, 2717, 2496, 1676, 1601, 1204 cm-1; 1H NMR (CDCl3, 300 MHz) δ 
10.02 (bs, 2NH), 7.46–7.38 (m, 5H), 2.98 (s, 3H). 13C NMR (CDCl3, 75 MHz) δ 162.6 
(q, J = 35 Hz), 137.9, 130.2, 128.9, 121.8, 116.3 (q, J = 288 Hz), 37.6. HRMS (ESI+) 
calcd for C7H10N requires m/z 108.0808, found 108.0812. HRMS (ESI–) calcd for 
C2F3O2 requires m/z 112.9850, found 112.9853. 
NH2Me
CH3CO2  
N-methylbenzenaminium acetate (VIII): To a stirred neat freshly distilled N-methyl 
aniline (100 mmol, 10.7 g) at 0 °C was added freshly distilled acetic acid dropwise (100 
mmol, 11.2 g). The reaction mixture was stirred at 0 °C for an additional 5 min to afford 
pure compound VIII (21.8 g, 99%) as colorless oil; IR (thin film) ν 3413, 3051, 2907, 
2814, 1713, 1606, 1510 cm-1; 1H NMR (CDCl3, 300 MHz) δ 7.23 (t, J = 8.2 Hz, 2H), 
6.99 (bs, 2NH), 6.76 (t, J = 7.6 Hz, 1H), 6.66 (d, J = 7.7 Hz, 2H), 2.85 (s, 3H), 2.11 (s, 
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3H). 13C NMR (CDCl3, 75 MHz) δ 177.7, 149.0, 129.1, 117.5, 112.7, 30.7, 20.8. HRMS 
(ESI+) calcd for C7H10N requires m/z 108.0808, found 108.0812. HRMS (ESI–) calcd 
for C2H3O2 requires m/z 59.0139, found 59.0138. 
NH2Me
Cl  
N-methylbenzenaminium chloride (IX): To a stirred mixture of N-methyl aniline (100 
mmol, 10.7 g) in Et2O (100 mL) at 0 °C was bubbled excess hydrochloric acid gas (from 
ammonium chloride and sulfuric acid) for 10 min. The reaction mixture was stirred at 0 
°C for an additional 5 min. The new-formed crystals were filtered and washed with Et2O 
(20 mL), dried under vacuum to afford pure compound IX (8.54 g, 64%) as colorless 
crystals; IR (thin film) ν 3417, 2689, 2458, 1600, 1497 cm-1; 1H NMR (CDCl3, 300 
MHz) δ 11.23 (bs, 2NH), 7.50 (d, J = 5.5 Hz 2H), 7.26 (m, 3H), 2.87 (s, 3H). 13C NMR 
(CDCl3, 75 MHz) δ 136.8, 129.8, 129.2, 122.3, 37.7. HRMS (ESI+) calcd for C7H10N–
Cl requires m/z 108.0808, found 108.0812.  
N
H2
CF3CO2  
1,2,3,4-tetrahydroquinolinium 2,2,2-trifluoroacetate (X): To a stirred mixture of 
1,2,3,4-tetrahydroquinoline (100 mmol, 13.3 g) in Et2O (100 mL) at 0 °C was added 
trifluoroacetic acid dropwise (100 mmol, 11.2 g). The reaction mixture was stirred at 0 
°C for and additional 5 min. The new-formed crystals were filtered and washed with 
Et2O (20 mL), dried under vacuum to afford pure compound X (22.3 g, 91%) as white 
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solid; IR (thin film) ν 3424, 2945, 2750, 1503, 1663, 1190 cm-1; 1H NMR (CDCl3, 300 
MHz) δ 11.05 (bs, 2NH), 7.36-7.19 (m, 4H,), 3.48 (t, J = 5.5 Hz, 2H), 2.91 (t, J = 6.7 
Hz, 2H), 2.18 (q, J = 5.5 Hz, 2H). 13C NMR (CDCl3, 75 MHz) δ 162.6 (q, J = 37 Hz), 
131.3, 130.4, 130.3, 128.2, 127.4, 122.8, 116.4 (q, J = 288 Hz), 42.3, 25.0, 19.6. HRMS 
(ESI+) calcd for C9H12N requires m/z 134.0964, found 134.0969. HRMS (ESI–) calcd 
for C2F3O2 requires m/z 112.9850, found 112.9853. 
NH2
CF3CO2  
Piperidinium 2,2,2-trifluoroacetate (XI): To a stirred mixture of piperidine (100 
mmol, 8.5 g) in Et2O (100 mL) at 0 °C was added trifluoroacetic acid dropwise (100 
mmol, 11.2 g). The reaction mixture was stirred at 0 °C for an additional 5 min. The 
new-formed crystals were filtered and washed with Et2O (20 mL), dried under vacuum 
to afford pure compound XI (16.15 g, 82%) as white solid; IR (thin film) ν 3430, 2966, 
2867, 2550, 1697, 1203 cm-1; 1H NMR (CDCl3, 300 MHz) δ 9.03 (bs, 2NH), 3.03 (m, 
4H), 1.76 (m, 4H), 1.60 (m, 2H). 13C NMR (CDCl3, 75 MHz) δ 162.2 (q, J = 35 Hz), 
116.5 (q, J = 293 Hz), 44.4, 22.4, 22.2. HRMS (ESI+) calcd for C5H12N requires m/z 
86.0964, found 86.0960. HRMS (ESI–) calcd for C2F3O2 requires m/z 112.9850, found 
112.9853. 
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NH2O
CF3CO2  
Morpholin-4-ium 2,2,2-trifluoroacetate (XII): To a stirred mixture of morpholine (100 
mmol, 8.7 g) in Et2O (100 mL) at 0 °C was added trifluoroacetic acid dropwise (100 
mmol, 11.2 g). The reaction mixture was stirred at 0 °C for an additional 5 min. The 
new-formed crystals were filtered and washed with Et2O (20 mL), dried under vacuum 
to afford pure compound XII (16.71 g, 84%) as white solid; IR (thin film) ν 3426, 3004, 
2872, 2513, 1681, 1204 cm-1; 1H NMR (CDCl3, 300 MHz) δ 8.39 (bs, 2NH), 3.89 (m, 
4H), 3.16 (m, 4H). 13C NMR (CDCl3, 75 MHz) δ 162.3 (q, J = 35 Hz), 116.5 (q, J = 290 
Hz), 63.6, 43.2. HRMS (ESI+) calcd for C4H10NO requires m/z 88.0757, found 88.0752. 
HRMS (ESI–) calcd for C2F3O2 requires m/z 112.9850, found 112.9853. 
NH2
CF3CO2  
Pyrrolidinium 2,2,2-trifluoroacetate (XIII): To a stirred mixture of pyrrolidine (100 
mmol, 7.1 g) in Et2O (100 mL) at 0 °C was added trifluoroacetic acid dropwise (100 
mmol, 11.2 g). The reaction mixture was stirred at 0 °C for an additional 5 min. The 
new-formed crystals were filtered and washed with Et2O (20 mL), dried under vacuum 
to afford pure compound XIII (17.01 g, 93%) as white solid; IR (thin film) ν 3413, 
2994, 2785, 2491, 1676, 1202 cm-1; 1H NMR (CDCl3, 300 MHz) δ 9.57 (bs, 2 NH), 3.20 
(t, J = 6.15 Hz, 4 H), 1.97 (m, 4 H). 13C NMR (CDCl3, 75 MHz) δ 162.1 (q, J = 34.4 
Hz), 116.5 (q, J = 292 Hz), 44.9, 24.1. HRMS (ESI+) calcd for C4H10N requires m/z 
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72.0808, found 72.0809. HRMS (ESI–) calcd for C2F3O2 requires m/z 112.9850, found 
112.9853. 
Me
N
H
Me
Me Me
CF3CO2  
Diisopropylammonium 2,2,2-trifluoroacetate (XIV): To a stirred mixture of 
diisopropylamine (100 mmol, 10.1 g) in Et2O (100 mL) at 0 °C was added trifluoroacetic 
acid dropwise (100 mmol, 11.2 g). The reaction mixture was stirred at 0 °C for an 
additional 5 min. The new-formed crystals were filtered and washed with Et2O (20 mL), 
dried under vacuum to afford pure compound XIV (20.23, 95%) as white solid; IR (thin 
film) ν 3436, 3048, 2794, 2503, 1675, 1601, 1190 cm-1; 1H NMR (CDCl3, 300 MHz) δ 
8.91 (bs, 2NH), 3.35 (h, J = 6.5 Hz, 2H), 1.31 (d, J = 6.6 Hz, 12H). 13C NMR (CDCl3, 
75 MHz) δ 161.6 (q, J = 35.5 Hz), 116.5 (q, J = 288 Hz), 46.8, 18.7. HRMS (ESI+) 
calcd for C6H16N requires m/z 102.1283, found 102.1286. HRMS (ESI–) calcd for 
C2F3O2 requires m/z 112.9850, found 112.9853. 
 
1.3.12 Characterization of the Unknown Adducts 69 and 71 
 
Me H
Me Me O
 
(S)-3,7-Dimethyl-2-methylene-6-octanal (69). The reaction was carried out following 
the general procedure using (S)-citronellal to yield 153 mg (92%) of 69 as colorless oil. 
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Lit. [α]20D = +5.2 (c = 13.4 in CHCl3).115 Obtained [α] 20D = +5.35 (c = 1.00 in CHCl3); 
1H NMR (CDCl3, 300 MHz): δ 9.53 (s, 1H); 6.22 (s, 1H); 5.98 (s, 1H); 5.07 (tt, 1H, J = 
1.2, 7.2 Hz); 2.71 (sextet, 1H, J = 6.8 Hz); 1.93 (m, 2H); 1.66 (s, 3H); 1.56 (s, 3H); 1.51 
(m, 1H); 1.37 (m, 1H) 1.06 (d, 3H, J = 6.8 Hz) 13C NMR (CDCl3, 75 MHz): δ 194.6, 
155.5, 132.9, 131.6, 124.1, 35.5, 30.9, 25.7, 25.6, 19.5, 17.6.  
O
TES  
5-(triethylsilyl)pent-1-en-4-yn-3-one (71): To a mixture of a 4-(triethylsilyl)but-3-yn-
2one (58 mg, 0.313 mmol) and paraformaldehyde (17 mg, 0.626 mmol) in dry THF (3 
mL) was added salt XIV (68 mg, 0.313 mmol) and i-PrNH2 (89 µL, 0.626 mmol) at 
room temperature. The reaction mixture was stirred at reflux until completion (2 h). 
Then, the reaction mixture was cooled down to room temperature and the solvent was 
removed under reduce pressure. The crude mixture was purified by silica gel column 
chromatography using 10% (EtOAc–Hexanes) as the eluent, to afford pure compound 71 
(38 mg, 62% yield) as colorless oil; IR (thin film) ν 2958, 2877, 1655, 1612, 1275, 1243, 
991, 819, 729 cm-1; 1H NMR (CDCl3, 300 MHz) δ 6.62 (dd, J = 1.25, 17.4 Hz, 1H), 6.41 
(dd, J = 1.03, 17.4 Hz, 1H), 6.22 (dd, J = 1.24, 10.3 Hz, 1H), 1.05 (t, J = 8.33 Hz, 9H), 
0.72 (q, J = 8.03 Hz, 6H). 13C NMR (CDCl3, 75 MHz) δ 178.6, 137.9, 133.9, 100.9, 
97.5, 7.3, 3.5. HRMS (ESI+) calcd for C11H19OSi requires m/z 195.1205, found 
195.1202. 
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CHAPTER II 
CHIRAL NICKEL AND PALLADIUM NCN-PINCER COMPLEXES AND 
THEIR APPLICATION IN CROSS–COUPLING 
 
2.1 Introduction and Background 
The development of chiral Lewis acid catalysts for the formation of carbon–
carbon (C–C) bonds is currently a challenging, but yet attractive endeavor in organic 
chemistry.124,125 Chelating aryl ligands have been utilized on metal centers that are 
catalytically active in a variety of C–C and C-X bond forming reactions.124,126 One such 
class of chelating ligands is the phebox ligand framework.127 Phebox ligands have three 
donor sites, one central C and two flanking N-atoms in fixed positions, making them so-
called “NCN-pincer” ligands.  The chelating sites are bonded to an aryl ring by one sp2 
carbon and two sp2 nitrogen centers (Figure 2.1).  
NR1
NR1
NR1
NR1
M
A B  
Figure 2.1 General structure of an “NCN-pincer” ligand (A) and an M(NCN)-pincer 
complex (B). 
This arrangement results in binding to metal centers that are predicted to be less 
flexible than other aryldiamine ligands.128,129 Another interesting feature of this class of 
ligands is the ease with which a number of chiral analogues can be synthesized from 
readily available homochiral amino alcohols.124,130 Organometallic pincer complexes of 
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the general structure B are multipurpose, often air-stable compounds that have attracted 
interest in catalysis.131 These pincer ligands can coordinate a variety of transition metals, 
including Ni,132,133 Pd,126,134-136 Pt,132,135,137 and Rh,124,130 to form complexes with C2-
symmetry.  The modular nature of these structures allow for straightforward 
modification of the activity of the metal center via steric and electronic effects. For 
example, metal complexes of these ligands can be transformed into cationic complexes 
for use in Lewis acid catalyzed reactions.127,132 
Shortly after the first report of the original pincer complexes in 1970s by Shaw138 
and van Koten,139 a large number of different pincer complexes has been synthesized 
and studied in miscellaneous catalytic applications, specially on palladium 
catalysis.140,141 The synthesis of palladium pincer complexes is sometimes considerated 
the limited factor for their application in catalysis due to proligands and complexes 
syntheses. 
We were inspired to develop a straightforward synthesis of air and moisture 
stable chiral NCN pincer complexes using short and simple reaction conditions. Also, 
the complexation with Pd(II) and Ni(II) to form NCN-pincer complexes was explored. 
Finally, they were applied to the highly selective α-arylation of ketones with a variety of 
aryl bromides and other metal catalyzed C-C bond-forming reactions. 
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2.2 Results and Discussion 
  
2.2.1 Pincer Ligand Syntheses  
 
Thirteen chiral phebox ligands were synthesized using modified literature 
procedures.124,130,142,143 All the chiral phebox ligands were derived from the 
aminoalcohols L-valine, L-phenylalanine and D-phenylglycine. The synthesis of [(S,S)-
phebox-i-Pr]Br (77a) was performed via the combination of methodologies reported by 
Nishiyama124 in 2001 and Kanazawa in 2006 (Scheme 2.1).130 2-Bromoisophthalic 
chloride (78) was obtained from 2-bromo-m-xylene using the reported protocol124 and 
coupled to two equivalents of L-valinol to form a bisamide,144 followed by 
MeSO2Cl/NEt3-promoted cyclization130 to furnish the pincer ligand 77a in 76% yield. 
 
Scheme 2.1 Synthesis of [(S,S)-phebox-i-Pr]Br (77a), [(R,R)-phebox-Ph]Br (77b) and 
[(S,S)-phebox-Bn]Br (77c). 
ClOC COCl
Br
77a
77b: R = Ph, R1 = H (67%)
77c: R = H, R1 = Bn (65%)
O
N N
O
i-Pr i-Pr
Br
O
N N
O
Br
R R1R R1
    L-valinol, Et3N
Amino alcohol, 
Et3N, CH2Cl2;
then BF3•Et2O
then MeSO2Cl
76%
78
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Pincer ligands [(R,R)-phebox-Ph]Br (77b) and [(S,S)-phebox-Bn]Br (77c) were 
synthesized using a similar procedure from acyl chloride 78 and D-phenylgycinol144 or 
L-phenylalaninol,144 respectively, to give the corresponding bisamides, from which 
bis(oxazolines) were formed using methodology reported by Davies et al,145 that utilizes 
BF3•Et2O to induce the cyclization to give 77b and 77c, in 67% and 65% yields, 
respectively (Scheme 2.1). 
The pincer ligand 77d was derived form commercially available isophthaloyl 
dichloride, which was transformed to the known pincer precursor (S,S)-phebox-i-Pr (79) 
using the known procedure.130 The resulting pincer ligand 79 was halogenated using the 
methodology of Richards et al132 by treatment of (S,S)-phebox-i-Pr (79) with 
LDA/TMEDA, followed by the addition of iodine to give [(S,S)-phebox-i-Pr]I (77d) 
(Scheme 2.2). Although bromine was initially employed as the electrophile in this 
halogenation, iodine resulted in a better yield for this transformation (11% vs 55%, 
respectively). 
Scheme 2.2 Synthesis of [(S,S)-phebox-i-Pr]I (77d). 
O
N N
O
i-Pr i-Pr
I
77d
   LDA/TMEDA
THF;
then I2, 55%
O
N N
O
i-Pr i-Pr79  
 
The pincer ligand 80a was derived form commercially available 5-tert-butyl-
isophthalic acid 81, which was transformed to the acyl chloride 82 with SOCl2146 before 
condensation with L-valinol. The resulting diamide was cyclized employing MeSO2Cl to 
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afford the corresponding (S,S)-t-Buphebox-i-Pr E-11 in 71% yield. Halogenation of the 
resulting bis(oxazoline) was again performed using the methodology of Richards147 
(LDA/TMEDA then I2) to give [(S,S)-t-Bu-phebox-i-Pr]I (80a) in 55% yield (Scheme 
2.3). A single crystal X-ray structure of 80a was obtained to corroborate the identity of 
this pincer ligand (Figure 2.2). 
Scheme 2.3 Synthesis of [(S,S)-phebox-i-Pr]I (80a). 
 
SOCl2,
cat. DMF
>99%
t-Bu
CO2HHO2C
t-Bu
COClClOC a) L-valinol, Et3N, CH2Cl2;
    then MeSO2Cl, 71%
O
N N
O
i-Pr i-Pr
t-Bu
I
80a
b) LDA,THF, TMEDA; 
     then I2, 55%
81 82
 
[t-BuPheBoxi-Pr]I  
Figure 2.2 X-Ray structure of [(S,S)-phebox-i-Pr]I (80a). 
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Unfortunately, synthesis of similar pincer ligands 80b and 80c, each containing 
acidic benzylic protons, could not incorporate the same final halogenation as used in the 
synthesis of 80a because deprotonation and ring opening of the oxazolines afforded the 
undesired bis(enamine). Stark et al in 2003 reported a similar finding, where compound 
83 was isolated from the corresponding bis(oxazoline) upon treatment with 
LDA/TMEDA, then iodomethane (Figure 2.3).126  
O
NMe MeN
O
Ph Ph
83  
Figure 2.3 Undesired bis(enamine). 
To avoid this problem, we incorporated the halogen at the beginning of the 
synthesis. We utilized the procedure of Field et al148 to synthesize 2-bromo-5-tert-butyl-
isophthalic acid (84) from 5-tert-butyl-m-xylene by bromination then oxidation (Scheme 
2.4). A modified solvent system of 1:1 t-BuOH:H2O was necessary for smooth oxidation 
of the intermediate 5-tert-butyl-2-bromo-m-xylene to 84. Diacid 84 was then treated 
with SOCl2 to obtain 85, which was condensed independently with two β-amino 
alcohols (L-phenylalaninol and D-phenylgycinol), to give the corresponding bisamides. 
Finally, bis(oxazoline) formation to give 80b in 71% yield was accomplished using a 
BF3•Et2O-promoted cyclization, whereas compound 80c was most efficiently prepared 
by utilizing using PPh3/CCl4, following the procedure of Vorbrüggen, albeit in only 58% 
yield.143 
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Scheme 2.4 Synthesis of [(R,R)-t-Buphebox-Ph]Br (80b) and [(S,S)-t-Buphebox-Bn]Br 
(80c). 
t-Bu
CO2HHO2C
Br
80c : R = H, R1 = Bn
80b: R = Ph, R1 = H
O
N N
O
Br
R R1R R1
t-Bu
t-Bu
COClClOC
Br
D-phenylglycine, Et3N;
L-phenylalaninol, Et3N;
then PPh3, CCl4, Et3N,
R = H, R1 = Bn, 58%
then BF3•Et2O, 120 °C,
R = Ph, R1 = H, 71%84
85
SOCl2, cat. DMF
quant.
 
The synthesis of monomethoxy ligand 86a began with a modification of a U.S. 
patent procedure149 used to synthesize 3,5-dimethyl-4-iodoanisole (88). This 
modification consisted of the inversion of the two reaction steps, to increase the overall 
yield from 11% to 93%. In our step one, the methylation of 3,5-dimethyl-phenol (87) 
using iodomethane was promoted by potassium carbonate in refluxed acetone to give 
3,5-dimethyl-anisole in 95% yield. Treatment of the resulting anisole with potassium 
iodide and potassium iodate in acidic water gave 88 in 98% yield. The oxidation of the 
88 and chlorination of the resultant isophthalic acid proceeded similarly to the 
procedures describe above to obtain 89 (Scheme 4). An important observation in the 
cyclization step to form 86a from the uncylclized bis(amide) intermediate is that for 
compounds possessing a methoxy group in the aryl ring, BF3•Et2O was not tolerated. 
Demethylation of the phenylmethyl ethers occurs when the bis(amide) is heated in the 
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presence of BF3•Et2O. For this reason, it was necessary to cyclize using MeSO2Cl/Et3N, 
which provided 86a in 62% yield. 
Scheme 2.5 Synthesis of [(S,S)-MeO-phebox- i-Pr]I (86a). 
 
OH
Me Me
OMe
Me Me
I
a) K2CO3, MeI
    Me2CO, reflux,95%
b) KI, KIO3, MeOH
     H2O, HCl, 98%
88
87
OMe
ClOC COCl
I
a) KMnO4
t-BuOH:H2O
b) SOCl2, 
cat. DMF
52%
O
N N
O
I
OMe
i-Pr i-Pr
 L-valinol, Et3N, CH2Cl2
then MeSO2Cl, rt
62%
86a
89
 
 
A method analogous to the synthesis of ligand 86a was employed to synthesize 
86b. Bromination of 3,5-dimethylanisole gave 90 in 66% yield.150 The oxidation of the 
90 with KMnO4 followed by chlorination of the resulting isophthalic acid with SOCl2 
gave bis(acyl chloride) 91 in 55% yield (Scheme 2.6). Condensation to provide the 
bis(amide) was uneventful. However, we again noted that BF3•Et2O was not tolerated for 
the cyclization of this oxygenated bis(amide). Unfortunately, treatment with 
MeSO2Cl/Et3N was also unable to induce the desired cyclization to provide product 86b. 
However, we were able to cyclize the bis(amide) using PPh3/CCl4, which furnished 
[(S,S)-MeO-phebox-Bn]Br (86b) in 62% yield (Scheme 2.6).143 
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Scheme 2.6 Synthesis of [(S,S)-MeO-phebox-Bn]Br (86b). 
OMe
Me Me
Br
OMe
ClOC COCl
Br
O
N N
O
Br
OMe
Bn Bn
a) KMnO4
t-BuOH:H2O (1:1)
b) SOCl2, cat. DMF
55%
then PPh3, 
CCl4, Et3N
L-phenylalaninol, 
Et3N, CH2Cl2;
66%
86b
90 91
 
The synthesis of pentasubstituted benzene ligand precursor 92a was challenging 
due to the regiochemistry of the methoxy groups and the halogen on the benzene ring. 
Several routes toward this compound were attempted, but the following synthesis proved 
to be the most viable. The sequence started with treatment of 1,3-dimethoxybenzene 
with 2 equiv of Br2 to afford dibromide 93  (Scheme 2.7).151 Metal-halogen exchange of 
93 with n-BuLi followed by MeI delivered the corresponding 1,3-dimethoxy-4,6-
dimethylbenzene. An additional 2 equiv of Br2 provided the fully substituted 2,5-
dibromo-1,3-dimethoxy-4,6-dimethylbenzene. Site-selective debromination via metal-
halogen exchange with n-BuLi afforded 94 in 89% yield for the three steps. Oxidation of 
94 with KMnO4 in t-BuOH:water gave 2-bromo-4,6-dimethoxy-isophthalic acid, which 
was then treated with SOCl2 to obtain bis(acyl chloride) 95 in 65% yield. This acid 
chloride was treated with L-valinol, and the resulting bis(amide) was cyclized with 
PPh3/CCl4 to give [(S,S)-(MeO)2-phebox-i-Pr]Br (92a) in 87% yield for the two steps. 
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Scheme 2.7 Synthesis of [(S,S)-(MeO)2-phebox-i-Pr]Br (92a). 
 
Me Me
Br
ClOC COCl
Br
MeO OMe
MeO OMe
MeO OMe
92a
Br Br
a) n-BuLi (2 equiv); then MeI
b) Br2 (2 equiv)
89%
c) n-BuLi (1 equiv); then H2O
then PPh3, CCl4, Et3N
L-valinol, Et3N, CH2Cl2;
87%
O
N N
O
Br
i-Pr i-Pr
MeO OMe
a) KMnO4,
t-BuOH:H2O (1:1)
b) SOCl2, cat. DMF
65%
93 94
95  
 
The synthesis of fully substituted aryl pincer ligand 96a was similar to the 
dimethoxy pincer ligand 92a synthesis (Scheme 2.8). The reaction of 1,2,3-
trimethoxybenzene 97 with 2 equiv of Br2 afforded 4,6-dibromo-1,2-3-
trimethoxybenzene. This dibromide, in one reaction flask, was treated sequentially with 
1 equiv of n-BuLi followed by 1 equiv of MeI and then again with 1 equiv of n-BuLi 
followed by 1 equiv of MeI to give 4,5,6-trimethoxy-m-xylene. Treatment of the m-
xylene with 1 equiv of Br2 afforded the fully substituted benzene 98 in 84% yield. 
Oxidation of 98 with KMnO4 followed by chlorination with SOCl2 gave 99 in 52% 
yield. Bis(acid chloride) 99 was treated with L-valinol to give corresponding bis(amide), 
followed by MeSO2Cl/NEt3 to give [(S,S)-(MeO)3-phebox-i-Pr]Br (96a) in 68% yield. 
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Scheme 2.8 Synthesis of [(S,S)-(MeO)3-phebox-i-Pr]Br (96a). 
 
Me Me
Br
ClOC COCl
Br
MeO OMe
MeO OMe
MeO OMe
96a
b) n-BuLi (1 equiv), Et2O;
c) repeat step b)
84%
then MeSO2Cl
L-valinol, Et3N, CH2Cl2;
68%
O
N N
O
Br
i-Pr i-Pr
MeO OMe
OMe a) Br2 (2 equiv), CH2Cl2
OMe
OMeOMe
a) KMnO4
t-BuOH:H2O (1:1)
b) SOCl2, cat. DMF
52%
then MeI (1 equiv)
d) Br2 (1 equiv), CH2Cl297
98
99
 
 
2.2.2 Synthesis of Ni(II) and Pd(II) Pincer Complexes 
 
A method similar to that reported by Richards152 was used to synthesize Ni(II) 
and Pd(II) pincer complexes of these ligands. Treatment of pincer ligands [PheBox-
Ph]Br (77b), [t-BuPheBox-Ph]Br (80b) or [t-BuPheBox-i-Pr]I (80a) with Ni(COD)2 in 
PhMe at rt resulting in a slow change of the color of the solution from yellow to orange 
over 2 hr and provided the nickel complexes [PheBox-Ph]NiBr (101), [t-BuPheBox-
Ph]NiBr (104) and [t-BuPheBox-i-Pr]NiI (103) respectively (Scheme 2.9). The identity 
of each of these nickel compounds was confirmed by X-ray structure analysis of a 
crystal obtained by slow evaporation from a CH2Cl2 solution in air. The resulting bright 
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orange crystals have been stored in air at room temperature for several months without 
decomposition. Anion exchange was accomplished by treatment of the (Phebox)NiX 
complexes 100-108 with AgClO4. After filtering and concentration in vacuo, the cationic 
complexes were obtained in quantitative yield. The X-ray structure of the nickel 
complex [PheBox-i-Pr]NiClO4•H2O (109), is shown in Figure 2.4. 
 
Scheme 2.9 Synthesis of neutral and cationic nickel pincer complexes. 
 
O
N N
O
X
R3 R3
R2 R2
R1
PhMe, rt,2 h
Ni(COD)2 O
N N
O
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R3 R3
R2 R2
R1
CH2Cl2, rt, 2 h
AgClO4 O
N N
O
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R3 R3
R2 R2
R1
OH2X
ClO4
77a:  R1 = R2 = H, R3 = i-Pr, X = Br
77b:  R1 = R2 = H, R3 = Ph, X = Br
77c:  R1 = R2 = H, R3 = Bn, X = Br
80a:  R1 = t-Bu, R2 = H, R3 = i-Pr, X = I
80b:  R1 = t-Bu, R2 = H, R3 = Ph, X = Br
80c:  R1 = t-Bu, R2 = H, R3 = Bn, X = Br
86a:  R1 = OMe, R2 = H, R3 = i-Pr, X = I
92a:  R1 = H, R2 = OMe, R3 = i-Pr, X = Br
96a:  R1 =  R2 = OMe, R3 = i-Pr, X = Br
100:  R1 = R2 = H, R3 = i-Pr, X = Br
101:  R1 = R2 = H, R3 = Ph, X = Br
102:  R1 = R2 = H, R3 = Bn, X = Br
103:  R1 = t-Bu, R2 = H, R3 = i-Pr, X = I
104:  R1 = t-Bu, R2 = H, R3 = Ph, X = Br
105:  R1 = t-Bu, R2 = H, R3 = Bn, X = Br
106:  R1 = OMe, R2 = H, R3 = i-Pr, X = I
107:  R1 = H, R2 = OMe, R3 = i-Pr, X = Br
108:  R1 =  R2 = OMe, R3 = i-Pr, X = Br
109:  R1 = R2 = H, R3 = i-Pr
110:  R1 = R2 = H, R3 = Ph
111:  R1 = R2 = H, R3 = Bn
112:  R1 = t-Bu, R2 = H, R3 = i-Pr
113:  R1 = t-Bu, R2 = H, R3 = Ph
114:  R1 = t-Bu, R2 = H, R3 = Bn
115:  R1 = OMe, R2 = H, R3 = i-Pr
116:  R1 = H, R2 = OMe, R3 = i-Pr
117:  R1 =  R2 = OMe, R3 = i-Pr  
 
A similar protocol for the synthesis of cationic palladium complexes was 
employed. A mixture of the pincer ligands: [t-BuPheBoxi-Pr]I (80a) or [t-
BuPheBoxBn]Br (80b) and Pd2(dba)3 was combined in PhMe. The reaction mixture was 
filtered through silica gel, eluting with toluene to remove the dba. The silica gel was then 
washed separately with ethyl acetate to give a yellow solution which was collected and 
the solvent was removed under reduce pressure to give the pincer complex as a yellow 
solid. Column chromatography was employed to purify the palladium complexes [t-
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BuPheBoxi-Pr]PdI (121) and [t-BuPheBoxBn]PdBr (123).  Samples suitable for X-ray 
analysis of [t-BuPheBoxi-Pr]PdI (121) and [t-BuPheBoxBn]PdBr (123)  were prepared 
by slow evaporation of a dichloromethane solution in air to give light yellow crystals. 
Their X-ray structure is shown in Figure 2.4. The resulting light yellow crystals have 
been stored in air at room temperature for several months without decomposition. 
 
Scheme 2.10 Synthesis of neutral and cationic palladium pincer complexes. 
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X
R R
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O
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CH2Cl2, rt, 2 h
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O
Pd
R R
R2 R2
R1
OH2X
ClO4
118:  R1 = R2 = H, R3 = i-Pr, X = Br
119:  R1 = R2 = H, R3 = Ph, X = Br
120:  R1 = R2 = H, R3 = Bn, X = Br
121:  R1 = t-Bu, R2 = H, R3 = i-Pr, X = I
122:  R1 = t-Bu, R2 = H, R3 = Ph, X = Br
123:  R1 = t-Bu, R2 = H, R3 = Bn, X = Br
124:  R1 = OMe, R2 = H, R3 = i-Pr, X = I
125:  R1 = H, R2 = OMe, R3 = i-Pr, X = Br
126:  R1 =  R2 = OMe, R3 = i-Pr, X = Br
127:  R1 = R2 = H, R3 = i-Pr
128:  R1 = R2 = H, R3 = Ph
129:  R1 = R2 = H, R3 = Bn
130:  R1 = t-Bu, R2 = H, R3 = i-Pr
131:  R1 = t-Bu, R2 = H, R3 = Ph
132:  R1 = t-Bu, R2 = H, R3 = Bn
133:  R1 = OMe, R2 = H, R3 = i-Pr
134:  R1 = H, R2 = OMe, R3 = i-Pr
135:  R1 =  R2 = OMe, R3 = i-Pr
77a:  R1 = R2 = H, R3 = i-Pr, X = Br
77b:  R1 = R2 = H, R3 = Ph, X = Br
77c:  R1 = R2 = H, R3 = Bn, X = Br
80a:  R1 = t-Bu, R2 = H, R3 = i-Pr, X = I
80b:  R1 = t-Bu, R2 = H, R3 = Ph, X = Br
80c:  R1 = t-Bu, R2 = H, R3 = Bn, X = Br
86a:  R1 = OMe, R2 = H, R3 = i-Pr, X = I
92a:  R1 = H, R2 = OMe, R3 = i-Pr, X = Br
96a:  R1 =  R2 = OMe, R3 = i-Pr, X = Br  
 
2.2.2.1 Structural Properties of Pincer Complexes 
 
Single crystals, suitable for X-ray crystallography, were obtained by slow 
evaporation from dichloromethane (Figure 2.4). The structure of nickel pincer 
complexes [PheBox-Ph]NiBr (101), [t-BuPheBox-Ph]NiBr (104) and [t-BuPheBox-i-
Pr]NiI (103) is correlated to the previously reported structures of (PheBox-Me2)NiI132 
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and [(S,S)-PheBox-i-Pr]NiBr.133 The square-planar Ni(II) center in these new pincer 
complexes are four-coordinate, NCN and halogen. 
[PheBoxi-Pr]NiClO4•H2O (109)
[t-BuPheBox-i-Pr]PdI (121)
[t-BuPheBoxPh]NiBr (104)
[PheBoxPh]NiBr (101)
[t-BuPheBoxBn]PdBr (123)
[t-BuPheBoxi-Pr]NiI (103)  
 
Figure 2.4 Crystal structures of M(NCN)-pincer complexes. 
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The M–C bond length in [PheBox-Ph]NiBr (101), [t-BuPheBox-Ph]NiBr (103), 
[t-BuPheBox-i-Pr]NiI (104), [PheBox-i-Pr]NiClO4•H2O (109), [t-BuPheBox-i-Pr]PdI 
(121), and [t-BuPheBoxBn]PdBr (123) follows the general trend as expected (Ni–C < 
Pd–C) (Table 2.1). For example, for complex [(S,S)-t-BuPheBox-i-Pr]NiI (103) has a 
Ni–C bond length of 1.841 Å, where its congener [(S,S)-t-BuPheBox-i-Pr]PdI (121) has 
a Pd–C bond length of 1.944 Å. Another structure feature is the effect of the electron 
donating groups on the benzene core, it is observed that [(R,R)-t-BuPheBoxPh]NiBr 
(104) has a Ni–C bond length of 1.835 Å, whereas [(R,R)-PheBoxPh]NiBr (101) has a 
Ni–C bond length of 1.844 Å. The tert-butyl group shortens the distance between the 
aryl group and the metal center by electron donation. The trans influence,153 or 
lengthening of the bonds trans to each other, can be seen by comparing the complex 
[(R,R)-t-BuPheBoxPh]NiBr (104) with a Ni–Br bond length of 2.3443 Å versus [(R,R)-
PheBoxPh]NiBr (101) with a Ni–Br bond length of 2.3164 Å. Is noticeable that the Ni–
Br bond is longer for the complex with an electron donating groups in the benzene core. 
The relative importance of the trans influences depends on the formal electron 
configuration of the metal center,153 proving our hypothesis of electro-donation to the 
metal center is possible by incorporation of electron donating groups in the benzene core 
of the pincer complex resulting in more electron rich complexes. Complex [(S,S)-
PheBox-i-Pr]NiClO4•H2O (109) also has differences from its precursor [(S,S)-PheBox-i-
Pr]NiBr (100), some of the differences are the Ni–C bond length, been shorter for the 
aqueous complex 109 and vice versa for the Ni–X bond length, been longer for the 
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halogenated complex 100. These bond lengths variations are explained by the trans 
influence as well. 
 
Table 2.1 Selected bond lengths and bond angles of the nickel and palladium pincer 
complexes. 
 
M(NCN) Complex M–N(1) M–C M–N(2) M–X Angle C–M–X
[t-BuPheBox-i-Pr]PdI (121)
[t-BuPheBoxBn]PdBr (123)
[t-BuPheBox-i-Pr]NiI (103)
[t-BuPheBoxPh]NiBr (104)
[PheBoxPh]NiBr (101)
[PheBox-i-Pr]NiClO4•H2O (109)
[PheBox-i-Pr]NiBr (100)
2.073(11)
2.071(7)
1.946(5)
1.896(8)
1.9371(19)
1.9195(13)
1.908(2)
1.944(12)
1.951(8)
1.841(6)
1.835(10)
1.844(3)
1.8333(4)
1.841(19)
2.077(11)
2.074(7)
1.929(5)
1.929(8)
1.9371(19)
1.9101(13)
1.910(2)
2.6846(18)
2.5226(10)
2.5301(16)
2.3443(18)
2.3164(5)
1.9403(12)
2.3572(4)
178.5(4)
178.2(2)
177.25(19)
178.4(3)
180.0
177.35(6)
178.10(6)
Entry
1
2
3
4
5
6a
7
 
a Previously reported by Van Koten in 2007. 
 
2.2.2.2 Lewis Acidity of the Pincer Complexes 
 
Figure 2.5 shows how the Lewis acidity of the pincer complexes can be tailored 
by incorporating substituents on the aryl group. Electron withdrawing groups will 
increase the Lewis acidity of the complex due to electron deficient metal center (Figure 
2.5, left). On the other hand, the new complexes with an electron-donating groups on the 
aryl ring will increase electron density at the metal center, thus presumably decreasing 
the Lewis acidity of the complex (Figure 2.5, right). 
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M NN
OO
M= Ni, Pd, Pt;   EWG= NO2;   EDG= MeO, t-Bu;   R= i-Pr, t-Bu, Ph, Bn
M NN
OO
EDG
M NN
OO
EWG
R R R RR R
 
Figure 2.5 Decreasing Lewis acidity of pincer complexes. 
 
The relative Lewis acidity of these pincer complexes can be measured by how 
tightly a Lewis base, such as MeCN, coordinates to the metal center (Figure 2.6).  
O
N N
O
R R
M
R2R2
R1
N
Me
ClO4
 
Figure 2.6 MeCN complexation by the cationic pincer complexes. 
 
This electron donation from MeCN to the metal can be indirectly measured by a 
shift in the 1H NMR of the methyl group of the MeCN. The downfield shift in the signal, 
relative to free MeCN, will be proportional to the Lewis acidity of the pincer complexes. 
According to the procedure of Richards,132 1.0 equiv of pincer complex was combined 
with 0.9 equiv of MeCN in CDCl3 (approximately 0.013 M) and the resulting solutions 
were analyzed by 300 MHz 1H NMR. Insignificant Lewis acidity was discovered for 
pincer complexes where X was a nondissociating anion (Br and I) with values lower 
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than 0.001 ppm (Table 2.2, Entries: 2, 3, 14, and 15). On the other hand, complexes 
where X was exchanged for a less coordinating counterion (ClO4) showed increased 
Lewis acidity. For example, [t-BuPheBox-i-Pr]NiClO4 (112) shows a shift at 2.381 ppm, 
0.024 smaller than [PheBox-i-Pr]NiClO4 (109). [(MeO)3PheBox-i-Pr]NiClO4 (117) 
shows a shift at 2.362, 0.043 smaller than [PheBox-i-Pr]NiClO4 (109). Although the 
palladium pincer complexes shown less Lewis acidity than the Ni(II) complexes, due to 
the greater inherent electronegativity of Ni(II) vs Pd(II),154-156 these complexes follow 
the same general pattern of electronegativity that the Ni(II) pincer complexes show, that 
is decreasing Lewis acidity as the number of electron donating group on the ligand is 
increased. For example, the nickel complex [PheBox-i-Pr]NiClO4 (109) has a shift of 
2.405 and palladium complex [PheBox-i-Pr]PdClO4 (127) has a shift at 2.138 ppm. 
 
Table 2.2 Relative Lewis acidity of Ni(II) and Pd(II) pincer complexes. 
Ni(NCN) Complex 1H NMR of NCCH3
a 1H NMR of NCCH3
a
none
[PheBoxPh]NiBr (101)
[t-BuPheBox-i-Pr]NiI (103)
[PheBoxi-Pr]NiClO4 (109)
[PheBoxPh]NiClO4 (110)
[t-BuPheBox-i-Pr]NiClO4 (112)
[PheBoxBn]NiClO4 (111)
2.020
2.021
2.020
2.405
2.381
2.381
2.385
none
[PheBoxPh]PdBr (119)
[t-BuPheBox-i-Pr]PdI (121)
[PheBoxi-Pr]PdClO4 (127)
[PheBoxPh]PdClO4 (128)
2.020
2.020
2.019
2.138
2.184
Pd(NCN) Complex
[t-BuPheBoxPh]NiClO4 (113)
[t-BuPheBoxBn]NiClO4 (114)
[(MeO)PheBox-i-Pr]NiClO4 (115)
2.350
2.354
2.379
[t-BuPheBoxPh]PdClO4 (131)
[t-BuPheBoxBn]PdClO4 (132)
[(MeO)PheBox-i-Pr]PdClO4 (133)
2.166
2.165
2.135
[PheBoxBn]PdClO4 (129)
[t-BuPheBox-i-Pr]PdClO4 (130)
2.207
2.053
Entry
1
2
3
4
5
6
7
Entry
13
14
15
16
17
18
19
20
21
22
8
9
10
[(MeO)2PheBox-i-Pr]NiClO4 (116)
[(MeO)3PheBox-i-Pr]NiClO4 (117)
2.366
2.362
[(MeO)2PheBox-i-Pr]PdClO4 (134)
[(MeO)3PheBox-i-Pr]PdClO4 (135)
2.133
2.130
23
24
11
12
 
a broad singlet 
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2.3 Applications of the Pincer Complexes 
 
Since several air and moisture stable Palladium complexes were synthesized via 
oxidative addition to PheBox pincer ligands with Ni(COD)2 or Pd2dba3. We decided to 
utilize them for C–C bond forming reactions such as: Negishi cross-coupling and α-
arylation of ketones. 
 
2.3.1 Negishi Cross-coupling Reaction 
 
In 1976, E. Negishi and co-workers reported the first stereospecific Ni-catalyzed 
alkenyl-alkenyl and alkenyl-aryl cross-coupling of organoaluminums with alkenyl- or 
aryl halides. After extended research, they found that organozinc reagents showed better 
reaction rate, yields and stereoselectivity.157,158 In 2010, E. Negishi received the Nobel 
price in chemistry for his work on Pd- and Ni-catalyzed stereoselective cross-coupling or 
organozincs and aryl-, alkenyl-, or alkynyl halides, the so call Negishi reaction. 
In 2009, G. Fu, reported a nickel complex capable of catalyzed the Negishi 
reaction between several α-bromoketones and organozinc reagents.159 He reported 
moderate to good yields and ee’s (Scheme 2.11). 
 
 
 
 
 99 
Scheme 2.11 Fu’s approach to α-aryl ketones. 
N
O
N N
O
Ar
NiCl2•diglyme 5 mol%
IZn
1.3 equiv
glyme/THF 1:1
–30 ºC, 4 h
16 entries
71 to 90% yields
72 to 96% ee
O
Br
R1 Ph Ar
O
Ph
R1
MeO OMe
PhPh
6.5 mol%
 
With this available information we decided to employ our Nickel- and 
Palladium- NCN-pincer complexes to catalyzed the Negishi reaction between racemic 2-
bromopropiophenone (136) and phenyl zinc iodide (137) to afford the adduct 1,2-
diphenylpropan-1-one (138) potentially with high enatiomeric excess (Scheme 2.12).  
 
Scheme 2.12 Proposed Negishi cross-coupling reaction. 
THF, –78 ºC
ZnI
1.3 equiv
O
Br
Me
O
!
Ph
Me
O
N N
O
R R
M
OMe
cat. X
136
137
138  
 
2.3.2 Synthesis of α-Bromoketones 
 
Due to the need of α-bromoketones, we started by synthesizing a library of these 
molecules using bromine to α-brominate their corresponding aryl ketones precursors 
(Table 2.3). All the adducts were obtained in good to excellent yields (59-96%). 
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Table 2.3 Synthesis of α-bromoketones.a 
Entry Product                (#)
144
143
2
3
4
5
6
139
Product              (#)
146
148
141
145
142
140
147
Entry
7
8
9
10
11
O
Br
Et
O
Br
iPr
O
Br
O
Br
14912
O
Br
O
Br
Me
O
Br
Me
O
Br
Me
O
Br
Me
O
Br
O
Br
Me
Ph
Cl
Cl
Me
MeO
F3C
F
S
84
92
Yield (%)b
93
85
88
96
83
59
94
95
Yield (%)b
78
1 136
O
Br
Me
N/A
Ar
O
R
Ar
O
Br
R
Br2( 1 equiv)
Et2O, rt, 0.5 to 2 h
 
a The reactions were performed with 6 mmol of ketone, 1.05 equiv of bromine, in 15 mL of Et2O at rt for 
0.5 to 2 h. b Isolated yield after purification by silica gel chromatography. 
 
 
The Negishi reaction turned out to be more complex than expected due to several 
factors including: the synthesis of arylzinc reagents, dimerization of starting material, 
byproduct formation, and debromination of the starting material. The outcome or ratio of 
product : byproducts was dependent on the reaction conditions (Scheme 2.13). The main 
byproduct formed was 2-iodopropiophenone (150), which in turn mislead us in view of 
the fact that compound 150 has the same retention time (13.99 min) when passed 
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through the chiralcel OJ-H HPLC column (hexane/iPrOH = 98/2), 1.0 mL/min, 254 nm) 
than one of the enantiomers of 1,2-diphenylpropan-1-one (138). This misinterpretation 
of a higher enantiomeric excess was corrected once the adduct 150 was isolated and 
characterized.  
 
Scheme 2.13 Outcome of the α-arylation of 136. 
THF, –78 ºC
ZnI
1.3 equiv
O
Br
Me
O
N N
O
R R
M
OMe
cat. X
136
137
O
!
Ph
Me
138
O
I
Me
150
O
Me
151  
After extended research, it was found that palladium pincer complexes afford the 
adduct 138 in low yield, while nickel pincer complexes delivered the adduct 138 in 
excellent yields. However, neither the palladium or nickel pincer complexes were 
successful to catalyze the asymmetric Negishi cross-coupling. It was demonstrated that 
all pincer complexes were unable to afford significant levels of enantioselectivity (Table 
2.4).  
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Table 2.4 Results of the α-arylation of ketones (Negishi).a 
THF, –30 ºC, 14 h
ZnI
1.3 equiv
O
Br
Me
O
!
Ph
Me
O
N N
O
R1 R1
M
R2
cat. X
136
137
138
Entry
1
Yield (%)b ee (%)cCatalyst (5 mol%)                 Cat. (#)
NRAgClO4 NA
2 37[PheBoxi-Pr]PdBr 5
3 36[t-BuPheBoxBn]PdClO4 14
–
118
132
4 39[MeOPheBoxi-Pr]PdClO4 8
5 55[PheBoxi-Pr]NiBr 18
6 88[t-BuPheBoxi-Pr]NiClO4 30
133
109
112
7 79[t-BuPheBoxPh]NiClO4 28
8 84[t-BuPheBoxBn]NiClO4 23
9 93[MeOPheBoxi-Pr]NiClO4 35
113
114
115  
a The reactions were performed with 0.25 mmol of 136, 1.3 equiv of 137, 0.5 equiv of 
catalyst, in 4 mL of THF at –30 ºC for 14 h. b Isolated yield after purification by silica gel 
chromatography. c Enantiomeric excess was determined by HPLC with a Chiralcel OJ-H 
column (hexane/iPrOH = 98/2), 1.0 mL/min, 254 nm. 
 
Unfortunately, the attempted enantioselective Negishi cross-coupling using our 
nickel or palladium pincer complexes was unsuccessful. However, we continued our 
research to further develop an easier and practical path to synthesize α-aryl ketones. This 
study is presented in the next pages. 
  
2.4 α-Arylation of Ketones Using Pd (II) Pincer Complexes  
 
In modern organic synthesis palladium catalysis has become one of the most 
important synthetic tools. A specially appealing synthetic characteristic of Pd catalysis is 
its extensive synthetic scope and the capability to control the selectivity of the 
 103 
reactions.160-162,163 A perfect catalyst has to be stable and highly selective, but also very 
active to guarantee high turnover numbers and allow low catalyst loadings. Furthermore, 
it needs to be simple and easy to synthesize. These issues can usually be addressed by an 
appropriate choice of ligands. One of the successful strategies is to use tridentate 
ligands, such as pincer ligands, to accomplish a well-defined metal-ligand bonding. In 
the lates 1970s, Shaw138 and van Koten,139 reported the first pincer complexes. Since 
then, a large number of different pincer complexes has been synthesized and studied in 
miscellaneous catalytic applications, specially on palladium catalysis.140,141  
 
Scheme 2.14 Synthesis of NCN pincer ligands 152-154. 
t-Bu
COClClOC
Br
85
ClOC COCl
Br
91
152
153
a) H2NC(CH3)2CH2OH,
    Et3N, CH2Cl2; 
    MeSO2Cl, 69%
OMe
a) H2NCH2CH2OH,
    Et3N, CH2Cl2;
b) NaH, THF, reflux
OMe
Br NN
O O
MeMeMeMe
154
t-Bu
Br NN
O O
t-Bu
Br NN
O O
MeMeMeMe
95%
    MeSO2Cl, 76%
b) NaH, THF, rt
a) H2NC(CH3)2CH2OH,
    Et3N, CH2Cl2;
    MeSO2Cl, 73%
b) NaH, THF, reflux
97%
92%
 
The synthesis of palladium pincer complexes is sometimes considered the limited 
factor for their application in catalysis due to proligands and complexes syntheses. 
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Recently, we reported a straightforward synthesis of air and moisture stable chiral NCN 
pincer complexes using short and simple reaction conditions.164 Here, the synthesis of 
new achiral NCN pincer ligands and complexation with Pd (II) to form NCN-pincer 
complexes are reported. Also, their highly selective α-arylation of ketones with a variety 
of aryl bromides is reported.  
The synthesis of pincer ligands took place from the known 2-bromo isophthalic 
acids 84 and 90164 which, were treated with SOCl2 to obtain  the 2-bromo isophthalic 
dichlorides 85 and 91. The latter acids chloride were reacted with 2-amino-2-mehtyl-1-
propanol or ethanolamine, to give the corresponding bisamide. The resulting bisamides 
were halogenated employing MeSO2Cl. Finally, the oxazoline formation was 
accomplished using sodium hydride to afford the NCN Pincer ligands 152-154 (97%, 
92%, and 95% yield respectively (Scheme 2.14). 
 
Scheme 2.15 Synthesis of Pd (II) NCN pincer catalysts XV-XXI. 
PhCH3, rt, 3h
Pd2(dba)3
99%
R1
Br NN
O O
R2R2R2R2
R1
Pd NN
O O
R2R2R2R2 Br
R1= t-Bu, R2= H      XV
R1= t-Bu, R2= Me    XVI
R1= MeO, R2= Me   XVII
152-154
O
N N
O
Pd
t-Bu
Me Me Me MeBr
O
N N
O
Pd
t-Bu
Me Me Me MeX
AgX, CH2Cl2
dark, rt, 2h
X = SbF6  XVIII
       ClO4  XIX
       OAc   XX
       OTf    XXI99%
XVI XVIII-XXI
XV-XVII
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The palladium pincer complexes XV-XXI were synthesized via oxidative 
addition of Pd2(dba)3 to PheBox Pincer ligands 152-154 in 99% yields (Scheme 2.15, 
top). X-ray of complex XVI was taken (Figure 2.7). To obtain the cationic complexes 
IV-VII a mixture of XVI and a silver salt was stirred in dry dichloromethane for 2 h at 
room temperature to give XVIII-XXI as a yellow solid in quantitative yield (Scheme 
2.15, bottom). 
 
Figure 2.7 X-Ray structure of [t-BuPhebox-Me2]PdBr XVI. 
 
The firsts reports over palladium mediated α-arylation of carbonyl compounds 
appeared independently in 1997 by Buchwald,165 Hartwig,166 and Miura167 (Scheme 
2.16). All these methods employ either an excess of the phosphine base ligand or an 
inorganic catalyst in concentrated reaction mixtures to accelerate the reaction.168 Since 
then, more methods are been reported for the α-arylation of carbonyl compounds,169,170 
such methods use Pd,171-175 Ni,176 and Cu177 as the transition metals. In addition to 
phosphine ligands178-181 some methods utilize binap derivatives,182 carbenes,183 modified 
ferrocenes,184 quinine and chinchonidine,185 proline derivatives,186 or phosphine pincer 
ligands187 to have higher selectivity, broader substrate scope and milder reaction 
conditions to increase the reaction rate of this metal catalyzed C-C bond transformation. 
Others attempts to archive this transformation have been reported through the use of 
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photoinduced SN1 reaction,188 solid phase189 or coupling with diaryl iodonium salts.190 
Although some of these methods are user-friendly, attractive, and successful at some 
extent. They could be problematic in certain cases due to the hazard of the reaction 
conditions and also each of these methods has been limited in substrate scope to varying 
extents.  
 
Scheme 2.16 Early examples of the catalytic α−arylation of carbonyl compounds. 
 
 
Br
G
R1
O
R2
NaOt-Bu, Pd2(dba)3
BINAP or Tol-BINAP
Buchwald
R1
O
R2
G
R1 = Ph, Ar, CH(Me)2,
        CH(Ph)2, t-Bu
R1 = H, Me
THF, 70 °C
63-93%
Br
G
R1
O
R2
KHMDS, Pd2(dba)3
DTPF or DPPF
Hartwig
R1
O
R2
G
R1 = Ph, Ar, t-Bu
R1 = H, Me
THF, 70 °C
51-94%
IO
Ph
PdCl2•4LiCl
Cs2CO3
Miura
O
Ph
DMF, 110 °C
48%
Ph Ph
Ph
 
 
Never before a NCN pincer complex has been utilized for this transformation, 
until now. The advantages of our method include: the ready availability of the 
inexpensive coupling substrates, no excess of ligand, shorter reaction times, diluted 
mixtures, lower reaction temperature, exclusively monoarylation, and above all the 
catalyst stability.  
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Table 2.5 Palladium cross-coupling reaction between propiophenone and 
bromobenzene.a 
 
[t-BuPheBoxMe2]PdBr
XVI  (1 mol%)
1
2
1
1
Toluene
Toluene
3 1Toluene
4 6Toluene
5 6Toluene
6 1THF
Entry Time (h)Solvent Yield (%)
b
99
97
96
95
11
84
7 61,4-dioxane 5
Temp ºC
120
90
70
50
rt
70
70
Ph
O
Me
Ph
Br
NaOt-Bu 1.3 equiv.
Ph
O
Me
Ph
1.1 equiv
8 2Toluene 99
9 0.5Toluene 78
70
70
10c 1Toluene 98
11d 0.5Toluene 97
70
70
12e 1Toluene 95
13f 1Toluene 99
70
70
1 equiv
151 138
 
a The reactions were performed with 0.33 mmol of 151, 1.1 equiv 
of bromobenzene, 1.3 equiv of NaOt-Bu, 0.01 equiv of catalyst, in 
1.5 mL of solvent (0.22M) . b Isolated yield after purification by 
silica gel chromatography. c 0.33mmol/1mL (0.33M) used instead 
of the usual 0.33mmol/1.5mL d [c] 0.33mmol/0.5mL (0.66M) used 
instead of the usual 0.33mmol/1.5mL  e 1 equiv. of bromobenzene 
used. f 1.1: 1 ratio of propiophenone : bromobenzene. 
 
 
Our initial Pd system made use of Pd complex XVI, which was capable of 
catalyzing the reaction of propiophenone with bromobenzene (Table 2.5). We have 
conducted a thorough optimization of this catalytic system and the results are depicted in 
Table 2.5 and 2.6. Toluene proved to be the best solvent, delivering the product in 
excellent yield (Table 2.5, entry 3). THF and 1,4-dioxane were also screened, but they 
resulted in low reactivity (84% and 5% yield respectively), possible due to a reasonable 
metal coordination (Table 2.5, entries 6 and 7). 
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At room temperature, the system allowed for the synthesis of the corresponding 
adduct 138 in 11% yield after 6 h using 1 mol% of XVI (Table 2.5, entry 5). However, 
increasing the temperature to 50 °C increased the yield from 11% to 95% in 6 h (Table 
2.5, entry 4). Further increase of temperature to 70 °C allows for drastic reduction of 
reaction time to 1 h providing 96% yield (Table 2.5, entry 3). At 70 °C in 30 min. the 
reaction is already 78% completed while at 2 h the reaction is totally complete (Table 
2.5, entries 8 and 9). Additional increase of temperature afforded the adduct in 97% and 
99% for 90 °C and 120 °C respectively in 1h (Table 2.5, entries 1 and 2). The use of 
more concentrated mixture (1mmol/3mL instead of the usual 1mmol/5mL) afforded a 
faster reaction rate with 98% yield (Table 2.5, entry 10). When 1mmol/1mL was used 
the corresponding product was obtained in 97% after 30 min. (Table 2.5, entry 11). Also, 
we verified the stoichiometry of the starting materials. It was found that employing 1:1 
ratio of propiophenone:bromobenzene the product was afforded in 95% yield (Table 2.5, 
entry 12). While, using 1.1:1 ratio 99% yield was obtained (Table 2.5, entry 13). 
With these data in hand and in view of the fact that higher reaction concentration 
and temperatures have a positive effect on the reaction rates. We decided to use milder 
conditions for further optimization, this means less diluted mixtures, lower catalyst 
loading, lower temperature, shorted reaction times and only 10 mol% excess of aryl 
bromide. 
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Table 2.6 Optimization of catalyst for the cross-coupling between propiophenone and 
bromobenzene.a 
 
151
138
Ph
O
Me
Ph
Br Catalyst (1 mol%)
NaOt-Bu 1.3 equiv 
PhMe, 70 ºC, 1 h
Ph
O
Me
Ph
1.1 equiv
1
2
none
Pd(OAc)2
3 [t-BuPheBoxH2]PdBr
4 [t-BuPheBoxMe2]PdBr
5 [MeOPheBoxMe2]PdBr
6 [t-BuPheBoxMe2]PdSbF6
Entry Cat. (#)Catalyst (1 mol%) Yield (%)
b
0
48
90
96
92
79
7
8
[t-BuPheBoxMe2]PdClO4
[t-BuPheBoxMe2]PdOAc
9 [t-BuPheBoxMe2]PdOTf
10c [t-BuPheBoxMe2]PdBr
86
87
77
36
–
XXII
XV
XVI
XVII
XIX
XVIII
XX
XXI
XVI
11d [t-BuPheBoxMe2]PdBr
12e [t-BuPheBoxMe2]PdBr
95
86
XVI
XVI
1 equiv
 
a The reactions were performed with 0.33 mmol of 151, 1.1 
equiv of bromobenzene, 1.3 equiv of NaOt-Bu, 0.01 equiv of 
catalyst, in 1.5 mL of toluene at 70 ºC for 1h . b Isolated yield 
after purification by silica gel chromatography. c Reaction 
performed open to the air. d 0.5 mol % of catalyst used instead of 
the usual 1 mol % and 2 h reaction time. e 0.1 mol % of catalyst 
used instead of the usual 1 mol % and 6 h reaction time. 
 
 
Table 2.6 depicts the catalytic activity of several Pd complexes (XV-XXII) 
towards the α-arylation of propiophenone with bromobenzene in the presence of only 1 
mol% of catalyst. The reaction mediated by [t-BuPheBox-Me2]PdBr (XVI) occurred 
with the highest yield (96%) (Table 2.6, entry 4). We have also found that switching 
from XVI to a more electron-rich metal center catalyst XVIII afforded slightly lower 
yield (92%) (Table 2.6, entry 3). The less steric hindered catalyst XV showed even lower 
yield (90%), possible due to be less stable than XVI (Table 2.6, entry 3). We compared 
the differences in performance between neutral and cationic Pd complexes, the formers 
showed lower reactivity  (82% average yield) due to less turnovers of the catalyst in the 
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system (Table 2.6, entries 6-9). Pd(OAc)2 was also notably less reactive  with 48% yield 
(Table 2.6, entries 2). In the absence of a Pd source the reaction did not proceed (Table 
2.6, entry 1). Also, was observed a formation of the corresponding adduct 138 in 36% 
yield for an aerobic reaction performed open to the air with catalyst XVI (Table 2.6, 
entries 10). To our delight, lower catalyst loading (0.5 mol%) showed high reactivity 
with 95% yield after only 2 h (Table 2.6, entries 11). Finally, 0.1 mol% of XVI gave 
86% yield after 6 h (Table 2.6, entries 12), proving the high turnover numbers for this 
catalytic system using XVI. 
 
Table 2.7 Cross-coupling of propiophenone with various aryl bromides.a 
1 equiv
Ph
O
Me
Ar
Br
[t-BuPheBoxMe2]PdBr
   XVI (1 mol%)
NaOt-Bu 1.3 equiv 
PhMe, 70 ºC, 1 h
Ph
O
Me
Ar
1.1 equiv
1
2c
138
155
Ph
2-MeO-C6H4
3 1563-MeO-C6H4
4 1574-MeO-C6H4
5 1583-Me-C6H4
6 1594-Me-C6H4
Entry Product (#)Ar Yield (%)
b
96
88
96
94
97
95
7
8
160
161
4-F-C6H4
4-Me2N-C6H4
9 1624-MeS-C6H4
10 1634-CF3-C6H4
11 1644-CH2CH-C6H4
12 1651-Naphthyl
94
91
89
93
85
87
13c 1661,3-CF3-C6H4 92
151
 
a The reactions were performed with 0.33 mmol of 151, 1.1 equiv of 
arylbromide, 1.3 equiv of NaOt-Bu, 0.01 equiv of catalyst XVI, in 
1.5 mL of toluene at 70 ºC for 1h . b Isolated yield after purification 
by silica gel chromatography. c 2 mol % of XVI was used. 
 
We investigated the scope of this cross-coupling reaction by examining a variety 
of aryl bromides with propiophenone (151). For both electon-deficient and electro-rich 
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aryl bromides, the system showed to be very efficient (Table 2.7, entries 3-10). The 
palladium cross-coupling reaction of 1-bromo naphthalene and 151 delivers the product 
in 87% yield; the yield is slighter lower since the coupling is ortho to a substituent 
(Table 2.7, entry 12). The adduct of the electron-rich 2-bromoanisole is obtained in 49% 
yield using 1 mol% catayst loading due to steric interactions with the ortho methoxy 
group, but when 2 mol% was used 88% yield was obtained in 1 h (Table 2.7, entry 2). 
The electron-poor 1-bromo-3,5-bis(trifluoromethyl)benzene afforded a lower yield 
(55%), due to electron density since it contains two electron withdrawing substituents at 
the meta position. Although, using twice as much catalyst loading the yield was 
increased up to 92% in the same amound of time (Table 2.7, entry 13). Additionally, this 
Palladium pincer complex XVI was highly chemoselective for the cross-coupling 
reaction of 4-bromo styrene, affording the adduct in 85% yield (Table 2.7, entry 11). 
 
Table 2.8 Cross-Coupling of bromobenzene with various ketonesia 
Ar
O
R
Ph
Br
[t-BuPheBoxMe2]PdBr
  XVI (1 mol%)
Ar
O
R
Ph
1.1 equiv
1
2
167
168
Ph
Ph
3c 169Ph
4 170Ph
5 1714-MeO-C6H4
6 1724-CF3-C6H4
Entry Product (#)Ar Yield (%)
b
96
91
95
98
82
99
7
8
173
174
4-MeC6H4
2-F-C6H4
84
83
Me
Et
i-Pr
CH2Ph
Me
Me
R
Me
Me
NaOt-Bu 1.3 equiv 
PhMe, 70 ºC, 1 h1 equiv
 
a The reactions were performed with 0.33 mmol of ketone, 1.1 
equiv of bromobenzene, 1.3 equiv of NaOt-Bu, 0.01 equiv of 
catalyst XVI, in 1.5 mL of toluene at 70 ºC for 1h . b Isolated yield 
after purification by silica gel chromatography. c 2 mol % of XVI 
was used. 
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To further examine the scope and utility of these reaction conditions, a variety of 
ketones were treated with bromobenzene, but no significant differences were observed 
(Table 2.8). The system was proven to be highly active for several ketones varying 
electron-poor or electron-rich group in the aromatic part. The electron-deficient 1-(4-
(trifluoromethyl)phenyl)propan-1-one showed higher reactivity with 99% yield (Table 
2.8, entry 6) versus its counterpart electron-rich 1-(4-methoxyphenyl)propan-1-one with 
82% yield (Table 2.8, entry 5). In the aliphatic side of the ketone, several groups where 
investigated. It was found that isovalerophenone showed lower reaction rate with only 
60% yield after 1 h, but using 2 mol% catalyst loading the yield was increased to 95% in 
the same period of time. This was likely to steric interaction of the isopropyl group with 
the transient stereocenter. (Table 2.8, entry 3). In general electron-withdrawing groups 
help to accelerate the reaction rates while electon-donating groups reduce slighty the 
reaction rate. 
In summary, we have developed a direct and highly active, (NCN)-Pd catalytic 
system for the α-arylation of ketones with a variety of aryl bromides using [t-
BuPheBox-Me2]PdBr (XVI) as the catalyst. Further efforts are needed to further 
elucidate the mechanistic details of this reaction system which should in turn allow for 
future advances to develop an asymmetric variant. 
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2.5 Experimental Section 
 
2.5.1 General Information 
 
All reactions were carried out under an argon atmosphere in oven-dried 
glassware with magnetic stirring. All commercially obtained reagents were used as 
received. Any impure starting material from stock was purified by distillation, column 
chromatography, or recrystallization. Solvents were distilled under its specific drying 
agent or obtained from a purification system. 
Cooling was accomplished using an ice bath or an isopropanol bath. Heating was 
accomplished by either a heating mantle or silicone oil bath. Purification of reaction 
products was carried out by flash column chromatography using silica gel, distillation or 
by recrystallization. Visualization was accompanied with UV light and/or ceric 
ammonium molybdate or potassium permanganate staining. 
1H NMR spectra were recorded on a 300 MHz instrument and recorded relative 
to the deuterated solvent used, in ppm units. 1H NMR coupling constants (J) are reported 
in Hertz (Hz) and multiplicities are indicated as follows: s (singlet), d (doublet), t 
(triplet), m (multiplet). Proton-decoupled 13C NMR spectra were recorded at 75 MHz. 
High-resolution mass spectra (HRMS) were obtained at Texas A&M. Infrared spectra 
were recorded on a spectrometer using a thin film on NaCl plates.  
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2.5.2 Synthesis and Characterization of Pincer Ligands 
The procedures and characterization data for the pincer ligands is described in 
the following pages. 
ClOC COCl
Br  
2-bromoisophthalyl dichloride (78): To a suspension of 2-bromoisophthalic acid (1 g, 
4 mmol) in benzene (40 mL) and a drop of DMF was added SOCl2 (9 mL, 61 mmol) at 0 
°C. After the mixture was refluxed for 3 h, excess SOCl2 was removed by distillation, 
which gave 78 in 99% yield (1.1 g). 1HNMR (300MHz, CDCl3) δ 8.00 (d, 2H), 7.62 (t, 
1H). 13C NMR (75 MHz, CDCl3) δ 166.1, 139.1, 134.5, 127.9, 117.3. MS (CI) LRMS 
calcd for C8H3BrCl2O2 + H requires m/z 280.87, found 280.9 and 282.9.  
O
N N
O
i-Pr i-Pr
Br
 
[(S,S)-Phebox-i-Pr]Br (77a):  A solution of 2-bromo-isophthaloyl dichloride 78 (1.02 g, 
4.0 mmol) in dichloromethane (20 mL) was slowly added to a solution of L-valinol (907 
mg, 8.8 mmol) and triethylamine (8.1 mL, 60 mmol) in dichloromethane (20 mL) at 0 
ºC. The mixture was stirred at room temperature for 5 h. Formation of the intermediate 
diamide–dialcohol was monitored by TLC examination; Rf = 0.4 (ethyl acetate/methanol 
= 10 :1). Then, methanesulfonyl chloride (1.003 g, 8.8 mmol) was added at 0 ºC, and the 
mixture was stirred at room temperature for 16 h. Formation of the product 77a was 
monitored by TLC examination; Rf = 0.8 (ethyl acetate/hexane = 3:1). At 0 ºC, aqueous 
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potassium carbonate (1 N, ca. 30 mL) was added and the mixture was extracted with 
ethyl acetate. The organic layer was washed with saturated brine, was dried over sodium 
sulfate, and concentrated. The crude product was purified by column chromatography 
(20% EtOAc-Hexanes) to give 77a in 76% yield (1.27 g, 2.71 mmol) as a colorless solid. 
[α]19D = –56.62° (c= 1 in CHCl3). IR  (thin film) ν 1628 cm-1. 1HNMR (300MHz, 
CDCl3) δ 7.66 (d, J = 8.3 Hz, 2H), 7.37 (t, J = 8.3 Hz, 1H), 4.42 (m, 2H), 4.18 (m, 4H), 
1.92 (m, 2H), 1.05 (d, J = 6.8 Hz, 6H), 0.99 (d, J = 6.8 Hz, 6H). 13C NMR (75 MHz, 
CDCl3) δ 163.03, 144.1, 132.57, 132.23, 126.93, 72.85, 70.53, 32.58, 18.75, 18.25. MS 
(ESI) LRMS calcd for C18H23BrN2O2 + H requires m/z 379.09, found 379.26 and 381.18. 
O
N N
O
Ph Ph
Br
 
[(R,R)-Phebox-Ph]Br (77b): A procedure analogous to the synthesis of 1a was 
employed using 2-bromo-isophthalic acid chloride (78) (1.02 g, 4.0 mmol) and (R)-
phenylglycinol (1.07 g, 7.8 mmol), to yield the uncyclized oxazoline (bisamide) as a 
white solid. A suspension of the crude bis(amide) in BF3•Et2O (10 mL)was heated to 
120 °C (the mixture became homogeneous at 75 °C) for 4 h. The solution was allowed to 
cool down, diluted with dichloromethane (50 mL), and poured into ice-cold 2N NaOH 
(50 mL). The phases were separated, and dried with sodium sulfate. Concentration of 
this solution gave crude [(R,R)-Phebox-Ph]Br (77b), which was purified by column 
chromatography (20% EtOAc-hexanes). Yield 1.06 g (67% after two steps) of 77b as a 
white solid. [α]19D = 67.98° (c= 1 in CHCl3). IR (thin film) ν 1651 cm-1. 1HNMR 
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(300MHz, CDCl3) δ 7.81 (d, J = 8.3 Hz, 2H), 7.44 (t, J = 8.3 Hz, 1H), 7.31-7.40 (m, 
10H), 5.45 (t, J = 5.6 Hz, 2H) 4.85 (t, J = 6.6 Hz, 2H), 4.32 (t, J = 5.6 Hz, 2H). 13C 
NMR (75 MHz, CDCl3) δ 164.25, 141.72, 132.93, 131.81, 128.6, 127.5, 127.0, 126.6, 
121.4, 75.09, 70.25. MS (ESI) LRMS calcd for C24H19BrN2O2 + H requires m/z 447.06, 
found 447.05 and 449.05. 
O
N N
O
Bn Bn
Br
 
[(S,S)-Phebox-Bn]Br (77c): A procedure analogous to the synthesis of 77b was 
employed using 2-bromo-isophthalic acid chloride (78) (1.02 g, 4.0 mmol) and L-
phenylalaninol (1.238 g, 8.2 mmol), to yield 1.09 g (65% after two steps) of 77c. [α]19D 
= –50.21° (c= 1 in CHCl3). IR (thin film) ν 1649 cm-1. 1HNMR (300MHz, CDCl3) δ 
7.64 (d, J = 8.3 Hz, 2H), 7.38 (t, J = 8.3 Hz, 1H), 7.22-7.33 (m, 10H), 4.64-4.67 (m, 
2H), 4.41 (t, J = 5.6 Hz, 2H), 4.20 (t, J = 6.6 Hz, 2H), 3.24 (dd, J = 5.6 Hz, 6.8 Hz, 2H). 
2.85 (dd, J = 5.8 Hz, 4.2 Hz, 2H). 13C NMR (75 MHz, CDCl3) δ 163.4, 137.5, 132.5, 
131.8, 129.2, 128.4, 126.4, 121.2, 72.0, 67.9, 41.3. MS (ESI) LRMS calcd for 
C26H23BrN2O2 + H requires m/z 475.09, found 475.10 and 477.09. 
O
N N
O
i-Pr i-Pr
I
 
[(S,S)-Phebox-i-Pr]I (1d): To a solution of diisopropylamine (0.34 g, 3.36 mmol) in 
THF (2 mL), cooled to –78 °C nBuLi in hexanes (3.7 mmol) and the resulting mixture 
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stirred at –78 °C min at room temperature. After re-cooling to –78 °C this was added via 
cannula to a separate flask, also cooled to –78 °C (S,S)-Phebox-i-Pr (79) (0.39 g, 1.12 
mmol) and TMEDA (0.43 g, 3.7mmol) in THF (10 mL). After the addition the resulting 
deep red solution was stirred at room temperature for 5 h prior to the addition of iodine 
(1.22 g, 4.8 mmol). The solvent was removed in vacuo and the crude product dissolved 
in CH2Cl2 (50 mL). After washing with aqueous sodium thiosulfate solution (50 mL), 
this was dried (MgSO4), filtered and the solvent removed in vacuo. Column 
chromatography of the residue (20% EtOAc-Hexanes) gave [(S,S)-Phebox-i-Pr]I (77d) 
as a pale yellow oil (0.303g, 52%). [α]19D = –58.32° (c= 1 in CHCl3). IR (thin film) ν 
1628 cm-1. 1HNMR (300MHz, CDCl3) δ 7.55 (d, J = 8.3 Hz, 2H), 7.39 (t, J = 8.1 Hz, 
1H), 4.46 (m, 2H), 4.16 (m, 4H), 1.93(m, 2H), 1.07 (d, J = 6.8 Hz, 6H), 1.00 (d, J = 6.8 
Hz, 6H). 13C NMR (75 MHz, CDCl3) δ 164.48, 142.12, 136.63, 131.64, 127.77, 73.03, 
70.69, 32.67, 18.96, 18.45. MS (ESI) LRMS calcd for C18H23IN2O2 + H requires m/z 
427.08, found 427.079.  
ClOC COCl
t-Bu
 
Isophthaloyl dichloride (82). To a suspension of 5-tert-butyl-isophthalic acid (81) (10 
g, 56 mmol) in benzene (40 mL) and a drop of DMF was added SOCl2 (30 mL, excess) 
at 0 °C. After the mixture was refluxed for 5 h, excess SOCl2 was removed by 
distillation, which gave 82 in 99% yield (11.63 g). IR (thin film) ν 1761 cm-1. 1HNMR 
(300MHz, CDCl3) δ 8.71 (s, 1H), 8.41 (s, 2H), 1.42 (s, 9H). 13C NMR (75 MHz, CDCl3) 
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δ 167.6, 153.9, 134.2, 134.0, 131.6, 35.2, 30.9. MS (CI) LRMS calcd for C12H12Cl2O2 + 
H requires m/z 259.02, found 259.0.  
O
N N
O
i-Pr i-Pr
t-Bu
 
(S,S)-tBuPhebox-i-Pr (E-11).  A solution of isophthaloyl dichloride 82 (1.55 g, 6.0 
mmol) in dichloromethane (20 mL) was slowly added to a solution of L-valinol (1.36 g, 
13.2 mmol) and triethylamine (12.5mL, 90 mmol) in dichloromethane (20 mL) at 0 ºC. 
The mixture was stirred at room temperature for 5 h. Formation of the intermediate 
diamide–dialcohol was monitored by TLC examination; Rf = 0.5 (ethyl acetate/methanol 
= 10:1). Then, methanesulfonyl chloride (1.25 mL, 13.2 mmol) was added at 0 ºC, and 
the mixture was stirred at room temperature for 16 h. Formation of the product E-11 was 
monitored by TLC examination; Rf = 0.8 (ethyl acetate/hexane = 3:1). At 0 ºC, aqueous 
potassium carbonate (1 N, ca. 50 mL) was added and the mixture was extracted with 
ethyl acetate. The organic layer was washed with saturated brine, was dried over sodium 
sulfate, and concentrated. The crude product was purified by column chromatography 
(20% EtOAc-Hexanes) to give (S,S)-t-BuPhebox-i-Pr (E-11) in 76 % yield (1.5 g, 4.7 
mmol) as a white solid. [α]19D = –72.56° (c= 1 in CHCl3). IR (thin film) ν 1648 cm-1. 
1HNMR (300MHz, CDCl3) δ 8.35 (s, 1H), 8.11 (s, 2H), 4.42 (m, 2H), 4.15 (m, 4H), 
1.88(m, 2H), 1.38 (s, 3H), 1.04 (d, J = 5.8 Hz, 6H), 0.94 (d, J = 5.8 Hz, 6H). MS (ESI) 
LRMS calcd for C22H32N2O2 + H requires m/z 357.25, found 357.2.  
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N N
O
i-Pr i-Pr
t-Bu
I
 
[(S,S)-tBuPhebox-i-Pr]I (80a).  To a solution of diisopropylamine (0.34 g, 3.36 mmol) 
in THF (2 mL), cooled to –78 °C nBuLi in hexanes (3.7 mmol) and the resulting mixture 
stirred at –78 °C min at room temperature. After re-cooling to –78 °C this was added via 
cannula to a separate flask, also cooled to –78 °C (S,S)-t-BuPhebox-i-Pr (E-11) (0.4 g, 
1.12 mmol) and TMEDA (0.43 g, 3.7mmol) in THF (10 mL). After the addition the 
resulting deep red solution was stirred at room temperature for 5 h prior to the addition 
of iodine (1.22 g, 4.8 mmol). The solvent was removed in vacuo and the crude product 
dissolved in CH2Cl2 (50 mL). After washing with aqueous sodium thiosulfate solution 
(50 mL), this was dried (MgSO4), filtered and the solvent removed in vacuo. Column 
chromatography of the residue (20% EtOAc-Hexanes) gave [(S,S)-t-BuPhebox-i-Pr]I 
(80a) as a pale brown crystalline solid (0.313 g, 58%). [α]19D = –63.99° (c= 1 in CHCl3). 
IR (thin film) ν 1658 cm-1. 1HNMR (300MHz, CDCl3) δ 7.52 (s, 2H), 4.44 (m, 2H), 4.13 
(m, 2H), 1.94 (m, 2H), 1.28 (s, 9H), 1.03 (d, J = 6.8 Hz, 6H), 0.98 (d, J = 6.8 Hz, 6H). 
13C NMR (75 MHz, CDCl3) δ 164.78, 151.2, 136.1, 128.9, 92.0, 73.0, 70.5, 34.5, 32.6, 
30.8, 19.0, 18.4. MS (ESI) LRMS calcd for C22H31IN2O2 + H requires m/z 483.14, found 
483.31. 
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ClOC COCl
Br
t-Bu
 
2-bromo-5-tert-butyl-isophthaloyl dichloride (85): To a suspension of 2-bromo-5-tert-
butyl-isophthalic acid (84) (5 g, 15 mmol), in benzene (25 mL) and a drop of DMF was 
added SOCl2 (25 mL, excess) at 0 °C. After the mixture was refluxed for 3 h, excess 
SOCl2 was removed by distillation to give 5.55 g of 85 in 99% yield as a white solid. 1H 
NMR (300 MHz, CDCl3) δ 7.97 (s, 2H), 1.39 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 
166.2, 152.0, 138.5, 131.3, 113.7, 35.12, 30.7. MS (CI) LRMS calcd for C12H11BrCl2O2 
+ H requires m/z 336.93, found 336.9 and 338.9.  
O
N N
O
Ph Ph
Br
t-Bu
 
 [(R,R)-tBuPhebox-Ph]Br (80b): A solution of isophthaloyl dichloride (85) (1 g, 3 
mmol) in dichloromethane (10 mL) was slowly added to a solution of (R)-
phenylglycinol (856 mg, 6.25 mmol) in dichloromethane (10 mL), then a solution of 
triethylamine (2.06 mL, 15 mmol) in dichloromethane (10 mL) was added slowly at 0 ºC 
under argon. The mixture was stirred at room temperature for 8 h. Formation of the 
intermediate diamide–dialcohol was monitored by TLC. After completion the mixture 
was washed with NH4Cl, dried with sodium sulfate. The solution is concentrated under 
reduce pressure to give the corresponding crude bis(amide). MS (ESI) LRMS calcd for 
C29H31BrN2O4 + H requires m/z 539.15, found 539.14 and 541.14. A suspension of the 
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crude bis(amide) (1g, 2 mmol) in BF3•Et2O (10 mL)was heated to 120 °C (the mixture 
became homogeneous at 75 °C) for 4 h. The solution was allowed to cool, diluted with 
dichloromethane (50 mL), and poured into ice-cold 2N NaOH (50 mL). The phases were 
separated, and dried with sodium sulfate. Concentration of this solution gave crude 
[(R,R)-tBuPhebox-Ph]Br (80b), which was purified by column chromatography (20% 
EtOAc-hexanes) affording a white solid, 800 mg (86% yield after two steps): [α]19D = 
+46.91° (c= 1 in CHCl3). IR (thin film) ν 1650 cm-1. 1HNMR (300MHz, CDCl3) δ 7.81 
(s, 2H), 7.31−7.42 (m, 10H), 5.47 (t, J = 8.3 Hz 2H), 4.87 (t, J = 5.6 Hz, 2H), 4.33 (t, J 
= 6.6 Hz, 2H), 1.37 (s, 9H) 13C NMR (75 MHz, CDCl3) δ 164.6, 150.5, 141.7, 131.3, 
130.1, 128.6, 127.5, 126.7, 118.1, 70.3, 34.6, 30.8. MS (ESI) LRMS calcd for 
C28H27BrN2O2 + H requires m/z 503.13, found 503.1 and 505.1. 
O
N N
O
Bn Bn
Br
t-Bu
 
[(S,S)-tBuPhebox-Bn]Br (80c): A procedure analogous to the synthesis of 80b was 
employed using 2-bromo-5-tertbutyl-isophthalic acid chloride (85) (600 mg, 1.78 mmol) 
and L-phenylalaninol (593 mg, 3.93 mmol), to yield the crude uncylized oxazoline 
(bisamide) as a white solid after removal of volatiles under reducer pressure. Acetonitrile 
(10 mL), PPh3 (981 mg, 3.7 mmol), and triethylamine (0.512 mL, 3.7 mmol) were added 
to the crude bisamide. The temperature was reduced to 0 °C, after which CCl4 (0.37 mL, 
3.7 mmol) was slowly added via syringe. The reaction mixture was warmed to room 
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temperature overnight, after which the mixture was quenched with H2O (10 mL) and the 
volatiles were removed in vacuum. The residue was dissolved in H2O (50 mL) and 
dichloromethane (100 mL). After separation of the layers, the organic layer was washed 
with H2O (30 mL) and brine (30 mL). The combined aqueous layers were extracted with 
dichloromethane (100 mL). The combined organic layers were dried on Na2SO4 and 
filtered. After the solvent was removed in vacuum, the crude product was purified by 
silica gel column chromatography (20% EtOAc-hexanes) to afford 80c as a white solid, 
549 mg (58% yield after two steps). [α]19D = –52.15° (c= 1 in CHCl3). IR (thin film) ν 
1658 cm-1. 1HNMR (300MHz, CDCl3) δ 7.60 (s, 2H), 7.25−7.38 (m, 10H), 4.65 (m, 2H), 
4.38 (t, J = 6.6 Hz, 2H), 4.22 (t, J = 5.6 Hz, 2H), 3.25 (dd, J = 5.6 Hz, 6.8 Hz, 2H), 2.88 
(dd, J = 5.8 Hz, 4.2 Hz, 2H), 1.33 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 163.7, 150.24, 
137.4, 131.3, 129.7, 129.3, 128.3, 126.4, 117.8, 71.8, 67.8, 41.2, 34.5, 30.8. MS (ESI) 
LRMS calcd for C30H31BrN2O2 + H requires m/z 531.16, found 531.16 and 533.16. 
OMe
Me Me  
3,5-dimethylanisol (E-12): To a solution of 3,5-dimethylphenol 87 (30g, 246 mmol) in 
acetone (200 mL) was added anhydrous K2CO3 (51 g, 369 mmol), and iodomethane 
(52.4 g, 369 mmol). The mixture was heated at reflux under argon for 24 hr.  After 
cooling the reaction to room temperature, it was filtrated through celite, washed with 
acetone, and concentrated under reduce pressure. The residue was dissolved in 
dichloromethane and washed with 1N NaOH. Further simple distillation afforded pure 
3,5-dimethylanisol (E-12) as a colorless liquid in 95% yield. 1HNMR (300MHz, CDCl3) 
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δ 6.99 (s, 1H), 6.63 (s, 2H), 3.85 (s, 3H), 2.38 (s, 6H). 13C NMR (75 MHz, CDCl3) δ 
159.5, 139.9, 122.3, 115.7, 54.9, 21.3. MS (CI) LRMS calcd for C9H12O + H requires 
m/z 137.09, found 137.10. 
OMe
Me Me
I  
3,5-dimethyl-4-iodoanisol (88): To a solution of 3,5-dimethylanisol E-12 (4 g, 30 
mmol) in 40 mL of methanol was added 20 mL of 36% hydrochloric acid, with 
occasional cooling to maintain the temperature at 20-30 °C. To the resulting solution 
was added a solution of potassium iodide (3.2 g, 20 mmol) and potassium iodate (2.1 g, 
10 mmol) in 25 ml water over a 10-minute period. Note that the solution color changed 
from colorless to brown and cloudy. After stirring at room temperature overnight, the 
reaction mixture was extracted with dichloromethane, washed with Na2S2O3 and 1N 
NaOH, dried with Na2SO4. The solvent was removed under reduce pressure. The 
resulting tan solid was recrystallized several times from hot methanol by cooling down 
to –4 °C to yield 7.7 g (98% yield) of white crystals, which were identified as 3,5-
dimethyl-4-iodoanisol (88). 1HNMR (300MHz, CDCl3) δ 6.67 (s, 2H), 3.78 (s, 3H), 2.45 
(s, 6H). 13C NMR (75 MHz, CDCl3) δ 159.1, 142.8, 112.8, 96.9. 55.2, 29.7. MS (CI) 
LRMS calcd for C9H11IO + H requires m/z 262.99, found 263.10.  
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OMe
ClOC COCl
I  
2-iodo-5-methoxy-isophthaloyl dichloride (89): In a 250 mL three-necked round-
bottom flask equipped with a mechanical stirrer and a reflux condenser was added 2-
iodo-5-methoxy-1,3-dimethylbenzene (88) (2 g, 8 mmol), dispersed in 30 mL of water 
and NaOH (1.3 g, 32 mmol). A hot solution of KMnO4 (10.8 g, 72 mmol) in 100 mL of 
water was added at 100 °C and the reaction mixture was heated at reflux for 8 h. After 
the mixture was cooled to room temperature, the reaction was filtered using vacuum 
filtration. The solution was acidified with concentrated HCl. The resulting white 
precipitate was collected by vacuum filtration and either oven-dried (∼80 °C) or dried 
under high vacuum overnight to give 1.3 g (53% yield) of the 2-iodo-5-methoxy-
isophthalic acid. To a suspension of 2-iodo-5-methoxy-isophthalic acid (0.7 g, 2.2 
mmol) in benzene (50 mL) and a drop of DMF was added SOCl2 (11 mL, 150 mmol) at 
0 °C. The mixture was warmed up to reflux. After the mixture was refluxed for 5 h, the 
excess SOCl2 was removed by distillation to give 772 mg (99% yield) of the 2-iodo-5-
methoxy-isophthalic acid chloride (89) as a pale yellow liquid: 1H NMR (300 MHz, 
CDCl3) δ 7.4 (s, 2H), 3.95 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 166.1, 158.9, 139.5, 
119.3, 106.8, 56.3. MS (CI) LRMS calcd for C9H5Cl2IO3 + H requires m/z 358.87, found 
358.9.  
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i-Pr i-Pr  
[(S,S)-MeOPhebox-i-Pr]I (86a): A solution of 2-iodo-5-methoxy-isophthaloyl 
dichloride (89) (750 mg, 2.09 mmol) in dichloromethane (10 mL) was slowly added to a 
solution of L-valinol (474 mg, 4.6 mmol), triethylamine (4.25 mL, 31 mmol) in 
dichloromethane (20 mL) at 0 ºC. The mixture was stirred at room temperature for 5 h. 
Formation of the intermediate diamide–dialcohol was monitored by TLC. Then, 
methanesulfonyl chloride (524.4 mg, 4.6 mmol) was added at 0 ºC, and the mixture was 
stirred at room temperature for 8 h. Formation of the product 86a was monitored by TLC 
examination; Rf = 0.4 (60% ethyl acetate/hexane). At 0 ºC, aqueous potassium carbonate 
(1 N, ca. 30 mL) was added and the mixture was extracted with ethyl acetate. The 
organic layer was washed with saturated brine, dried over sodium sulfate, and 
concentrated under reduce pressure. The crude product was purified by column 
chromatography (20% EtOAc-Hexanes) to give 86a in 62 % yield after two steps (580 
mg, 1.27 mmol) as colorless oil. [α]19D = –62.42° (c= 1 in CHCl3). IR (thin film) ν 1650 
cm-1. 1HNMR (300MHz, CDCl3) δ 7.11 (s, 2H), 4.47 (m, 2H), 4.14 (m, 4H), 3.79 (s, 
3H), 1.89 (m, 2H), 1.04 (d, J = 6.8 Hz, 6H), 0.96 (d, J = 6.8 Hz, 6H). 13C NMR (75 
MHz, CDCl3) δ 164.8, 159.0, 137.8, 117.7, 84.0, 72.3, 70.6, 55.0, 32.6, 18.9, 18.4. MS 
(ESI) LRMS calcd for C19H25IN2O3 + H requires m/z 457.091, found 457.085. 
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OMe
Me Me
Br  
2-bromo-5-methoxy-1,3-dimethylbenzene (90): To a stirred solution of 3,5-
dimethylanisol (E-12) (8.2 g, 60 mmol) in CH2Cl 2 (100 mL) was added dropwise a 1.0 
M solution of bromine in CH2Cl 2 (9.95 g, 63 mmol) at 0 °C via cannula over a 2-min 
period of time under argon. The reaction was stirred for 1 hour at room temperature; 
progress was monitored by TLC analysis. The product was washed with sodium 
thiosulfate until the organic phase is colorless, dried with sodium sulfate. The solvent 
was removed under reduce pressure. The residue was purified by simple distillation to 
give 10.88 g (66%) of pure 2-bromo-5-methoxy-1,3-dimethylbenzene (90) as a colorless 
liquid: 1HNMR (300MHz, CDCl3) δ 6.56 (s, 2H), 3.78 (s, 3H), 2.40 (s, 6H), 13C NMR 
(75 MHz, CDCl3) δ 158.1, 138.8, 118.8, 113.9, 55.6, 24.2. MS (CI) LRMS calcd for 
C9H11BrO + H requires m/z 215.0, found 215.1 and 217.1.  
OMe
ClOC COCl
Br  
2-bromo-5-methoxy-isophthaloyl dichloride (91): In a 250 mL three-necked round-
bottom flask equipped with a mechanical stirrer and a reflux condenser was added 2-
bromo-5-methoxy-1,3-dimethylbenzene (90) (2.5 g, 11.7 mmol), dissolved in 30.0 mL 
of t-BuOH–water (1:1) and KMnO4 (3.7 g, 23.4 mmol). The mixture was set at reflux for 
2 h, cool down to room temperature, then more KMnO4 (3.7 g, 23.4 mmol) was added. 
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The reaction mixture was refluxed for another 16 hours. After the mixture was cooled to 
room temperature, and filtered using vacuum filtration, the t-BuOH was removed under 
reduce pressure. The solution was acidified with concentrated HCl. The resulting white 
precipitate was collected by vacuum filtration and either oven-dried (∼80 °C) or dried 
under high vacuum overnight to give 1.79 g (56% yield) of the 2-bromo-5-methoxy-
isophthalic acid. To a suspension of 2-bromo-5-methoxy-isophthalic acid (1.0 g, 3.7 
mmol) in benzene (50 mL) and a drop of DMF was added SOCl2 (11 mL, 150 mmol) at 
0 °C. After the mixture was refluxed for 5 h, the excess SOCl2 was removed by 
distillation to give 1.12 g (99% yield) of the 2-bromo-5-methoxy-isophthaloyl dichloride 
(91) as a white solid: 1H NMR (300 MHz, CDCl3) δ 7.55 (s, 2H), 3.98 (s, 3H). 13C NMR 
(75 MHz, CDCl3) δ 166.1, 158.9, 139.5, 119.3, 106.8, 56.3. MS (CI, CH4) LRMS calcd 
for C9H5BrCl2O3 + H requires m/z 310.88, found 310.9 and 312.9. 
O
N N
O
Br
OMe
Bn Bn  
[(S,S)-MeOPhebox-Bn]Br (86b): A solution of 2-bromo-5-methoxy-isophthaloyl 
dichloride (91) (806 mg, 2.6 mmol) in dichloromethane (10 mL) was slowly added to a 
solution of L-phenylalaninol (824 mg, 5.4 mmol) and triethylamine (1.6 mL, 11.25 
mmol) in dichloromethane (20 mL) at 0 ºC. The mixture was stirred at room temperature 
for 5 h. The volatiles were removed under reduce pressure to afford the crude bisamide 
that was used without further purification. Acetonitrile (10 mL), PPh3 (1.52 g, 5.7 
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mmol), and triethylamine (551 mg, 5.46 mmol) were added to the crude bisamide. The 
temperature was reduced to 0 °C, after which CCl4 (840 mg, 5.46 mmol) was slowly 
added via syringe. The reaction mixture was warmed to room temperature and stirred 
overnight, after which the mixture was quenched with H2O (10 mL) and the volatiles 
were removed under vacuum. The residue was dissolved in H2O (50 mL) and 
dichloromethane (100 mL). After separation of the layers, the organic layer was washed 
with H2O (30 mL) and brine (30 mL). The combined aqueous layers were extracted with 
dichloromethane (100 mL). The combined organic layers were dried on Na2SO4 and 
filtered. After the solvent was removed under reducer pressure, the crude product was 
purified by silica gel column chromatography (20% EtOAc-hexanes) to afford 86b as 
colorless oil. 858 mg (66% after two steps). [α]19D = –55.68° (c= 1 in CHCl3). IR (thin 
film) ν 1645 cm-1. 1HNMR (300MHz, CDCl3) δ 7.24−7.35 (m, 10H), 7.17 (s, 2H), 4.63 
(m, 2H), 4.40 (t, J = 7.6 Hz, 2H), 4.20 (t, J = 5.6 Hz, 2H), 3.81 (s, 3H), 3.23 (dd, J = 5.6 
Hz, 6.8 Hz, 2H). 2.86 (dd, J = 5.8 Hz, 4.2 Hz, 2H), 1.33 (s, 9H). 13C NMR (75 MHz, 
CDCl3) δ 163.2, 157.8, 137.4, 132.4, 129.2, 128.5, 128.3, 126.3, 126.4, 118.2, 111.35, 
71.9, 67.8, 55.6, 41.2. MS (ESI) LRMS calcd for C27H25BrN2O3 + H requires m/z 
505.10, found 505.10 and 507.10. 
MeO OMe
Br Br  
1,5-dibromo-2,4-dimethoxybenzene (93). To a stirred solution of 1,3-
dimethoxybenzene (15 g, 108 mmol) in CH2Cl 2 (100 mL) was added dropwise a 1.0 M 
solution of bromine in CH2Cl 2 (36 g, 230 mmol) at 0 °C via cannula over a 2-min period 
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under argon. The reaction was stirred for 30 min., progress was monitored by TLC 
analysis. The product was washed with sodium thiosulfate until the organic phase is 
colorless, dried with sodium sulfate, and the solvent was removed under reduced 
pressure to give 32 g (99%) of pure 1,5-dibromo-2,4-dimethoxybenzene (93) as a white 
solid: 1HNMR (300MHz, CDCl3) δ 7.65 (s, 1H), 6.48 (s, 1H), 3.9 (s, 6H). 13C NMR (75 
MHz, CDCl3) δ 156.1, 135.8, 102.3, 97.3, 56.4. MS (CI, CH4) LRMS calcd for 
C8H8Br2O2 + H requires m/z 293.89, found 294.0, 295.0, 297.0, and 299.0.  
MeO OMe
Me Me  
1,5-dimethoxy-2,4-dimethylbenzene (E-13). An n-BuLi (2.39 g, 37.4 mmol) solution 
was added to a solution of 1,5-dibromo-2,4-dimethoxybenzene (93) (5 g, 17 mmol) in 
100 mL of ether at –78 °C under argon, the colorless solution was stirred at –78 °C for 
30 min. Iodomethane (4.7 mL, 74.8 mmol) was added slowly at –78 °C under argon via 
syringe.  The mixture was allowed to warm up to room temperature while stirred for 1h. 
The mixture was quenched with NH4Cl and washed with 1N NaOH, water and brine. It 
was dried with sodium sulfate and concentrated under reduce pressure to give 2.8 g 
(99%) of pure 1,5-dimethoxy-2,4-dimethylbenzene (E-13) as white solid: 1HNMR 
(300MHz, CDCl3) δ 6.89 (s, 1H), 6.43 (s, 1H), 3.83 (s, 6H), 2.13 (s, 6H). 13C NMR (75 
MHz, CDCl3) δ 156.3, 132.3, 117.6, 95.3, 55.69, 15.14. MS (CI, CH4) LRMS calcd for 
C10H14O2 + H requires m/z 167.10, found 167.10.  
 130 
Me Me
Br
MeO OMe
Br
 
1,4-dibromo-2,6-dimethoxy-3,5-dimethylbenzene (E-14). To a stirred solution of 1,5-
dimethoxy-2,4-dimethylbenzene (E-13) (2.8 g, 17 mmol) in CH2Cl 2 (70 mL) was added 
dropwise a 1.0 M solution of bromine (6.7 g, 42 mmol) in CH2Cl 2 (30 mL) at 0 °C via 
cannula over a 2-min period under argon. The reaction was stirred for 16 h at room 
temperature; progress was monitored by TLC analysis. The product was washed with 
sodium thiosulfate until the organic phase is colorless, dried with sodium sulfate, and the 
solvent was removed under reduce pressure to give 5.02 g (93%) of pure 1,4-dibromo-
2,6-dimethoxy-3,5-dimethylbenzene (E-14) as white solid after recrystallization from 
ether: 1HNMR (300MHz, CDCl3) δ 3.78 (s, 6H), 2.4 (s, 6H). 13C NMR (75 MHz, 
CDCl3) δ 154.1, 129.3, 127.7, 112.2, 60.6, 17.3. MS (CI, CH4) LRMS calcd for 
C10H12Br2O2 + H requires m/z 322.92, found 323.1, 325.1, and 327.1.  
Me Me
Br
MeO OMe
 
3-bromo-1,5-dimethoxy-2,4-dimethylbenzene (94). An n-BuLi (795 mg, 12.4 mmol) 
solution was added to a solution of 1,4-dibromo-2,6-dimethoxy-3,5-dimethylbenzene (E-
14) (4 g, 12.4 mmol) in 100 mL of ether at –78 °C under argon, the colorless solution 
was stirred at –78 °C for 1 h. H2O (50 mg, 25 mmol) in 5 mL of THF was added slowly 
at –78 °C under argon.  The mixture was allowed to warm up to room temperature and 
stirred for 1h. The mixture was quenched with NH4Cl and washed with NH4OH, water 
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and brine. It was dried with sodium sulfate and concentrated under reduce pressure to 
give 3.04 g (98%) of pure 3-bromo-1,5-dimethoxy-2,4-dimethylbenzene (94) as white 
solid after recrystallization from ether: 1HNMR (300MHz, CDCl3) δ 6.44 (s, 1H), 3.83 
(s, 6H), 2.28 (s, 6H). 13C NMR (75 MHz, CDCl3) δ 156.1, 129.2, 118.8, 94.7, 56.0, 15.7. 
MS (CI, CH4) LRMS calcd for C10H13BrO2 + H requires m/z 245.0, found 245.1, and 
247.1.  
ClOC COCl
Br
MeO OMe
 
2-bromo-4,6-dimethoxy-isophthaloyl dichloride (95). In a 250 mL three-necked 
round-bottom flask equipped with a mechanical stirrer and a reflux condenser was added 
3-bromo-1,5-dimethoxy-2,4-dimethylbenzene (94) (2.85 g, 12 mmol), dispersed in 100 
mL of a 1:1 mixture of tert-butyl alcohol and water. KMnO4 (11.4 g, 72 mmol) was 
added, and the reaction mixture was heated to reflux for 2 h. After the mixture was 
cooled to room temperature, more KMnO4 (11.4 g, 72 mmol) was added and the reaction 
mixture was refluxed for an additional 16 h. After the mixture was cooled to room 
temperature, the reaction was filtered through Celite and the filtrate was reduced by 1/3 
under reduce pressure. The solution was acidified with concentrated HCl. The resulting 
white precipitate was collected by vacuum filtration and the precipitate collected and 
either oven-dried (∼80 °C) or high vacuum dried overnight to give 2.30 g (65% yield) of 
2-bromo-4,6-dimethoxy-isophthalic acid as yellowish solid: IR (thin film) ν 3463, 1663 
cm-1. To a suspension of 2-bromo-4,6-dimethoxy-isophthalic acid (1.5 g, 5 mmol) in 
benzene (40 mL) and a drop of DMF was added SOCl2 (9 mL, 61 mmol) at 0 °C. After 
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the mixture was refluxed for 3 h, the excess SOCl2 was removed by distillation, which 
gave 2-bromo-4,6-dimethoxy-isophthaloyl dichloride (95) in 99% yield (1.6 g) as a pale 
yellow solid. 1HNMR (300MHz, CDCl3) δ 6.49 (s, 1H), 3.97 (s, 6H). 13C NMR (75 
MHz, CDCl3) δ 165.5, 158.3, 123.0, 114.2, 94.6, 56.7. MS (CI, CH4) LRMS calcd for 
C10H7BrCl2O4 + H requires m/z 340.89, found 340.9 and 342.9.  
O
N N
O
Br
i-Pr i-Pr
MeO OMe
 
[(S,S)-(MeO)2Phebox-i-Pr]Br (92a). A solution of 2-bromo-4,6-dimethoxy-
isophthaloyl dichloride (95) (110 mg, 0.324 mmol) in dichloromethane (5 mL) was 
slowly added to a solution of L-valinol (70 mg, 0.679 mmol) and triethylamine (0.2 mL, 
1.4 mmol) in dichloromethane (5 mL) at 0 ºC. The mixture was stirred at room 
temperature for 5 h. Formation of the intermediate diamide–dialcohol was monitored by 
TLC. The volatiles were removed under reduce pressure to afford the crude bisamide 
that was used without further purification. Acetonitrile (5 mL), PPh3 (254.6 mg, 0.972 
mmol), and triethylamine (98 mg, 0.972 mmol) were added to the crude bisamide. The 
temperature was reduced to 0 °C, after which CCl4 (150 mg, 0.972 mmol) was slowly 
added via syringe. The reaction mixture was warmed to room temperature overnight, 
after which the mixture was quenched with H2O (10 mL) and the volatiles were removed 
in vacuo. The residue was dissolved in H2O (50 mL) and dichloromethane (100 mL). 
After separation of the layers, the organic layer was washed with H2O (30 mL) and brine 
(30 mL). The combined aqueous layers were extracted with dichloromethane (100 mL). 
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The combined organic layers were dried on Na2SO4 and filtered. After the solvent was 
removed under reduced pressure, the crude product was purified by silica gel column 
chromatography (20% EtOAc-hexanes) to afford 92a as colorless oil. 123 mg (87% after 
two steps). [α]19D = –64.75° (c= 1 in CHCl3). IR (thin film) ν 1652 cm-1. 1HNMR 
(300MHz, CDCl3) δ 6.39 (s, 1H), 4.39 (m, 2H), 4.14 (m, 4H), 3.82 (s, 6H), 1.93(m, 2H), 
1.02 (d, J = 6.5 Hz, 6H), 0.92 (d, J = 6.5 Hz, 6H). 13C NMR (75 MHz, CDCl3) δ 160.6, 
160.3, 124.2, 113.5, 94.0, 72.4, 70.1, 56.1, 32.2, 18.74, 18.19. MS (ESI) LRMS calcd for 
C20H27BrN2O4 + H requires m/z 439.11, found 439.12 and 441.11. 
Br Br
MeO OMe
OMe
 
1,5-dibromo-2,3,4-trimethoxybenzene (E-15). To a stirred solution of 1,2,3-
trimethoxybenzene (97) (4 g, 24 mmol) in CH2Cl2 (40 mL) was added dropwise a 1.0 M 
solution of bromine in CH2Cl2 (8.4 g, 53 mmol) at 0 °C via cannula over a 2-min period 
under argon. The reaction was stirred for 1h at room temperature; progress was 
monitored by TLC analysis. The product was washed with sodium thiosulfate until the 
organic phase is colorless and dried with sodium sulfate. The solvent was removed under 
reduce pressure to give 7.4 g (97%) of pure 1,5-dibromo-2,3,4-trimethoxybenzene (E-
15) as a colorless liquid after simple distillation: 1HNMR (300MHz, CDCl3) δ 7.49 (s, 
1H), 3.94 (s, 3H), 3.9 (s, 6H). 13C NMR (75 MHz, CDCl3) δ 150.8, 148.2, 129.7, 112.2, 
61.2, 60.9. MS (CI, CH4) LRMS calcd for C9H10Br2O3 + H requires m/z 324.9, found 
324.9, 325.9, and 327.9.  
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MeO OMe
OMe
 
2,3,4-trimethoxy-1,5-dimethylbenzene (E-16). An n-BuLi (1.66 g, 26 mmol) solution 
was added to a solution of 1,5-dibromo-2,3,4-trimethoxybenzene (E-15) (7 g,  22 mmol) 
in 100 mL of ether at –78 °C under argon, the cloudy solution was stirred at –78 °C for 
30 min. Iodomethane (3.3 mL, 52.8 mmol) was added slowly at –78 °C under argon via 
syringe.  The mixture was allowed to warm up to room temperature and stirred for 1h, 
the mixture becomes clear. A second addition of n-BuLi (1.66 g, 26 mmol) was added at 
–78 °C under argon and stirred at –78 °C for 30 min. Iodomethane (3.3 mL, 52.8 mmol) 
was added again slowly at –78 °C under argon via syringe. The mixture was allowed to 
warm up to room temperature and stirred for 1h. The mixture was diluted with ether (50 
mL) and quenched with aqueous NH4Cl and washed with 1N NaOH, water and brine. It 
was dried with sodium sulfate and concentrated under reduced pressure to give 4.2 g 
(99%) of pure 2,3,4-trimethoxy-1,5-dimethylbenzene (E-16) as colorless liquid after 
distillation: 1HNMR (300MHz, CDCl3) δ 6.70 (s, 1H), 3.92 (s, 3H), 3.84 (s, 6H), 2.20 (s, 
6H). 13C NMR (75 MHz, CDCl3) δ 149.8, 146.1, 126.3, 126.1, 60.5, 60.3, 15.3. MS (CI, 
CH4) LRMS calcd for C11H16O3 + H requires m/z 197.11, found 197.1. 
Me Me
Br
MeO OMe
OMe
 
1-bromo-3,4,5-trimethoxy-2,6-dimethylbenzene (98). To a stirred solution of 2,3,4-
trimethoxy-1,5-dimethylbenzene (E-16) (2 g, 10 mmol) in CH2Cl2 (20 mL) was added 
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dropwise a 1.0 M solution of bromine (3.18 g, 11 mmol) in CH2Cl 2 (10 mL) at 0 °C via 
cannula over a 2-min period under argon. The reaction was stirred for 2 h at room 
temperature; progress was monitored by TLC analysis. The product was washed with 
sodium thiosulfate until the organic phase becomes colorless, dried with sodium sulfate, 
and the solvent is removed under reduced pressure to give 2.4 g (86%) of pure 1-bromo-
3,4,5-trimethoxy-2,6-dimethylbenzene (98) as colorless oil after silica gel column 
chromatography: 1HNMR (300MHz, CDCl3) δ 3.90 (s, 3H), 3.81 (s, 6H), 2.32 (s, 6H). 
13C NMR (75 MHz, CDCl3) δ 150.0, 145.6, 127.7, 121.8, 60.8, 60.7, 16.47. MS (CI, 
CH4) LRMS calcd for C11H15BrO3 + H requires m/z 275.02, found 275.0 and 277.0.  
ClOC COCl
Br
MeO OMe
OMe
 
2-bromo-4,5,6-trimethoxy-isophthaloyl dichloride (99). In a 250 mL three-necked 
round-bottom flask equipped with a mechanical stirrer and a reflux condenser was 1-
bromo-3,4,5-trimethoxy-2,6-dimethylbenzene (98) (2 g, 7.3 mmol), dispersed in 30 mL 
water and NaOH (2.34 g, 58.4 mmol), the mixture was heated to 100 °C. Hot solution of 
KMnO4 (6.95 g, 44 mmol) in 100 mL of water was added, and the reaction mixture was 
stirred at 100 °C for 8 h. After the mixture was cooled to room temperature, the reaction 
was filtered through Celite and the filtrate was reduced by 1/3 under reduced pressure. 
The solution was acidified with concentrated HCl. The resulting white precipitate was 
collected by vacuum filtration and the precipitate collected and either oven-dried (∼80 
°C) or high vacuum dried overnight to give 1.42 g (52% yield) of 2-bromo-4,5,6-
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trimethoxy-isophthalic acid as white solid: IR (thin film) ν 3460, 1675 cm-1. To a 
suspension of 2-bromo-4,5,6-trimethoxy-isophthalic acid (1 g, 3 mmol) in benzene (40 
mL) and a drop of DMF was added SOCl2 (9 mL, 61 mmol) at 0 °C. After the mixture 
was refluxed for 3 h, the excess SOCl2 was removed by distillation, which gave 2-
bromo-4,5,6-trimethoxy-isophthaloyl dichloride (99) in 99% yield (1.1 g) as a pale 
yellow oil. 1HNMR (300MHz, CDCl3) δ 4.05 (s, 6H), 3.92 (s, 3H). 13C NMR (75 MHz, 
CDCl3) δ 165.04, 152.34, 145.2, 130.8, 105.7, 62.07, 61.13. MS (CI, CH4) LRMS calcd 
for C11H9BrCl2O5 + H requires m/z 370.9, found 370.9 and 372.9.  
O
N N
O
Br
i-Pr i-Pr
MeO OMe
OMe
 
[(S,S)-(MeO)3Phebox-i-Pr]Br (96a). A solution of 2-bromo-4,5,6-trimethoxy-
isophthaloyl dichloride (99) (1 g, 2.7 mmol) in dichloromethane (10 mL) was slowly 
added to a solution of L-valinol (1.114 mg, 11 mmol) and triethylamine (6.3 mL, 45 
mmol) in dichloromethane (20 mL) at 0 ºC. The mixture was stirred at room temperature 
for 5 h. Formation of the intermediate diamide–dialcohol was monitored by TLC. Then, 
methanesulfonyl chloride (1.5 g, 13.2 mmol) was added at 0 ºC, and the mixture was 
stirred at room temperature for 16 h. Formation of the product 96a was monitored by 
TLC. At 0 ºC, aqueous potassium carbonate (1 N, ca. 30 mL) was added and the mixture 
was extracted with ethyl acetate. The organic layer was washed with saturated brine, 
dried over sodium sulfate, and concentrated under reduced pressure. The crude product 
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was purified by column chromatography (20% EtOAc-Hexanes) to give [(S,S)-
(MeO)3Phebox-i-Pr]Br (96a) in 68 % yield after two steps (862 mg, 1.83 mmol) as a 
white solid. [α]19D = –67.86° (c= 1 in CHCl3). IR (thin film) ν 1650 cm-1. 1HNMR 
(300MHz, CDCl3) δ 4.41 (t, J = 8.8 Hz, 2H), 4.16 (m, 4H), 3.88 (s, 6H), 3.84 (s, 3H), 
1.87 (m, 2H), 1.03 (d, J = 4.5 Hz, 6H), 0.98 (d, J = 4.5 Hz, 6H). 13C NMR (75 MHz, 
CDCl3) δ 160.0, 154.2, 145.5, 122.9, 116.3, 72.8, 70.3, 61.6, 60.8, 32.4, 18.7, 18.39. MS 
(ESI) LRMS calcd for C21H29BrN2O5 + H requires m/z 469.12, found 469.11 and 471.11. 
 
2.5.3 Synthesis and Characterization of Pincer Complexes 
O
N N
O
Ph Ph
Ni
t-Bu
Br  
[(R,R)-t-BuPhebox-Ph]NiBr (104): A mixture of [(R,R)-t-BuPhebox-Ph]Br (80b) (385 
mg, 0.385 mmol) and Ni(COD)2 (115.2 mg, 0.424 mmol) in dry toluene (9 mL) was 
stirred for 2 h at room temperature, by which time the reaction was deemed complete by 
TLC (60% EtOAc-Hexanes). The reaction mixture was filtered through silica gel eluting 
with ethyl acetate. The yellow band was collected and the solvent was removed under 
reduce pressure to give 104 as a yellow solid (207 mg, 0.37 mmol) 96% yield. A sample 
suitable for X-ray analysis was prepared by slow evaporation of dichloromethane 
solution in air to afford bright yellow crystals. IR (thin film) ν 1650 cm-1. 1HNMR 
(300MHz, CDCl3) δ 7.42 (s, 2H), 7.28–7.34 (m, 10H), 5.07 (dd, J = 4.3 Hz, 2H), 4.96 (t, 
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J = 8.6 Hz, 2H), 4.68 (dd, J = 4.3 Hz, 2H), 1.36 (s, 9H). MS (ESI) HRMS calcd for 
C28H27BrN2NiO2 – Br requires m/z 481.1426, found 481.1422. 
O
N N
O
i-Pr i-Pr
Ni
OH2
ClO4
 
[(S,S)-Phebox-i-Pr]NiClO4•H2O (109): A mixture of [(S,S)-Phebox-i-Pr]NiBr (100) 
(207 mg, 0.37 mmol)) and AgClO4 (82 mg, 0.42 mmol) was stirred in dry 
dichloromethane (10 mL) for 2 h at room temperature, under argon and wrapped in 
aluminum foil to protect the reaction mixture from light by which time the reaction was 
monitored by TLC (60% EtOAc-Hexanes). The reaction mixture was filtered through 
celite eluting with dichloromethane. The solvent was removed under reduce pressure to 
give 109 as a red solid (211 mg, 0.37 mmol) quantitative yield. A sample suitable for X-
ray analysis was prepared by slow evaporation of a diethyl ether solution in air to give a 
greenish yellow crystal. MS (ESI) HRMS calcd for C18H23ClN2NiO6 – ClO4 requires m/z 
357.1113, found 357.1109. 
O
N N
O
Ph Ph
Pd
t-Bu
Br  
 [(R,R)-t-BuPhebox-Ph]PdBr (122): A mixture of [(R,R)-t-BuPhebox-Ph]Br (80b) 
(50.2 mg, 0.1 mmol) and Pd2(dba)3 (50 mg, 0.11 mmol) was stirred in dry toluene (5 
mL) for 3 h at room temperature, by which time the reaction was deemed complete by 
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TLC (60% EtOAc-Hexanes). The reaction mixture was filtered through silica eluting 
with toluene to remove dba. The silica gel was then washed separated with ethyl acetate 
to give a yellow solution which was collected. The solvent was removed under reduced 
pressure to give 36 as yellow solid (44 mg, 0.08 mmol) 88% yield. A sample suitable for 
X-ray analysis was prepared by slow evaporation of a dichloromethane solution in air to 
give light yellow crystals. IR (thin film) ν 1635 cm-1. 1HNMR (300MHz, CDCl3) δ 7.50 
(s, 2H), 7.29–7.35 (m, 10H), 5.38 (q, J = 4.3 Hz, 2H), 5.03 (t, J = 5.6 Hz, 2H), 4.77 (q, J 
= 4.3 Hz, 2H), 1.37 (s, 9H). MS (ESI) HRMS calcd for C28H27BrN2PdO2 – Br requires 
m/z 529.1107, found 529.1109. 
O
N N
O
Ph Ph
Pd
t-Bu
OH2
ClO4
 
 [(R,R)-t-BuPhebox-Ph]PdClO4•H2O (131): A mixture of [(R,R)-t-BuPhebox-Ph]PdBr 
(122) (20 mg, 0.03 mmol)) and AgClO4 (10.3 mg, 0.05 mmol) was stirred in dry 
dichloromethane (10 mL) for 2 h at room temperature under argon. Wrapped in 
aluminum foil to protect the reaction mixture from light by which time the reaction was 
monitored by TLC (60% EtOAc-Hexanes). The reaction mixture was filtered through 
celite eluting with dichloromethane. The solvent was removed under reduce pressure to 
give 131 as a yellow solid (19 mg, 0.03 mmol) quantitative yield. IR (thin film) ν 1645 
cm-1. 1HNMR (300MHz, CDCl3) δ 7.52 (s, 2H), 7.32–7.42 (m, 10H), 5.43 (t, J = 6.3 Hz, 
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2H), 5.25 (t, J = 8.6 Hz, 2H), 4.64 (t, J = 6.3 Hz, 2H), 1.75 (s, 2H), 1.38 (s, 9H). MS 
(ESI) HRMS calcd for C28H27ClN2PdO6 – ClO4 requires m/z 529.1107, found 529.1110. 
 
2.5.4 Synthesis and Characterization of α-Bromoketones 
 
All compounds are known compounds except 142 (Table 2.9). Full-tabulated 
data is available below for the new compound.  
 
Ar
O
R
Ar
O
Br
R
Br2( 1 equiv)
Et2O, rt, 0.5 to 2 h
 
 General method for preparation of α-Bromoketones: Bromine (1.05 equiv) was 
added to an ice cooled solution of a ketone (1.0 equiv, 6 mmol) in 15 mL of Et2O. The 
solution was stirred for 30 min. at room temperature, and then the reaction was quenched 
with 10% aqueous potassium carbonate (10 mL). The organic layer was washed with 
sodium thiosulfate (10 mL) and brine (10 mL), dried over sodium sulfate, and 
concentrated. The α-bromoketone was purified by flash silica gel column 
chromatography (10% CH2Cl2/Hexanes). 
O
Br
Cl
 
2-bromo-3-chloro-1-phenylpropan-1-one (142): To a ice bath cooled and stirred 
mixture of 3-chloro-1-phenylpropan-1-one (1.0 g, 5.93 mmol) in 15 mL of Et2O was 
added bromine (996 mg, 6.22 mmol, 1.05 equiv). The solution was stirred for 30 min at 
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room temperature, and then the reaction was quenched with 10% aqueous potassium 
carbonate (10 mL). The organic layer was washed with sodium thiosulfate (10 mL) and 
brine (10 mL), dried over sodium sulfate. The solvent was removed under reduced 
pressure, and the residue was purified by flash silica gel column chromatography (10% 
CH2Cl2/hexanes) to give compound 142 (1.24 g, 85%) as a colorless oil. IR (thin film) ν 
3403, 3028, 2920, 1695, 1611, 960 cm-1; 1H NMR (CDCl3, 300 MHz) δ 8.04 (d, J = 7.4 
Hz, 2H), 7.62 (t, J = 7.4 Hz, 1H), 7.55 (t, J = 7.4 Hz, 2H), 5.30 (dd, J = 4.8 Hz, J = 5.1 
Hz, 1H), 4.36 (t, J = 10.1 Hz, 1H), 3.95 (dd, J = 5.1 Hz, J = 5.8 Hz, 1H). 13C NMR (75 
MHz, CDCl3) δ 190.66, 134.23, 134.02, 128.93, 128.90, 42.24, 42.15. HRMS (ESI) 
calcd for C9H8BrClO + Li requires m/z 245.9447, found 245.9441. 
Table 2.19 References to known compounds (α-Bromoketones).159,191,192 
Compound No. Product
96
84
139
140
141
142
143
92
Yield (%)Product
83
59
93
94
85
88
96
Compound No.
144
145
146
147
148
Yield (%)
O
Br
Et
O
Br
iPr
O
Br
O
Br
78149
O
Br
O
Br
Me
O
Br
Me
O
Br
Me
O
Br
Me
O
Br
O
Br
Me
Ph
Cl
Cl
Me
MeO
F3C
F
S
159
159
Reference
159
–
159
191
159
192
159
159
Reference
159
136 N/A
O
Br
Me
159
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2.5.5 Asymmetric α-Arylation (Negishi Reaction) 
General procedure: A solution of the phenylmagnesium bromide (1.6 mmol; 1.6 
equiv) was added to a solution of ZnI2 (510 mg, 1.6 mmol; 1.6 equiv) in THF (final 
concentration of PhZnI = 0.20 M) at 0 ºC under argon. The mixture was stirred for 1 h at 
room temperature (a white precipitate is immediately observed), and then it was cooled 
to –60 °C. To an oven-dried 10-mL vial was added a pincer complex [(R)PheBoxR1]MX 
(0.050 mmol; 0.05 equiv) in 2 mL of THF  under argon. Then, the α-bromoketone (0.25 
mmol; 1.0 equiv) was added. This solution was cooled to –30 °C. The suspension of 
PhZnI (2.0 mL, 0.325 mmol; 1.3 equiv) was added dropwise over 3 min, and the 
reaction mixture was stirred at –30 °C for 14 h. Then, the reaction was quenched with 
saturated ammonium chloride (10 mL). The reaction mixture was diluted with Et2O (20 
mL), washed with distilled water (10 mL) and brine (10 mL), dried over sodium sulfate, 
and concentrated. The product 138159 was purified by flash silica gel column 
chromatography. 
Scheme 2.17 Studied Negishi reaction. 
THF, –30 ºC
ZnI
1.3 equiv
O
Br
Me
O
!
Ph
Me
O
N N
O
R R
M
OMe
cat. X
136
137
138  
 
Retention times for the enantiomers of compound 138 was determined by HPLC 
with a Chiralcel OJ-H column (hexane/iPrOH = 98/2), 1.0 mL/min, 254 nm. T1 = 13.99 
min and T2 = 15.00 min. 
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2.5.6 Synthesis of Palladium Pincer Catalysts XV-XXI 
 
Compounds 85 and 91 are known compounds. The rest of the compounds for the 
synthesis of palladium complexes XV-XXI are unknown compounds. Full-tabulated 
data is available below for all these compounds.  
O
NH HN
O
Br
t-Bu
ClCl
 
2-bromo-5-tert-butyl-N1,N3-bis(2-chloroethyl)benzene-1,3-dicarbamide (E-17): A 
solution of isophthaloyl dichloride 8542 (0.50 g, 1.48 mmol) in dichloromethane (5 mL) 
was slowly added to a solution of ethanolamine (190 mg, 3.12 mmol) in 
dichloromethane (5 mL), then a solution of triethylamine (1.023 mL, 7.4 mmol) in 
dichloromethane (5 mL) was added slowly at 0 ºC under argon. The mixture was stirred 
at room temperature for 5 h. Formation of the intermediate diamide–dialcohol was 
monitored by TLC. Then, methanesulfonyl chloride (1.69 g, 14.8 mmol) was added at 0 
ºC, and the mixture was stirred at room temperature for 16 h. Formation of the product 
S-1 was monitored by TLC. At 0 ºC, aqueous potassium carbonate (1 N, ca. 30 mL) was 
added and the mixture was extracted with ethyl acetate. The organic layer was washed 
with saturated brine, dried over sodium sulfate, and concentrated under reduce pressure. 
The crude product was purified by column chromatography (20% EtOAc-Hexanes) to 
give E-17 in 76 % yield (474.6 mg, 1.12 mmol) as a white solid. IR (thin film) ν 3265, 
1642 cm-1. 1HNMR (300MHz, CDCl3) δ 7.57 (s, 2H), 6.35 (t, J = 5.4 Hz, 2 NH), 3.79 
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(m, 8H), 1.31 (s, 9H). MS (ESI) HRMS calcd for C16H21BrCl2N2O2 + H requires m/z 
423.0163, found 423.0164 and 425.0135. 
t-Bu
Br NN
O O
 
[t-BuPheBox-H2]Br (152): To a suspension of NaH (60 mg, 2.5 mmol) in THF (5 mL) 
under argon was added a solution of dichloro carbamide E-17 (105.5 mg, 0.25 mmol) in 
THF (5 mL) at room temperature and stirred for 3h. The mixture was diluted with 
dichloromethane (50 mL), and washed with saturated NH4Cl (10 mL) and brine. The 
organic phase was separated, and dried with sodium sulfate. Concentration of this 
solution gave [t-BuPhebox-H2]Br (152), which was purified by column chromatography 
(20% EtOAc-hexanes) affording a colorless oil, 85 mg (97% yield): IR (thin film) ν 
1655 cm-1. 1HNMR (300MHz, CDCl3) δ 7.67 (s, 2H), 4.46 (t, J = 9.3 Hz, 4H), 4.09 (t, J 
= 9.3 Hz, 4H), 1.37 (s, 9H) 13C NMR (75 MHz, CDCl3) δ 164.4, 150.3, 131.3, 129.9, 
117.9, 67.8, 55.2, 34.6, 30.8. MS (ESI) HRMS calcd for C16H19BrN2O2 + H requires m/z 
351.0630, found 351.0635 and 353.0639. 
O
N HN
O
Br
t-Bu
Cl
Me MeMeMe  
2-bromo-5-tert-butyl-N-(1-chloro-2-methylpropan-2-yl)-3-(4,4-dimethyl-4,5-dihydr-
ooxazol-2-yl)benzamide (E-18): A solution of isophthaloyl dichloride 85 (0.50 g, 1.48 
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mmol) in dichloromethane (5 mL) was slowly added to a solution of 2-amino-2-methyl-
1-propanol (291 mg, 3.27 mmol) in dichloromethane (5 mL), then a solution of 
triethylamine (2.05 mL, 14.8 mmol) in dichloromethane (5 mL) was added slowly at 0 
ºC under argon. The mixture was stirred at room temperature for 5 h. Formation of the 
intermediate diamide–dialcohol was monitored by TLC. Then, methanesulfonyl chloride 
(1.69 g, 14.8 mmol) was added at 0 ºC, and the mixture was stirred at room temperature 
for 16 h. Formation of the product S-2 was monitored by TLC. At 0 ºC, aqueous 
potassium carbonate (1 N, ca. 30 mL) was added and the mixture was extracted with 
ethyl acetate. The organic layer was washed with saturated brine, dried over sodium 
sulfate, and concentrated under reduce pressure. The crude product was purified by 
column chromatography (20% EtOAc-Hexanes) to give E-18 in 73 % yield (477.5 mg, 
1.08 mmol) as a white solid. IR (thin film) ν 3284, 1651 cm-1. 1HNMR (300MHz, 
CDCl3) δ 7.51 (d, J = 2.7 Hz, 1H), 7.44 (d, J = 2.4 Hz, 1H), 5.81 (s, 1NH), 4.09 (s, 2H), 
3.86 (s, 2H), 1.45 (s, 6H), 1.36 (s, 6H), 1.26 (s, 9H). MS (ESI) HRMS calcd for 
C20H28BrClN2O2 + H requires m/z 443.1023, found 443.1017 and 445.0959. 
t-Bu
Br NN
O O
MeMeMeMe  
[t-BuPheBox-Me2]Br (153): To a suspension of NaH (136 mg, 5.6 mmol) in THF (10 
mL) under argon was added a solution of chloro benzamide E-18 (250 mg, 0.56 mmol) 
in THF (5 mL) at room temperature. Then, the mixture was stirred at reflux for 3 h. The 
mixture was diluted with dichloromethane (50 mL), and washed with saturated NH4Cl 
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(10 mL) and brine. The organic phase was separated, and dried with sodium sulfate. 
Concentration of this solution gave [t-BuPhebox-Me2]Br (153), which was purified by 
column chromatography (20% EtOAc-hexanes) affording a light yellow oil, 211.2 mg 
(92% yield): IR (thin film) ν 1656 cm-1. 1HNMR (300MHz, CDCl3) δ 7.56 (s, 2H), 4.12 
(s, 4H), 1.40 (s, 12H), 1.29 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 162.0, 150.3, 131.6, 
129.5, 118.0, 79.3, 68.0, 34.6, 30.9, 28.1. MS (ESI) HRMS calcd for C20H27BrN2O2 + H 
requires m/z 407.1256, found 407.1257 and 409.1302. 
O
N HN
O
Br
OMe
Cl
Me MeMeMe  
2-bromo-N-(1-chloro-2-methylpropan-2-yl)-3-(4,4-dime- thyl-4,5-dihydrooxazol-2-
yl)-5-methoxybenzamide (E-19): A solution of 2-bromo-5-methoxy-isophthaloyl 
dichloride 91164 (917 mg, 2.96 mmol) in dichloromethane (10 mL) was slowly added to 
a solution of 2-amino-2-methyl-1-propanol (580 mg, 6.51 mmol) in dichloromethane (10 
mL), then a solution of triethylamine (4.095 mL, 29.6 mmol) in dichloromethane (10 
mL) was added slowly at 0 ºC under argon. The mixture was stirred at room temperature 
for 5 h. Formation of the intermediate diamide–dialcohol was monitored by TLC. Then, 
methanesulfonyl chloride (3.374 g, 29.6 mmol) was added at 0 ºC, and the mixture was 
stirred at room temperature for 16 h. Formation of the product E-19 was monitored by 
TLC. At 0 ºC, aqueous potassium carbonate (1 N, ca. 50 mL) was added and the mixture 
was extracted with ethyl acetate. The organic layer was washed with saturated brine, 
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dried over sodium sulfate, and concentrated under reduce pressure. The crude product 
was purified by column chromatography (20% EtOAc-Hexanes) to give E-19 in 69 % 
yield (849.6 mg, 2.04 mmol) as a white solid. IR (thin film) ν 3279, 1657 cm-1. 1HNMR 
(300MHz, CDCl3) δ 7.14 (d, J = 3.0 Hz, 1H), 7.05 (d, J = 3.0 Hz, 1H), 5.74 (s, 1NH), 
4.15 (s, 2H), 3.91 (s, 2H), 3.82 (s, 3H), 1.51 (s, 6H), 1.41 (s, 6H). MS (ESI) HRMS calcd 
for C17H22BrClN2O3 + H requires m/z 417.0502, found 417.0508 and 419.0587. 
OMe
Br NN
O O
MeMeMeMe  
[MeOPheBox-Me2]Br (154): To a suspension of NaH (288 mg, 12 mmol) in THF (10 
mL) under argon was added a solution of chloro benzamide E-19 (500 mg, 1.2 mmol) in 
THF (10 mL) at room temperature. Then, the mixture was stirred at reflux for 3 h. The 
mixture was diluted with dichloromethane (50 mL), and washed with saturated NH4Cl 
(10 mL) and brine. The organic phase was separated, and dried with sodium sulfate. 
Concentration of this solution gave crude [MeOPhebox-Me2]Br (154), which was 
purified by column chromatography (20% EtOAc-hexanes) affording 154 in 95% yield 
(433 mg, 1.14 mmol) as colorless oil, which crystallized to colorless crystals after some 
period of time. IR (thin film) ν 1665. 1HNMR (300MHz, CDCl3) δ 7.16 (s, 2H), 4.12 (s, 
4H), 3.80 (s, 3H), 1.39 (s, 12H). 13C NMR (75 MHz, CDCl3) δ 161.7, 158.0, 132.8, 
118.2, 111.4, 79.5, 68.0, 55.7, 28.1. MS (ESI) HRMS calcd for C17H21BrN2O3 + H 
requires m/z 381.0736, found 381.0734 and 383.0790. 
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O
N N
O
Pd
t-Bu
Br  
[t-BuPheBox-H2]PdBr (XV): A mixture of [t-BuPheBox-H2]Br (152) (35 mg, 0.1 
mmol) and Pd2(dba)3 (50 mg, 0.055 mmol) were stirred in dry toluene (4 mL) for 3 h at 
room temperature, by which time the reaction was deemed complete by TLC (60% 
EtOAc-Hexanes). The reaction mixture was filtered through silica eluting with toluene 
to remove dba. The silica gel was then washed separated with ethyl acetate to give a 
reddish solution which was collected and the solvent was removed under reduce pressure 
to give XV as a reddish solid (45 mg, 0.099 mmol) in 99% yield. IR (thin film) ν 1640, 
1559 cm-1. 1HNMR (300MHz, CDCl3) δ 7.41 (s, 2H), 4.83 (t, J = 7.2 Hz, 4H), 4.14 (t, J 
= 7.2 Hz, 4H), 1.32 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 171.3, 163.8, 143.3, 130.5, 
125.3, 82.7, 66.9, 34.9, 31.3. MS (ESI) HRMS calcd for C16H19BrN2O2Pd – Br requires 
m/z 377.0481, found 377.0489. 
O
N N
O
Pd
t-Bu
Me Me Me MeBr  
[t-BuPheBox-Me2]PdBr (XVI): A mixture of [t-BuPheBox-Me2]Br (153) (90 mg, 0.22 
mmol) and Pd2(dba)3 (111 mg, 0.12 mmol) were stirred in dry toluene (6 mL) for 3 h at 
room temperature, by which time the reaction was deemed complete by TLC (60% 
EtOAc-Hexanes). The reaction mixture was filtered through silica eluting with toluene 
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to remove dba. The silica gel was then washed separated with ethyl acetate to give a 
reddish solution which was collected and the solvent was removed under reduce pressure 
to give XVI as a reddish solid (112 mg, 0.217 mmol) 99% yield. A sample suitable for 
X-ray analysis was prepared by slow evaporation of a biphasic dichloromethane/ 
hexanes solution in air to give yellow crystals. IR (thin film) ν 1630, 1558 cm-1. 1HNMR 
(300MHz, CDCl3) δ 7.33 (s, 2H), 4.44 (s, 4H), 1.65 (s, 12H), 1.29 (s, 9H) 13C NMR (75 
MHz, CDCl3) δ 172.6, 163.8, 147.9, 129.4, 124.0, 82.7, 65.9, 34.9, 31.3, 28.1. MS (ESI) 
HRMS calcd for C16H19BrN2O2Pd – Br requires m/z 433.1107, found 433.1102. 
XVI
O
N N
O
Pd
t-Bu
Me Me Me MeBr
 XVI  
X-Ray Crystal Structure Data for [t-BuPheBox-Me2]PdBr (XVI): C20H27BrN2O2Pd, 
M = 513.75, yellow needle, 0.26 x 0.12 x 0.01 mm3, monoclinic, space group P21/n (No. 
14), a = 12.6447(12), b = 21.628(2), c = 15.6491(15) Å, β = 103.716(6)°, V = 4157.7(7) 
Å3, Z = 8, Dc = 1.641 g/cm3, F000 = 2064, MWPC area detector, Cu Kα radiation, λ = 
1.54178 Å,  T = 110(2)K, 2θmax = 120.0º, 74692 reflections collected, 6004 unique (Rint 
= 0.0634).  Final GooF = 1.004, R1 = 0.0311, wR2 = 0.0690, R indices based on 5333 
reflections with I >2sigma(I) (refinement on F2), 514 parameters, 18 restraints.  Lp and 
absorption corrections applied, µ = 9.576 mm-1. Absolute structure parameter 0.000(4). 
Displacement ellipsoid plot (50% probability) of XVI is shown above with important 
atoms numbered. Some hydrogen atoms have been omitted for clarity. Selected bond 
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distances (Å) and angles (deg): Pd(1A)-C(9A) 1.937(4), Pd(1A)-Br(1A) 2.5278(6), 
Pd(1A)-N(1A) 2.078(3), Pd(1A)-N(2A) 2.074(4), N(1A)-C(3A) 1.291(5), N(2A)-
C(10A) 1.293(6), C(9A)-Pd(1A)-Br(1A) 173.96(11), N(1A)-Pd(1A)-N(2A) 157.79(13), 
C(9A)-Pd(1A)-N(1A) 79.14(115), C(9A)-Pd(1A)-N(2A) 78.69(16), Br(1A)-Pd(1A)-
N(1A) 101.43(9), Br(1A)-Pd(1A)-N(2A) 100.47(10). 
 
O
N N
O
Pd
OMe
Me Me Me MeBr  
 [MeOPheBox-Me2]PdBr (XVII): A mixture of [MeOPheBox-Me2]Br (154) (90 mg, 
0.22 mmol) and Pd2(dba)3 (111 mg, 0.12 mmol) were stirred in dry toluene (6 mL) for 3 
h at room temperature, by which time the reaction was deemed complete by TLC (60% 
EtOAc-Hexanes). The reaction mixture was filtered through silica eluting with toluene 
to remove dba. The silica gel was then washed separated with ethyl acetate to give a 
reddish solution which was collected and the solvent was removed under reduce pressure 
to give XVII as a reddish solid (106 mg, 0.218 mmol) 99% yield. IR (thin film) ν 1620, 
1559 cm-1. 1HNMR (300MHz, CDCl3) δ 6.89 (s, 2H), 4.44 (s, 4H), 3.79 (s, 3H), 1.66 (s, 
12H). 13C NMR (75 MHz, CDCl3) δ 172.4, 157.0, 130.0, 128.1, 112.8, 82.7, 66.1, 55.9 
28.1. MS (ESI) HRMS calcd for C16H19BrN2O2Pd – Br requires m/z 407.0587, found 
407.0589. 
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Me Me Me MeX
AgX, CH2Cl2
dark, rt, 2h
X = SbF6  XVIII
       ClO4  XIX
       OAc   XX
       OTf    XXI99%
XVI XVIII-XXI  
[t-BuPheBox-Me2]PdX (XVIII-XXI): A mixture of [t-BuPheBox-Me2]PdBr (XVI) (5.1 
mg, 0.01 mmol)) and AgX (1.5 equiv., 0.015 mmol) under argon was stirred in dry 
dichloromethane (4 mL) for 2 h at room temperature. The mixture was wrapped in 
aluminum foil to protect the reaction mixture from light during the all reaction time. The 
reaction mixture was filtered through celite eluting with dichloromethane. The solvent 
was removed under reduce pressure to give XVIII-XXI as a yellow solid (0.01 mmol) in 
quantitative yield. IR (thin film) ν 1642 cm-1. MS (ESI) HRMS calcd for 
C16H19N2O2PdX – X requires m/z 433.1107, found 433.1098. 
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2.5.7 Procedures and Characterization for the α-Arylation 
 
Compounds 138, 155-163, 165 and 167-174 are known compounds (Table 2.10). 
Compounds 164 and 166 are new compounds. Full-tabulated data is available below for 
the new compounds. 
1 equiv
Ar1
O
R
Ar2
Br
[t-BuPheBoxMe2]PdBr
   XVI (1-2 mol%)
Ar1
O
R
1.1 equiv
NaOt-Bu 1.3 equiv. 
PhMe, 70 ºC, 1 h
Ar2
 
General Procedure for the Selective α-Arylation of Ketones with Aryl Bromides: 
To an 8 mL glass vial containing a stir bar was added the respective catalyst XV-XXII 
(0.01 equiv, 0.0033 mmol) and capped with a phenolic cap equipped with a 
teflon/silicone septa. The vial was filled and purged with argon. A solution of sodium 
tert-butoxide (41.2 mg, 1.3 equiv, 0.429 mmol) in toluene (1.5 mL) was added via 
syringe under argon. Then, arylbromide (1.1 equiv, 0.363 mmol) was added via syringe 
followed by the respective ketone (44 mg, 1 equiv, 0.33 mmol) at room temperature. The 
mixture was stirred for 1 h at 70 ºC under argon. Then it was cooled down to room 
temperature. The reaction mixture was quenched with saturated ammonium chloride (4 
mL), diluted with Et2O (20 mL), washed with distilled water (10 mL) and brine (10 mL), 
dried over sodium sulfate, and concentrated under reduce pressure. The product was 
purified by flash silica gel column chromatography using either (60% toluene-hexanes) 
or (50% dichloromethane-hexanes) as the eluents. 
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1-phenyl-2-(4-vinylphenyl)propan-1-one (164): To an 8 mL glass vial containing a stir 
bar was added the catalyst XVI (1.7 mg, 0.01 equiv, 0.0033 mmol) and capped with a 
phenolic cap equipped with a teflon/silicone septa. The vial was filled and purged with 
argon. A solution of sodium tert-butoxide (41.2 mg, 1.3 equiv, 0.429 mmol) in toluene 
(1.5 mL) was added via syringe under argon. Then, 4-bromostyrene (66.4 mg, 1.1 equiv, 
0.363 mmol) was added via syringe followed by propiophenone (151) (44 mg, 1 equiv, 
0.33 mmol) at room temperature. The mixture was stirred for 1 h at 70 ºC under argon. 
Then it was cooled down to room temperature. The reaction mixture was quenched with 
saturated ammonium chloride (4 mL), diluted with Et2O (20 mL), washed with distilled 
water (10 mL) and brine (10 mL), and dried over sodium sulfate. The solvent was 
removed under reduced pressure, and the residue was purified by flash silica gel column 
chromatography (50% dichloromethane-hexanes) to give compound 164 (67.6 mg, 85%) 
as a colorless oil; IR (thin film) ν 3403, 3028, 2920, 1695, 1611, 960 cm1; 1H NMR 
(CDCl3, 300 MHz) δ 7.97 (d, J = 7.6 Hz, 2H), 7.47 (t, J = 7.2 Hz, 1H), 7.47 (m, 4H), 
7.26 (d, J = 7.6 Hz, 2H), 6.67 (dd, J = 10.8 Hz, J = 6.4 Hz, 1H), 5.71 (d, J = 17.6 Hz, 
1H), 5.22 (d, J = 11.4 Hz, 1H), 4.69 (q, J = 6.8 Hz, 1H), 1.55 (d, J = 6.8 Hz, 3H). 13C 
NMR (75 MHz, CDCl3) δ 200.1, 141.0, 136.4, 136.3, 136.2, 132.7, 128.7, 128.2, 127.9, 
126.6, 113.7, 47.5, 19.3. HRMS (ESI) calcd for C17H12O + Li requires m/z 243.1361, 
found 243.1331 (Table 2.10). 
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2-(3,5-bis(trifluoromethyl)phenyl)-1-phenylpropan-1-one (166): To an 8 mL glass 
vial containing a stir bar was added the catalyst XVI (1.7 mg, 0.01 equiv, 0.0033 mmol) 
and capped with a phenolic cap equipped with a teflon/silicone septa. The vial was filled 
and purged with argon. A solution of sodium tert-butoxide (41.2 mg, 1.3 equiv, 0.429 
mmol) in toluene (1.5 mL) was added via syringe under argon. Then, 1-bromo-3,5-
bis(trifluoromethyl)benzene (106.3 mg, 1.1 equiv, 0.363 mmol) was added via syringe 
followed by propiophenone (151) (44 mg, 1 equiv, 0.33 mmol) at room temperature. The 
mixture was stirred for 1 h at 70 ºC under argon. Then it was cooled down to room 
temperature. The reaction mixture was quenched with saturated ammonium chloride (4 
mL), diluted with Et2O (20 mL), washed with distilled water (10 mL) and brine (10 mL), 
and dried over sodium sulfate. The solvent was removed under reduced pressure, and the 
residue was purified by flash silica gel column chromatography (50% dichloromethane-
hexanes) to give compound 166 (105 mg, 92%) as a colorless oil; IR (thin film) ν 3400, 
3026, 2921, 1691, 1605, 970 cm1; 1H NMR (CDCl3, 300 MHz) δ 7.98 (d, J = 7.4 Hz, 
2H), 7.79 (s, 2H), 7.76 (s, 1H), 7.59 (t, J = 7.2 Hz, 1H), 7.48 (t, J = 7.6 Hz, 2H), 4.89 (q, 
J = 11.6 Hz, 1H), 1.62 (d, J = 6.3 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 199.1, 143.5, 
135.7, 133.5, 132.05 (q, J = 50.3 Hz, 2CF3), 128.8, 128.6, 128.2, 124.9, 121.5, 46.8, 
19.6. HRMS (ESI) calcd for C17H12F2O + Li requires m/z 346.0792, found 346.0792 
(Table 2.10). 
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Table 2.10 References to known compounds (α-arylketones).159,193-196 
Compound 
No.
Product
159
Reference
(racemic)
Product
159
159
159
159
Compound
No.
138
155
156
157
158
Reference
(racemic)
Ph
O
Me
Ph
O
Me
Ph
O
Me
Ph
O
Me
Ph
O
Me
159
159
194,195
159
159
160
161
162
Ph
O
Me
Ph
O
Me
Ph
O
Me
Ph
O
Me
–
196
196
163
164
165
Ph
O
Me
O
Me
O
Me
CF3
CF3
OMe
OMe
OMe
Me
Me
F
NMe2
SMe
CF3
166
167
168
169
–
159
159
159
O
Me
O
Ph
Et
O
Ph
iPr
O
Ph
159
170
171
159
O
Ph
Me
O
Ph
Me
173 159
O
Ph
Me
Ph
MeO
F3C
F
172 193
O
Ph
Me
Me
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CHAPTER III 
CONCLUSIONS AND OUTLOOK 
 
We have developed a new catalytic system for the Morita-Baylis-Hillman 
reaction employing a 1:1:1 ratio of catalytic amounts (10 mol%) of MgI2, TMEDA and 
DMAP, which proved to be highly effective at promoting the reaction of a variety of 
electrophiles, including both electron-poor and electron-rich aldehydes, with various 
cyclic enones as the nucleophilic substrates in the MBH reaction. Both α,β-unsaturated 
esters and thioesters were also shown to undergo the MBH sequence even more readily. 
Furthermore, these studies provided a valuable platform for the development of chiral 
ligands to promote enantioselective MBH reactions, as chiral TMEDA-equivalent 
ligands are well known. This newly developed asymmetric MBH reaction involved the 
effective addition of cyclopentenone to aromatic and aliphatic aldehydes catalyzed by 
Fu’s planar chiral DMAP derivative II in conjunction with readily available MgI2 as a 
cocatalyst. The products were obtained in good to excellent yields and moderate to 
excellent enantioselectivity. Perhaps more importantly, the work described here showed 
that the scope of reactions catalyzed by Fu’s planar chiral DMAP catalysts can be 
increased by employing a simple cocatalyst, a concept which, to our knowledge, had not 
been documented previously.  
We also extended our reaction conditions to the synthesis of β-iodo Baylis-
Hillman adducts and to the synthesis of α-hydroxyalkyl allenic esters. Furthermore, we 
found that some of the β-iodo Baylis-Hillman adducts underwent 1,3-allylic 
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transpositions. The products of these reactions are quite functionalized and are amenable 
for subsequent transformations such as aldol, Michael, and Diels-Alder reactions, or 1,2- 
additions, cross-couplings, among others. Also this approach offers a unique entry to 
differentiated 1,3 carbonyls as well as β-iodo-dieneoates. 
While the Morita-Baylis-Hillman reaction project was ongoing, we also 
developed an α-methylenation of carbonyls for the synthesis of α,β-unsaturated 
carbonyls, which in turn served as substrates for the MBH reactions. Using the readily 
available diisopropylammonium trifluoroacetate salt (XIV) as a catalyst, the α-
methylenation of carbonyls compounds has been successfully accomplished under mild 
reaction conditions in good to excellent yields (62 to 99%, 17 of 18 examples above 
80%) using various aromatic and aliphatic ketones, aldehydes and esters at 67 ºC in 8 h. 
No isomerization of the double bond is detected, no over alkylation or polymerization of 
any adduct was detected and functional group tolerance turned out to be excellent. We 
believe that this is the simplest and most straightforward method currently available for 
the α-methylenation of carbonyl compounds.  
We anticipate that these new methods will be useful to the general synthetic 
community for the synthesis of building of significant chiral building blocks as well as 
in applications to the synthesis of complex molecules, including; but not limited to, 
Bioactive Natural Products and other pharmaceutically important molecules. 
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Thirteen PheBox(NCN) pincer ligands were synthesized, varying the electronics 
of the basic backbone structure, from ready available enantiomeric pure aminoalcohols 
and aromatic compounds. Air and moisture nickel(II) and palladium(II) bisoxazoline 
pincer complexes were synthesized via oxidative addition of Ni(COD)2 or Pd2(dba)3 to 
PheBox pincer ligands. These pincer complexes were then transformed into cationic 
complexes by halide abstraction using AgClO4. Their relative Lewis acidity was 
measured and reported. The identity of several neutral and cationic complexes was 
confirmed by X-ray crystal structure analysis.  
These chiral palladium and nickel “NCN” pincer complexes were subjected to 
Negishi cross-coupling reactions. They were demonstrated to be very efficient to 
catalyze the Negishi reactions although not significant enantiomeric excess was 
obtained. Due to the need of α-bromoketones for the Negishi reaction, several α-
bromoketones were prepared using bromine to α-brominate their corresponding aryl 
ketones with good to excellent yields.  
Although, the attempted enantioselective Negishi cross-coupling reaction was 
fruitless to synthesize enatioenriched α-aryl ketones; afterward, we developed a direct 
and highly active, (NCN)-Pd catalytic system for the α-arylation of ketones with a 
variety of aryl bromides using [t-BuPheBox-Me2]PdBr (XVI) as the catalyst. The 
adducts were obtained in excellent yields (92% average) in only 1 hour using 1 mol% of 
catalyst loading. Perhaps more importantly, the work described here showed that XVI is 
highly reactive, highly selective, even on substrates bearing challenging functional 
groups such alkenes.  
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Efforts are underway to further elucidate the mechanistic details of this reaction 
system, which should in turn allow for future advances to develop an asymmetric 
variant, as well as to expand the scope of this reaction. We also anticipate that these 
catalysts will be effective in other related Palladium and Nickel catalyzed cross-
couplings. 
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APPENDIX A 
1H AND 13C NMR SPECTRA 
 
1H NMR (CDCl3, 300 MHz)  
 
3
OMe
OMe
 
 
 
 
 
 
 
 
 174 
1H NMR (CDCl3, 300 MHz) 
 
13C NMR (CDCl3, 75 MHz) 
 
4
OH O
 175 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
5
OH O
O2N
 176 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
 
6
OH O
MeO
 177 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
 
OH O
7
 178 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
8
OH O
 179 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
OH O
Me
Me
9
 180 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
OH O
10
 181 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
OH O
Me Me11
 182 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
OH O
12
 183 
 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
OH O
Me Me13
 184 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
14
OH O
 185 
1H NMR (CDCl3, 300 MHz)  
 
 
 
 
13C NMR (CDCl3, 75 MHz) 
 
OH O
O
15
 186 
1H NMR (CDCl3, 300 MHz) 
 
13C NMR (CDCl3, 75 MHz) 
 
OH
O
O
16
 187 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
OH
S
O
17
 188 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
21
O
O
 189 
1H NMR (CDCl3, 300 MHz) 
 
13C NMR (CDCl3, 75 MHz) 
 
23
OH O
 190 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
24
OH O
Me
 191 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
25
OH O
F3C
 192 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
N N
Me
Me
Me
Me
E-1
 193 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
E-2
N
Mg
N
Me
Me
Me
Me
I I
 194 
1H NMR (CD3OD, 300 MHz)  
 
13C NMR (CD3OD, 75 MHz) 
 
N N
Me
Me
Me
Me
E-1
 195 
1H NMR (CD3OD, 300 MHz)  
 
13C NMR (CD3OD, 75 MHz) 
 
E-2
N
Mg
N
Me
Me
Me
Me
I I
 196 
1H and 13C NMR Spectra of Starting Materials 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
O
H
E-4
 197 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
E-6
H
O
Ph
 198 
1H NMR (CDCl3, 300 MHz) 
E-8
OH
HO
 
 
13C NMR (CDCl3, 75 MHz) 
 
 199 
1H NMR (CDCl3, 300 MHz) 
E-9
OH
TBSO
 
 
13C NMR (CDCl3, 75 MHz) 
 
 200 
1H NMR (CDCl3, 300 MHz) 
E-10
O
TBSO
H
 
 
13C NMR (CDCl3, 75 MHz) 
 
 
 201 
1H and 13C NMR Spectra of Adducts 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
26
OH
I
OEt
O
 202 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
27
OH
I
OEt
O
O2N
 203 
1H NMR (CDCl3, 300 MHz) 
 
13C NMR (CDCl3, 75 MHz) 
 
28
OH
I
OEt
O
MeO
 204 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
29
OH
I
Me
O
 205 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
30
OH
I
OEt
O
Me
 206 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
31
OH
I
OEt
O
Ph
 207 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
32
OH
I
Me
O
Ph
 208 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
33
OH
I
OEt
O
Ph
 209 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
34
OH
I
OEt
O
Ph
 210 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
35
OH
I
OEt
O
Me
 211 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
36
OH
I
OEt
O
Ph
 212 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
37
OH
I
OEt
O
TBSO
 213 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
OH
I
Ph
O
Ph
38
 214 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
39
OH
I
Ph
O
Me
 215 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
OH
I
Me
O
40Me
 216 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
OH
I
Me
O
41Ph
 217 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
O2N
OH
46
 218 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
50
O
OEt
O
Ph H
 219 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
51
O
Ph
O
Ph H
 220 
1H NMR (CDCl3, 300 MHz) 
 
13C NMR (CDCl3, 75 MHz) 
 
 
52 I
OEt
O
Me
OH
 221 
1H and 13C NMR Spectra 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
O
OEt
53
 222 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
OH O
OEt
O2N
54
 223 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
O
O2N
O
EtO O
NO2
55
 224 
1H and 13C NMR Spectra 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
VII
NHMe
CF3CO2H
 225 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
VIII
NHMe
CH3CO2H
 226 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
IX
NHMe
HCl
 227 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
X
CF3CO2H
N
H
 228 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
XI
CF3CO2H
N
H
 229 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
XII
CF3CO2H
N
H
O
 230 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
XIII
N
H
CF3CO2H
 231 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
XIV
Me
N
H
Me
Me Me
CF3CO2H
 232 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
57
Ph
O
 233 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
t-Bu
O
58
 234 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
O
59
 235 
1H NMR (CDCl3, 300 MHz) 
 
13C NMR (CDCl3, 75 MHz) 
 
O
60
 236 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
61
O
Me
Me Me
Me
 237 
1H NMR (CDCl3, 300 MHz)  
  
13C NMR (CDCl3, 75 MHz) 
 
O
62
 238 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
O
CO2Et
63
 239 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
O
Me
64
 240 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
O
Cl
65
 241 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
 
O
66
 242 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
H
O
Ph
67
 243 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
68
O
H
TBDPSO
 244 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
69
Me H
Me Me O
 245 
1H NMR (CDCl3, 300 MHz)  
  
13C NMR (CDCl3, 75 MHz) 
 
 
70
Ot-But-BuO
OO
 246 
1H NMR (CDCl3, 300 MHz)  
  
 
13C NMR (CDCl3, 75 MHz) 
 
 
O
TES
71
 247 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
CO2H
Ph
O
72
 248 
1H NMR (CDCl3, 300 MHz) 
 
 
 
13C NMR (CDCl3, 75 MHz) 
 
73
Ph
O
 249 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
O
O
74
 250 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
75
O
OH
O
Me
O
 251 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
Me
O
O
Ph
76
 252 
Reproduction of 1H and 13C NMR Spectra 
1H NMR (CDCl3, 300 MHz) 
 
 
 
13C NMR (CDCl3, 75 MHz) 
 
 
78
ClOC COCl
Br
 253 
1H NMR (CDCl3, 300 MHz) 
 
 
13C NMR (CDCl3, 75 MHz) 
 
77a
O
N N
O
i-Pr i-Pr
Br
 254 
1H NMR (CDCl3, 300 MHz) 
 
 
13C NMR (CDCl3, 75 MHz) 
 
77b
O
N N
O
Ph Ph
Br
 255 
1H NMR (CDCl3, 300 MHz) 
 
13C NMR (CDCl3, 75 MHz) 
 
77c
O
N N
O
Bn Bn
Br
 256 
1H NMR (CDCl3, 300 MHz) 
 
 
13C NMR (CDCl3, 75 MHz) 
 
 
77d
O
N N
O
i-Pr i-Pr
I
 257 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
 
ClOC COCl
t-Bu
82
 258 
1H NMR (CDCl3, 300 MHz)  
 
 
 
13C NMR (CDCl3, 75 MHz) 
 
O
N N
O
i-Pr i-Pr
t-Bu
E-11
 259 
1H NMR (CDCl3, 300 MHz) 
 
 
13C NMR (CDCl3, 75 MHz) 
 
O
N N
O
i-Pr i-Pr
t-Bu
I
80a
 260 
1H NMR (CDCl3, 300 MHz)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13C NMR (CDCl3, 75 MHz) 
 
 
 
 
 
 
 
 
 
 
 
 
85
ClOC COCl
Br
t-Bu
 261 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
80b
O
N N
O
Ph Ph
Br
t-Bu
 262 
1H NMR (CDCl3, 300 MHz)  
 
 
 
13C NMR (CDCl3, 75 MHz) 
 
 
 
80c
O
N N
O
Bn Bn
Br
t-Bu
 263 
1H NMR (CDCl3, 300 MHz) 
 
 
 
13C NMR (CDCl3, 75 MHz) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OMe
Me Me
E-12
 264 
1H NMR (CDCl3, 300 MHz) 
 
13C NMR (CDCl3, 75 MHz) 
OMe
Me Me
I
88
 265 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
 
 
OMe
ClOC COCl
I
89
 266 
1H NMR (CDCl3, 300 MHz) 
 
 
 
13C NMR (CDCl3, 75 MHz) 
 
 
O
N N
O
I
OMe
i-Pr i-Pr86a
 267 
1H NMR (CDCl3, 300 MHz) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13C NMR (CDCl3, 75 MHz) 
 
 
OMe
Me Me
Br
90
 268 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
 
OMe
ClOC COCl
Br
91
 269 
1H NMR (CDCl3, 300 MHz) 
 
 
13C NMR (CDCl3, 75 MHz) 
 
 
O
N N
O
Br
OMe
Bn Bn86b
 270 
1H NMR (CDCl3, 300 MHz) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13C NMR (CDCl3, 75 MHz) 
 
 
MeO OMe
93
Br Br
 271 
1H NMR (CDCl3, 300 MHz) 
 
13C NMR (CDCl3, 75 MHz) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MeO OMe
Me Me
E–13
 272 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
 
 
 
 
 
 
 
 
Me Me
Br
MeO OMe
E–14
Br
 273 
1H NMR (CDCl3, 300 MHz) 
13C NMR (CDCl3, 75 MHz) 
 
Me Me
Br
MeO OMe
94
 274 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz)  
 
ClOC COCl
Br
MeO OMe
95
 275 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
92a
O
N N
O
Br
i-Pr i-Pr
MeO OMe
 276 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
Br Br
MeO OMe
OMe
E–15
 277 
1H NMR (CDCl3, 300 MHz)  
13C NMR (CDCl3, 75 MHz) 
Me Me
MeO OMe
OMe
E–16
 278 
1H NMR (CDCl3, 300 MHz) 
13C NMR (CDCl3, 75 MHz) 
 
Me Me
Br
MeO OMe
OMe
98
 279 
1H NMR (CDCl3, 300 MHz) 
 
 
13C NMR (CDCl3, 75 MHz) 
 
ClOC COCl
Br
MeO OMe
OMe
99
 280 
1H NMR (CDCl3, 300 MHz) 
 
13C NMR (CDCl3, 75 MHz) 
 
96a
O
N N
O
Br
i-Pr i-Pr
MeO OMe
OMe
 281 
1H NMR (CDCl3, 300 MHz) 
O
N N
O
Ni
i-Pr i-Pr
t-Bu
I
103  
 
 
 
 
 
 
 
 
 
 
 282 
1H NMR (CDCl3, 300 MHz) 
 
O
N N
O
Pd
i-Pr i-Pr
t-Bu
I
121  
 
 
 
 
  
 
 
 
 
 
 
 
 
 283 
1H NMR (CDCl3, 300 MHz) 
O
N N
O
Ph Ph
Pd
t-Bu
Br
122  
 
 
 
 
 
 284 
1H and 13C NMR Spectra of α-Bromoketones 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
139
O
Br
Et
 285 
 
1H NMR (CDCl3, 300 MHz)  
 
 
 
13C NMR (CDCl3, 75 MHz) 
 
140
O
Br
iPr
 286 
1H NMR (CDCl3, 300 MHz)  
 
 
 
13C NMR (CDCl3, 75 MHz) 
 
 
 
141
O
Br
Ph
 287 
1H NMR (CDCl3, 300 MHz)  
 
 
 
13C NMR (CDCl3, 75 MHz) 
 
 
 
 
142
O
Br
Cl
 288 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
 
143
O
Br
Cl
 289 
1H NMR (CDCl3, 300 MHz)  
 
 
 
 
13C NMR (CDCl3, 75 MHz) 
 
144
O
Br
Me
Me
 290 
1H NMR (CDCl3, 300 MHz) 
 
 
  
 
 
13C NMR (CDCl3, 75 MHz) 
 
 
145
O
Br
Me
MeO
 291 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
146
O
Br
Me
F3C
 292 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
147
O
Br
Me
F
 293 
1H NMR (CDCl3, 300 MHz)  
 
 
 
13C NMR (CDCl3, 75 MHz) 
 
 
148
O
Br
 294 
1H NMR (CDCl3, 300 MHz)  
 
 
 
13C NMR (CDCl3, 75 MHz) 
 
149
O
Br
Me
S
 295 
1H NMR (CDCl3, 300 MHz) 
 
 
 
13C NMR (CDCl3, 75 MHz) 
 
 
O
Ph
Me
138
 296 
1H and 13C NMR Spectra (α-Arylation) 
 
1H NMR (CDCl3, 300 MHz) 
E-17
O
NH HN
O
Br
t-Bu
ClCl
 
 
 
 
 
 
 
 
 
 297 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
152
t-Bu
Br NN
O O
 298 
1H NMR (CDCl3, 300 MHz) 
 
E-18
O
N HN
O
Br
t-Bu
Cl
Me MeMeMe  
 
 299 
1H NMR (CDCl3, 300 MHz) 
 
 
13C NMR (CDCl3, 75 MHz) 
 
153
t-Bu
Br NN
O O
MeMeMeMe
 300 
1H NMR (CDCl3, 300 MHz) 
E-19
O
N HN
O
Br
OMe
Cl
Me MeMeMe    
 
 
 
 
 
 
 
 
 301 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
OMe
Br NN
O O
MeMeMeMe
154
 302 
1H NMR (CDCl3, 300 MHz)  
  
13C NMR (CDCl3, 75 MHz) 
 
 
XVI
O
N N
O
Pd
t-Bu
Me Me Me MeBr
 XVI
 303 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
O
N N
O
Pd
OMe
Me Me Me MeBr
XVII
 304 
1H and 13C NMR Spectra 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
138
Ph
O
Me
 305 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
155
Ph
O
Me OMe
 306 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
156
Ph
O
Me
OMe
 307 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
157
Ph
O
Me
OMe
 308 
1H NMR (CDCl3, 300 MHz) 
 
 
13C NMR (CDCl3, 75 MHz) 
 
 
158
Ph
O
Me
Me
 309 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
159
Ph
O
Me
Me
 310 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
160
Ph
O
Me
F
 311 
1H NMR (CDCl3, 300 MHz) 
 
13C NMR (CDCl3, 75 MHz) 
 
 
161
Ph
O
Me
NMe2
 312 
1H NMR (CDCl3, 300 MHz) 
 
13C NMR (CDCl3, 75 MHz) 
 
162
Ph
O
Me
SMe
 313 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
 
163
Ph
O
Me
CF3
 314 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
O
Me
164
 315 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
 
165
O
Me
 316 
1H NMR (CDCl3, 300 MHz)  
 
 
13C NMR (CDCl3, 75 MHz) 
 
O
Me
CF3
CF3
166
 317 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
 
167
O
Ph
Et
 318 
1H NMR (CDCl3, 300 MHz) 
 
 
13C NMR (CDCl3, 75 MHz)  
 
168
O
Ph
i-Pr
 319 
1H NMR (CDCl3, 300 MHz)  
 
13C NMR (CDCl3, 75 MHz) 
 
 
169
O
Ph
Ph
 320 
1H NMR (CDCl3, 300 MHz) 
 
13C NMR (CDCl3, 75 MHz) 
 
 
170
O
Ph
Me
MeO
 321 
1H NMR (CDCl3, 300 MHz) 
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1H NMR (CDCl3, 300 MHz) 
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APPENDIX B 
X-RAY COLLECTION DATA 
 
Table B.1 Crystal and Intensity Collection Data for Nickel Complexes.
 101                      103                     104                       109
Chemica formula
Formula weight
Temperature (°K) !
Wavelength (Å) !
Crystal system !
Space group 
a (Å)
b (Å)
c (Å)
! (deg)
" (deg)
# (deg)
V (Å3)
Z!
$calc (mg• m
-3)
Absorp coeff!(mm-1) 
F(000)
Crystal size!(mm3)
Scan rage (deg)!
Index ranges!
Reflections collected!
No. of unique refins
R(int) 
Absorption correction
Max. and min. transmission
Data/restraints/parameters!
Goodness-of-fit on F2!
R1a,  wR2a [I>2%(I)]!
R1a, wR2a  (all data)
Largest diff. peak / hole! (e.Å-3)
C18H25ClN2NiO7
475.56
90(2) 
0.71073 
Orthorhombic
P2(1)2(1)2(1)
6.1341(6) 
11.6353(10)  
29.016(3) 
90
90
90
2070.9(3) 
4
1.525 
1.108 
992
0.26 x 0.12 x 0.12 
2.24 to 28.73
-8 & h & 8
-15 & k & 15
-39 & l & 38 
23472
4942 
0.0277
Semi-empirical 
0.8785, 0.7615
4942/48/314
1.041
0.0224, 0.0539
0.0243, 0.0546
0.341, -0.171
C24H19BrN2NiO2
506.03
110(2) 
1.54178 
Orthorhombic
P2(1)2(1)2
13.1670(9) 
5.8235(4) 
13.0951(8) 
90
90
90
1004.11(12) 
2
1.674
3.921
512
0.09 x 0.06 x 0.01 
3.37 to 59.98
-14 & h & 14
-6 & k & 6
-14 & l & 14
7380
1406
0.0339
Semi-empirical 
0.9961, 0.7192
1406/0/138
1.035
0.0196, 0.0474
0.0210, 0.0478
0.303, -0.175
C33H46.5I1.5N3Ni1.5O3
811.65
60(2) 
0.71073 
Monoclinic
P2(1)
5.901(3) 
32.739(19)  
18.306(10) 
90
95.54(9)
90
3520(3) 
4
1.532 
2.161
1644
0.50 x 0.10 x 0.10 
1.67 to 25.00
-7 & h & 7 
-38 & k & 38
-21 & l & 21
33048
12179
0.0575
Semi-empirical 
0.8129, 0.74113
12179/133/813
1.029
0.0413, 0.0761
0.0626, 0.0842
0.576, -0.480
C112H108Br4N8Ni4O8
2248.54
293(2) 
1.54178 
Orthorhombic
P2(1)2(1)2(1)
6.2679(8)
10.9501(13)  
35.488(5) 
90
90
90
2435.7(5) 
1
1.533
3.293 
1152
0.12 x 0.01 x 0.01 
4.23 to 59.98
-7 & h & 7
-12 & k & 11
-39 & l & 39 
17814
3349 
0.1626
Semi-empirical 
0.9678, 0.6856
3349/326/307
1.035
0.0720, 0.1645
0.0854, 0.1728
1.946, -0.939
n = number of reflections, p = parameters used.
a R1 = ['!!F o!-!Fc)/'!Fo!); wR2 = ['(w(Fo2-Fc2)2/'( wFo4)]1/ 2. S = ['(w(Fo2-Fc2)2]/(n-p)1/2 . 
 
 325 
Table B.2 Crystal and Intensity Collection Data for Palladium Complexes.
121                        123                     XVI
Chemica formula
Formula weight
Temperature (°K) !
Wavelength (Å) !
Crystal system !
Space group 
a (Å)
b (Å)
c (Å)
! (deg)
" (deg)
# (deg)
V (Å3)
Z!
$calc (mg• m
-3)
Absorp coeff!(mm-1) 
F(000)
Crystal size!(mm3)
Scan rage (deg)!
Index ranges!
Reflections collected!
No. of unique refins
R(int) 
Absorption correction
Max. and min. transmission
Data/restraints/parameters!
Goodness-of-fit on F2!
R1a,  wR2a [I>2%(I)]!
R1a, wR2a  (all data)
Largest diff. peak / hole! (e.Å-3)
C22H31IN2O2Pd
588.79
110(2) 
1.54184
Monoclinic
P2(1)
6.0186(12)
32.173(6)  
12.237(3)
90
94.131(9)
90
2363.3(8)  
4
1.655 
16.731
1168
0.20 x 0.02 x 0.02 
2.75 to 59.96
-6 & h & 6 
-35 & k & 36
-13 & l & 13
18046
6390
0.1589
Semi-empirical 
0.7308 , 0.1347
6390/601/505
1.015
0.0784, 0.1515
0.1307, 0.1759
1.477, -0.757
C30H31BrN2O2Pd
637.88
110(2) 
1.54178 
Orthorhombic
P2(1)2(1)2
6.6808(7) 
19.625(2)
20.422(2)
90
90
90
2677.6(5)
4
1.582
7.570 
1288
0.10 x 0.01 x 0.01 
4.33 to 59.99
-7 & h & 7
-22 & k & 22
-22 & l & 22
19307
3920
0.0846
Semi-empirical 
0.9281, 0.5182
3920/0/326
1.005
0.0453, 0.1079
0.0530, 0.1121
2.414, -0.529
C20H27BrN2O2Pd
513.75
110(2) 
1.54178 
Monoclinic
P2(1)/n
12.6447(12) 
21.628(2)
15.6494(15)
90
103.716(6)
90
4157.7(7)
8
1.641
9.576 
2060
0.26 x 0.12 x 0.01 
4.14 to 60.00
-14 & h & 14
-24 & k & 24
-17 & l & 17
74692
6004
0.0634
Semi-empirical 
0.9103, 0.1897
6004/18/514
1.004
0.0311, 0.0690
0.0364, 0.0707
1.114, -0.729
n = number of reflections, p = parameters used.
a R1 =  ['!!Fo!-!Fc)/'!Fo!); wR2 = ['(w(Fo2-Fc2)2/'( wFo4)]1/ 2. S = ['(w(Fo2-Fc2)2]/(n-p)1/2 . 
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Table B.3 Crystal and Intensity Collection Data for 80A and 31.
80A                                           31
Chemica formula
Formula weight
Temperature (°K) !
Wavelength (Å) !
Crystal system !
Space group 
a (Å)
b (Å)
c (Å)
! (deg)
" (deg)
# (deg)
V (Å3)
Z!
$calc (mg• m
-3)
Absorp coeff!(mm-1) 
F(000)
Crystal size!(mm3)
Scan rage (deg)!
Index ranges!
Reflections collected!
No. of unique refins
R(int) 
Absorption correction
Max. and min. transmission
Data/restraints/parameters!
Goodness-of-fit on F2!
R1a,  wR2a [I>2%(I)]!
R1a, wR2a  (all data)
Largest diff. peak / hole! (e.Å-3)
C22H31IN2O2
482.39
163(2) 
0.71073 
Monoclinic
P2(1)
9.478(6) 
21.389(13)
11.315(7)
90
95.246(8)
90
2677.6(5)
4
1.403
1.420 
!984
0.40 x 0.10 x 0.10 
1.81 to 25.00
-11 & h & 11
-25 & k & 25
-13 & l & 13
18541
7590
0.0729
Semi-empirical 
0.8711, 0.6006
7590/424/489
1.019
0.0461, 0.0862
0.0618, 0.0906
1.720, -0.719
C18H17IO3
408.22
110(2) 
0.71069 
Monoclinic
C2/c
20.654(10) 
7.358(4)
22.576(11)
90
98.350(6)
90
3395(3)
8
1.598
1.896
!1616
0.30 x 0.20 x 0.20 
13.92 to 25.00
-24 & h & 24
-8 & k & 8
-26 & l & 26
14935
2902
0.0278
Semi-empirical 
0.7030, 0.6001
2902/0/200
1.002
0.0405, 0.0797
0.0441, 0.0814
0.633, -1.213
n = number of reflections, p = parameters used.
a R1 =  ['!!F o!-!Fc)/'!Fo!); wR2 = ['(w(Fo2-Fc2)2/'( wFo4)]1/ 2. S = ['(w(Fo2-Fc2)2]/(n-p)1/2 . 
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